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II. Abstract 
 
In nearly all eukaryotic cells, genomic DNA is condensed into the cell nucleus through association 
with histones to form a nucleoprotein complex called chromatin. The structure of chromatin 
affects all DNA-dependent processes, in particular transcription, replication and DNA repair. 
Histone variants and histone post-translational modifications can alter the structure of chromatin, 
which in turn governs access of regulatory factors to the DNA. Presented in this thesis is an 
investigation, using X. laevis, to study the functions of histone variants and two potential histone 
modifying proteins, hnRNP AB and hnRNP D, in the early vertebrate embryo.  
 
Spatial and temporal mRNA expression analyses of the histone variants and hnRNPs were 
performed using wholemount in situ hybridisation (WISH), demonstrating various mRNA levels at 
differing points in the embryos. At the later stages of embryogenesis the majority of the 
transcripts were expressed in the anterior neural tissues, which correlated with cell proliferation. 
To investigate the roles of two recently identified isoforms of the histone variant H2A.Z and the 
two hnRNP proteins, loss of function studies were performed using morpholino oligonucleotides. 
Loss of both hnRNP AB and hnRNP D resulted in paralysis of the embryos. Phenotypic analysis of 
these morphant embryos revealed a decrease in the number of primary neurons, whilst hnRNP D 
morphants additionally lacked blood differentiation. Inhibition of H2A.Z2 expression likewise 
caused paralysis. In embryos lacking H2A.Z2 however, a significant increase in primary neurons 
was observed, although other developmental pathways were unaffected. This increase appeared 
to be caused by a down-regulation of Notch expression, which rescue experiments showed to be 
due to the specific loss of H2A.Z2. The loss of H2A.Z1 resulted in slowly developing embryos 
having morphological defects. Phenotypic analysis showed that the inhibition of H2A.Z1 caused 
problems in the development of many tissues. A down-regulation of Xbra in these H2A.Z1 
morphant embryos resulted in a decrease in mesoderm induction, shown by rescue experiments 
to be due to the specific loss of H2A.Z1. The effect on the control of Xbra was direct since 
signalling and transduction functioned normally and acetylated H2A.Z1 was seen at the Xbra 
promoter by ChIP experiments. 
 
The data presented here serve to further understanding of the gene regulatory roles of chromatin 
structure during development and shows that hnRNP AB, hnRNP D and the H2A.Z isoforms are 
crucial for normal embryogenesis. 
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1. Introduction 
 
Ever since Aristotle (384BC – 322BC), the first embryologist known to history, broke open 
fertilised chicken eggs and observed the transformation of a thin band of cells into a complete 
bird, the process of development has fascinated people (Aristotle, 1943). 
 
The fertilised egg, a single cell, is the origin of all multi-cellular organisms, from the smallest insect 
to the largest mammal. Between the stages of fertilisation and birth (or equivalent), the organism 
is known as an embryo. Between these two points of development, each animal undergoes 
embryogenesis. These developmental stages that occur after fertilisation are incredibly similar 
throughout the animal kingdom, and although embryonic types can be highly divergent, most 
patterns of embryogenesis are based on five fundamental processes; cleavage, gastrulation, 
organogenesis, metamorphosis and gametogenesis (Figure 1.1). Developmental biology is the 
study of these processes, the understanding of which is essential to understand all other areas of 
biology (Gilbert, 2006). 
 
1.1 Xenopus laevis as a Model of Development 
 
A number of different animals are used as model organisms for developmental studies and one of 
the most common is the South African clawed frog, Xenopus laevis. The advantages of this model 
organism are numerous and well documented since female X. laevis frogs were first used as 
human pregnancy tests during the early twentieth century. This use led to the discovery that 
female X. laevis can be induced to ovulate with a simple hormone injection, which led to their 
adoption as scientific models (Gurdon and Hopwood, 2000).  
 
The embryos produced by X. laevis are large and abundant, ensuring the availability of many 
embryos throughout the year. Furthermore, these embryos are robust and develop externally, 
making microinjection and surgical manipulations easier to perform. The rapid development of X. 
laevis embryos, together with the well defined developmental stages (Nieuwkoop and Faber, 
1967), makes them particularly useful for early vertebrate developmental studies, which has led 
to several fundamental discoveries in developmental and cell biology (Harland and Grainger, 
2011). 
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Figure 1.1 – Life cycle of the leopard frog, Rana pipiens. 
An example of one of the many types of life cycle found in the animal kingdom. Embryogenesis, 
the period from fertilisation to hatching, includes the processes of cleavage, gastrulation and 
organogenesis. After embryogenesis is complete, the larva then develops into a sexually mature 
adult through a process called metamorphosis. Gametogenesis, the process of gamete 
development, begins at fertilisation with the formation of the germ plasm (purple shading) and is 
completed in the adult frog (Gilbert, 2006).  
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X. laevis has two main disadvantages as a model organism. Firstly, it can take up to two years for 
these frogs to reach sexual maturity, and secondly, they have a pseudotetraploid genome 
(Hughes and Hughes, 1993). These factors make X. laevis unsuitable for genetic investigations. 
The closely related Xenopus tropicalis has more recently been used for genetic and genomic 
studies since these frogs have a diploid genome and reach sexual maturity after only four months. 
The disadvantage of these frogs is that their embryos are significantly smaller and more fragile 
than X. laevis (Harland and Grainger, 2011). 
 
Both X. laevis and X. tropicalis share similar developmental and cellular processes with higher 
vertebrates (Harland and Grainger, 2011). Also, since the publication of the X. tropicalis genome 
(Hellsten et al., 2010), a high level of conservation of genes and genomic organisation between 
this Xenopus species and mammals can be seen. Therefore, together with the experimental 
advantages of Xenopus, investigations into the development of this model organism can provide 
significant information in understanding development and disease in humans (Harland and 
Grainger, 2011). 
 
1.1.1 Early Development of X. laevis 
The development of a fully formed adult frog begins with the fertilised egg. In X. laevis, this egg is 
divided into two hemispheres, known as the animal hemisphere and the vegetal hemisphere. The 
lower, vegetal hemisphere contains the majority of the egg’s yolk and is used for yolk storage. The 
upper, animal hemisphere contains less yolk and contributes most to the final body. Fertilisation 
of this egg results in the activation of molecules that are required to initiate cell cleavage and 
begin the organism’s development (Gilbert, 2006). 
 
The process of cleavage involves a series of rapid cell divisions that are achieved by omitting the 
gap phases from each cell cycle (Figure 1.2A). During this process, the large volume of cytoplasm 
from the egg is divided into thousands of progressively smaller cells, called blastomeres. In X. 
laevis, the first cell division following fertilisation begins in the animal hemisphere. Since the yolk 
of the vegetal hemisphere delays cleavage, the second division begins before the first has 
finished. The third cell division of X. laevis development occurs horizontally but is displaced more 
towards the animal hemisphere. This results in the cells of the animal hemisphere dividing into 
smaller cells than those of the vegetal hemisphere. Towards the end of the cleavage stage, the 
embryo is known as a blastula and the blastocoel, a fluid filled cavity in the animal hemisphere, 
forms. 
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Figure 1.2 – Processes of early Xenopus laevis development. 
The process of cleavage involves a rapid series of cell divisions (A.). The first five cell divisions are 
indicated by the Roman numerals (I-V) in order of appearance. At the end of cleavage, the embryo 
develops into a blastula, with the formation of the blastocoel in the animal hemisphere. The 
blastocoel allows the cell movements that occur as part of the process of gastrulation (B.). The 
embryos are sectioned to allow visualisation of the internal cell movements. Gastrulation begins 
with the formation of the dorsal blastopore lip, which extends to form the blastopore. The 
mesoderm migrates into the blastopore, which internalises the endoderm, whilst the ectoderm 
surrounds the outside of the embryo. Neurulation begins at the end of gastrulation and involves 
the formation of the neural tube from the dorsal ectoderm (C.). The embryos are sectioned in two 
planes to allow visualisation of the internal cell movements and structures (Gilbert, 2006). 
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After the 12th cell division of the rapid cleavage stage, the point at which the cell cycles become 
slower and asynchronous is known as the mid-blastula transition (MBT) (Newport and Kirschner, 
1982). Up until this point, the development of the embryo is co-ordinated by stores of maternal 
molecules and only a small amount of zygotic gene transcription occurs (Tadros and Lipshitz, 
2005). The MBT however, marks the point in X. laevis development when the zygotic genome is 
activated and the blastomeres become motile for the first time (Newport and Kirschner, 1982). 
The timing of the MBT is thought to occur due to a decrease in the ratio of cytoplasm to nuclei, 
through the titration of maternal molecules into the increasing nuclear material, such as dNTPs 
(Newport and Kirschner, 1982). It has also been suggested that maternal histone proteins 
associate with the genome to inhibit transcription, and when the amount of DNA becomes too 
great, the histone protein is unable to bind to the entire genome and zygotic transcription is 
activated (Prioleau et al., 1994). More recently, this transcriptional repression has been linked to 
DNA methylation, since the methyl-CpG specific binding protein, xKaiso, is required for the 
transcriptional repression until the MBT (Ruzov et al., 2004). 
 
After the MBT, an extensive rearrangement of the blastomeres occurs, a process known as 
gastrulation (Figure 1.2B). At this stage of development the embryo is called a gastrula. In X. 
laevis, gastrulation begins with the formation of the dorsal blastopore lip, which then expands 
into a ring to form the blastopore. The cells destined to be the mesoderm migrate into the 
blastopore, whilst the larger vegetal cells that will become the endoderm are enveloped by the 
expanding cells of the animal hemisphere, which become the ectodermal cells. Therefore, at the 
end of gastrulation, the ectoderm is on the outside of the embryo, the mesoderm is in the middle 
and the endoderm is on the inside. 
 
After the organisation of the germ layers has been established, the process of neurulation occurs 
(Figure 1.2C). This process begins when the dorsal ectodermal cells are signalled to extend and 
fold into the embryo, forming the neural tube, which will ultimately form the nervous system. At 
this stage of development the embryo is known as a neurula. During and after the neurula stage, 
the process of organogenesis occurs, whereby the cells of the embryo begin to interact and 
migrate to form tissues and organs. The embryo continues to elongate into a tadpole and is said 
to be at the tailbud stage. At this stage of development, the tadpole hatches from its jelly coat 
and continues its growth. 
 
In order to become a sexually mature adult, the X. laevis tadpoles must first undergo 
metamorphosis, the transitional process where the larva develops into an adult. Once the adult 
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frog is fully grown, gametogenesis, the development of the gametes that started in the fertilised 
egg as germ plasm is also completed. 
 
The development of an adult X. laevis is achieved by the fertilised egg undergoing multiple 
divisions. The cells produced by this process go on to become specialised into the hundreds of 
different cell types found in each animal through a process of differentiation. With a small 
number of exceptions, each cell in an organism contains the same set of genes. Therefore, in 
order for the normal proliferation and differentiation of the egg into a fully functioning organism, 
cell type-specific genes must be regulated at precise points over the course of development 
(Gilbert, 2006).  
 
Control of this gene expression can occur at each step in the production of a gene product, 
including transcription, mRNA processing and translation. Gene expression is also regulated 
through the structure of DNA and the proteins that pack it, at the epigenetic level (Wolffe, 1998, 
Cockerill, 2011).  
 
1.2 Chromatin 
 
Epigenetics is most commonly defined as the study of heritable changes in gene expression that 
occur without changes in the DNA sequence. These changes are essential for normal cellular 
processes, and the differentiation and development of an organism. Furthermore, epigenetic 
changes play an important role in disease, especially in cancer development. Changes that occur 
at the epigenetic level include the covalent modification of DNA and the proteins associated with 
DNA (Bird, 2007). 
 
In humans, approximately 2m of genomic DNA is compacted into the nucleus of each cell, the 
average diameter of which is 10µm. This incredible compaction is achieved through the 
association of DNA with small, highly conserved proteins called histones. This association is the 
template for the nucleoprotein complex known as chromatin. The structure of chromatin varies 
throughout the cell cycle, affecting all processes involving DNA, such as transcription, replication, 
repair and recombination. Conformational changes in chromatin structure are crucial to the 
regulation and control of these processes since it determines the access and subsequent 
recruitment of transcription factors and other proteins to important DNA sequences (Wolffe, 
1998, Tremethick, 2006).   
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1.2.1 Structure and Function 
Chromatin is composed of histone and non-histone proteins bound to genomic DNA. This enables 
the DNA to be organised into increasingly compacted structures in order to be packaged into the 
nucleus (Figure 1.3). The basic repeating, structural unit of chromatin is the nucleosome. Each 
nucleosome is composed of a core histone octamer, around which approximately 146 base pairs 
of DNA is wrapped in 1.7 turns. Each nucleosome is connected to the next by variable lengths of 
linker DNA. Nucleosomal arrays form the first layer of DNA compaction, which is known as the 
‘beads on a string’ form of chromatin (Wolffe, 1998, Cockerill, 2011).  
 
Within each histone octamer there are two molecules of each of the four core histones; H2A, 
H2B, H3 and H4. The formation of the nucleosome occurs when a H3/H4 tetramer first binds to a 
region of DNA and these two histones are central to organising the nucleosome. Two H2A/H2B 
dimers are then recruited, which bind either side of the H3/H4 tetramer, and further organise the 
surrounding DNA into the nucleosome (Wolffe, 1998, Cockerill, 2011). In X. laevis, these core 
histones are stored in the oocyte in large quantities to facilitate the assembly of chromatin during 
the rapid cell divisions that occur as a part of cleavage (Adamson and Woodland, 1974). 
 
Core histone proteins are small, around 11-16kDa, and basic, and each contains a central 
conserved histone-fold domain that is essential for histone octamer formation. This core domain 
is flanked by unstructured N- and C-terminal tails that protrude outwards from each nucleosome 
(Arents and Moudrianakis, 1995). Since the core histones are involved in important protein-
protein interactions in the nucleosome, the length and sequence of these proteins are highly 
conserved throughout evolution. Whilst histones H2A and H2B are highly conserved compared to 
most other proteins, histones H3 and H4 are among the most highly conserved proteins 
throughout evolution (Thatcher and Gorovsky, 1994).  
 
Eukaryotic cells also contain a fifth histone protein, the linker histone, H1. Histone H1 is highly 
basic and is slightly larger than the core histones at around 20kDa. Unlike the core histones, the 
linker histone has a conserved globular domain, a relatively short N-terminal tail and a long C-
terminal tail (Graziano et al., 1990). These tail regions are both highly charged and show 
considerable divergence throughout evolution (Wolffe, 1997). 
 
 
 
 
9 
 
 
 
 
 
 
Figure 1.3 – The compaction of DNA into chromatin and chromosomes.  
The DNA is first wound twice around core histone octamers to form nucleosomes, the basic 
structural units of chromatin. Arrays of nucleosomes are known as the ‘beads on a string’ form of 
chromatin. With the linker histone bound, the nucleosomes are folded into a 30nm fibre. These 
fibres then form large loops and are compacted further into higher-order structures of chromatin 
and chromosomes (Felsenfeld and Groudine, 2003).  
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Histone H1 binds to the DNA at the point where it enters and exits the nucleosome. This 
association influences the organisation of the DNA wrapped around the histone octamer as well 
as the linker DNA, and therefore, stabilises the structure of the nucleosome. Although histone H1 
binds less tightly to the DNA than the core histones, it is important for the further compaction of 
chromatin and causes the ‘beads on a string’ form to associate into the 30nm fibre form of 
chromatin. This compaction is achieved through the inter-nucleosomal interactions of H1, though 
the precise structure of the 30nm fibre in vivo is still not fully understood (Wolffe, 1998, Happel 
and Doenecke, 2009). The 30nm chromatin fibre forms large loops, which are then anchored to 
the nuclear matrix and are condensed further into more complex structures to assemble the 
chromosomes (Wolffe, 1998, Belmont et al., 1999).  
 
Since histones are consistently moving in and out of nucleosomes, the structure of chromatin is 
not static. Large scale changes in chromatin structure morphology occur during the cell cycle, 
through decondensation and condensation of the chromosomes, which can positively or 
negatively regulate all processes within the nucleus, respectively. Furthermore, the structure of 
chromatin is altered throughout development, which has been observed in a number of model 
organisms. The substantial remodelling of chromatin from fertilisation through to the terminal 
differentiation of cells is a process that appears to be common to all animals. In X. laevis, the 
global changes in gene expression associated with each developmental process are driven by 
conformational changes in chromatin structure (Wolffe, 1998). 
 
The various structures that chromatin can adopt are commonly classed as either euchromatin or 
heterochromatin. Euchromatin generally exists in a decondensed, open conformation and is 
associated with genomic regions that contain transcriptionally active or poised genes. 
Heterochromatin, however, exists in a highly condensed, closed conformation and is associated 
with regions of the genome containing transcriptionally inactive genes (Wolffe, 1998, Cockerill, 
2011). Large arrays of repeating non-coding DNA (Lohe et al., 1993), centromeres and telomeres 
are also found in heterochromatic regions.  
 
The existence of euchromatin and heterochromatin is highly dynamic and conformational changes 
can be induced in the structure of chromatin through the reversible modification of chromosomal 
proteins, such as the post-translational modification of histone N-terminal tails or through the 
exchange of the canonical histones with sequence variants (Wolffe, 1998, Cockerill, 2011). 
Alterations in chromatin structure by both of these histone modification mechanisms have roles 
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in DNA replication and repair, transcriptional regulation and cell cycle progression (Quina et al., 
2006). 
 
1.3 Histone Variants 
 
Although histones are amongst the most conserved proteins in eukaryotes, functional 
homologues of these proteins exist in the form of histone variants, which possess differences in 
primary amino acid sequence compared to their canonical histone counterparts. Although the 
primary function of the canonical histones is to package the DNA into the cell nucleus, the histone 
variants have evolved for diverse functions, such as transcription activation or repression, DNA 
repair and chromosome segregation (Figure 1.4). These functions occur due to the sequence 
differences found in the variant histones, which alter the properties and structure of the 
nucleosomes containing these proteins, causing changes in chromatin structure (Wolffe, 1998, 
Ausio, 2006).  
 
In most organisms, the genes of canonical histones are present in multiple copies that are 
grouped together in intron-less clusters. These genes code for the majority of the histone proteins 
that are present in the cell and their expression is tightly coupled with DNA replication at S-phase 
of the cell cycle. Unlike the canonical histones, histone variants are encoded by genes that are 
only usually present in one or two copies throughout the genome, some of which contain introns, 
and are often expressed independently of replication (Wolffe, 1998, Kamakaka and Biggins, 2005).  
 
The primary structure of histone variants can vary dramatically from that of their major histone 
counterparts, or can vary in only a small number of amino acids (Malik and Henikoff, 2003). In the 
core histone variants, these amino acid changes often occur in the N-terminal tails without 
affecting the histone fold domain. Whilst, in the linker histone variants, the sequence changes are 
generally found in the N- and C-terminal tails, without altering the conserved globular domain 
(Kasinsky et al., 2001).  
 
Numerous sequence variants have been identified for linker histone, H1, and the core histone, 
H2A, whereas only a small number of histone variants have been identified for H3 and H2B. 
Histone H4 is the most highly conserved histone as well as being one of the slowest evolving 
proteins and no sequence variants of this histone have been identified to date (Kamakaka and 
Biggins, 2005).  
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Variant  Species  Chromatin Structure  Function  
H1o  Mouse  Closed  Transcription repression  
H5  Chicken  Closed  Transcription repression  
SpH1  Sea Urchin  Closed  Chromatin packaging  
H1t  Mouse  Open  Histone exchange, recombination  
Macro-H2A  Vertebrate  Closed  X-chromosome inactivation, 
Transcription repression  
H2A.Bbd  Mammals  Open  Transcription activation  
H2A.X  Ubiquitous  Closed  DNA repair/recombination, 
Transcription repression  
H2A.Z  Ubiquitous  Open/Closed  Transcription activation/repression, 
Chromosome Segregation  
SpH2B  Sea Urchin  Closed  Chromatin packaging  
CENPA  Ubiquitous   Kinetochore formation/function  
H3.3  Ubiquitous  Open  Transcription activation  
 
Figure 1.4 – A table of histone variants and their functions.  
A summary of some of the histone variants that occur in eukaryotes and their species distribution. 
The main functions of these proteins are listed, which more recent studies have investigated 
further (Kamakaka and Biggins, 2005).  
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It has been suggested that the reason for such a high degree of conservation of this protein is that 
histone H4 makes multiple interactions with the other three core histones and, therefore, plays 
an essential role in maintaining the structure of the core histone octamer (Pusarla and Bhargava, 
2005).  
 
1.3.1 Linker Histone Variants 
Many variants of histone H1 have been identified, which differ mainly in the length and charge of 
their C-terminal regions (Wolffe, 1997), although the number and primary structure of these 
variants varies between species (Khochbin and Wolffe, 1994).  
 
The expression of the histone H1 variants is conserved during embryonic development, in both 
plants and animals, including X. laevis (Khochbin and Wolffe, 1994) and mice (Franke et al., 1998). 
During early embryogenesis, the replacement of embryonic-specific H1 variants with somatic 
subtypes occurs. In later development, cell differentiation and loss of proliferation is associated 
with the replacement of somatic variants with differentiation-specific variants. Therefore, the 
linker histones can be grouped into three classes depending on when they are expressed; early 
development, normal somatic cells and differentiated cells (Khochbin and Wolffe, 1994). In 
mammals, eight linker histone variants have been identified in these three categories; an oocyte-
specific histone, H1oo (Tanaka et al., 2001), six somatic subtypes, H1.1-H1.5 and H1X (Parseghian 
et al., 1994, Happel et al., 2005), and a differentiation-dependent variant, H1o (Smith et al., 1980). 
In addition, spermatogenic-specific linker histone variants are also found in a number of species, 
such as H1t (Seyedin and Kistler, 1980), H1T2 (Martianov et al., 2005) and HILS1 (Yan et al., 2003) 
in mammals, H1s in sea urchins (Osipova et al., 1985), and H1B.Sp in X. laevis (Shechter et al., 
2009b). All of these linker histone variants, with the exception of H1.1-H1.5, are expressed 
independently of replication but are developmentally regulated (Khochbin, 2001). 
 
In vertebrates, histone H1 variants are synthesised in the oocyte to produce stores of histone 
protein that are used during early development (Khochbin and Wolffe, 1994). The oocyte-specific 
histone in X. laevis is B4 (Smith et al., 1988) and is H1oo in mice (Tanaka et al., 2001), which are 
both expressed in the early cell divisions of cleavage. Histone B4 is much less basic than the 
somatic H1 proteins (Dimitrov et al., 1993), suggesting that the nucleosomes containing this 
histone variant would be less stable (Wolffe, 1998). Therefore, these oocyte-specific or cleavage 
stage H1 variants have been suggested to be involved in allowing the quick successions of DNA 
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replication that enable the rapid cellular divisions that take place after fertilisation (Khochbin, 
2001). 
 
In X. laevis, a dramatic decrease in the amount of B4 protein occurs at the MBT and it completely 
disappears from the embryo by gastrulation (Cho and Wolffe, 1994). As B4 is disappearing, an 
increase in the somatic linker histones occurs (Khochbin and Wolffe, 1994). Three of these 
somatic linker variants have been identified in X. laevis; H1A, H1B and H1C, and their transcripts 
increase at the gastrula stage, when they become the predominant linker histones (Risley and 
Eckhardt, 1981). In eukaryotes, the expression of the H1 variants found in somatic cells occurs 
after early development is complete and is coupled to DNA replication during the S-phase of the 
cell cycle (Khochbin and Wolffe, 1994). 
 
During later embryonic development, as cell proliferation slows down and specific cell types 
differentiate, the differentiation-dependent linker histone variants are expressed (Khochbin and 
Wolffe, 1994). H1o is the primary differentiation-dependent H1 variant in eukaryotes (Khochbin, 
2001). In X. laevis, two linker histone variants, H1D and H1E, were identified as being similar to 
mammalian H1o (Risley and Eckhardt, 1981); they were later named H1o-1 and H1o-2 (Brocard et 
al., 1997). Immunohistochemical analysis of the X. laevis H1o variants, only found the proteins 
after stage 42 of embryogenesis, but they were localised in all adult cell types tested (Moorman 
and de Boer, 1985, Moorman et al., 1986). It has, therefore, been suggested that the H1o linker 
histone variants are involved in generating specific gene expression patterns during cell 
differentiation (Zlatanova and Doenecke, 1994).  
 
Many properties of these three types of linker histone variants are conserved throughout 
evolution, indicating an important role for these proteins (Kasinsky et al., 2001). Functional 
analysis however, has generated differing results in a number of model organisms. The first 
histone H1 knockouts were performed in Tetrahymena thermophila. Although these organisms 
had nuclei twice the size of the wild-types, the mutants were able to grow normally (Shen et al., 
1995). The overall levels of transcription were unaffected by the loss of H1, however, specific 
genes were either positively or negatively affected by its loss (Shen and Gorovsky, 1996). These 
observations were also made when each of the six chicken linker histone variants were knocked 
out in separate cell lines, since these cells grew normally but exhibited up-regulation or down-
regulation in the expression of specific genes, indicating individual, specific roles in transcription 
for each H1 variant (Takami et al., 2000). 
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In X. laevis, the somatic linker histone variant, H1A, was shown to be involved in the regulation of 
several developmentally expressed genes. The expression of H1A was knocked down using a 
ribozyme targeted to the H1A mRNA, which resulted in an activation of the oocyte-type 5S rRNA 
gene at gastrulation but had no effect on the somatic 5S rRNA genes (Kandolf, 1994). 
Furthermore, the loss of H1A was also shown to interfere with the timing of mesoderm 
differentiation at gastrulation (Steinbach et al., 1997). Knockout of H1o (Sirotkin et al., 1995) and 
H1.1 (Rabini et al., 2000) from mouse embryos showed that these linker histone variants are not 
essential for development. Furthermore, mice lacking the testis-specific H1t variant displayed 
normal spermatogenesis and were able to produce offspring (Lin et al., 2000). In each of these 
studies in mice, an up-regulation of the other linker histone variants was observed, which 
compensated for the knockouts (Sirotkin et al., 1995, Rabini et al., 2000, Lin et al., 2000).  
 
Despite the functional implications of the linker histone variants not being completely clear, these 
previous studies indicate that the structural variability of these proteins is biologically important, 
since the H1 variants are involved in the regulation of specific genes but not global levels of 
transcription. 
 
1.3.2 Histone H2A Variants 
The largest number of core histone variants have been identified for histone H2A, including the 
extensively studied H2A.X and H2A.Z (Redon et al., 2002), the vertebrate-specific macro-H2A 
isoforms, mH2A1 and mH2A2 (Pehrson et al., 1997), and the mammalian-specific H2A.Barr body-
deficient variant, H2A.Bbd (Chadwick and Willard, 2001); all of which have crucial roles in a 
number of nuclear processes (Ausio and Abbott, 2002). Sequence changes occur in both the N- 
and C-terminal regions of these H2A variants, though the majority of the alterations are in the 
length and sequence of the C-terminal tails (Ausio et al., 2001). These histone variants are all 
expressed throughout the cell cycle (Pusarla and Bhargava, 2005), unlike H2A.1 and H2A.2, which 
become the predominant H2A proteins and are only expressed during S-phase (Hurt et al., 1989, 
Fecker et al., 1990). 
 
H2A.X accounts for approximately 10-15% of the total H2A protein in animals and is evenly 
distributed in nucleosomes throughout the genome (Rogakou et al., 1999). In mammals, the 
sequence of this histone variant is nearly identical to the canonical H2A histones, H2A.1 and 
H2A.2, although H2A.X has an elongated C-terminal region (Redon et al., 2002). This histone H2A 
variant is required for genomic stability, since it is involved in the DNA damage response, where a 
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conserved serine residue in the C-terminal tail is phosphorylated in response to double-strand 
DNA breaks (Rogakou et al., 1999). This phosphorylation site is conserved throughout eukaryotes 
(Malik and Henikoff, 2003) and is required for recruiting proteins involved in DNA repair (Celeste 
et al., 2003). The phosphorylation of H2A.X is also required for DNA recombination (Mahadevaiah 
et al., 2001) and apoptosis (Rogakou et al., 1998).  
 
Along with H2A.X, H2A.Z is one of the most studied histone H2A variants and homologues of this 
histone variant are found throughout evolution (Thatcher and Gorovsky, 1994). Although the 
exact function of H2A.Z is still unclear, histone H2A.Z is one of the few histone variants that is 
required for survival. In Tetrahymena thermophila (Liu et al., 1996), Drosophila melanogaster (van 
Daal and Elgin, 1992), Xenopus laevis (Ridgway et al., 2004) and mice (Faast et al., 2001), H2A.Z 
has been shown to be indispensable for normal development. In X. laevis, the H2A.Z homologue 
was only found to be expressed after the MBT (Iouzalen et al., 1996).  
 
Approximately 5-10% of the total H2A protein is H2A.Z (Leach et al., 2000), and it has been shown 
that this histone variant is involved in transcriptional activation (Bruce et al., 2005) and repression 
(Guillemette et al., 2005). H2A.Z has also been suggested to play roles in a number of other 
nuclear processes.  H2A.Z has been suggested to be involved in heterochromatin organisation and 
chromosome segregation, since this H2A variant localises with the heterochromatic protein HP1α 
and defects in genomic stability are caused when H2A.Z is knocked out in mice (Rangasamy et al., 
2003, Rangasamy et al., 2004). Furthermore, in the absence of H2A.Z in yeast, delays in DNA 
replication and progression through the cell cycle were observed (Dhillon et al., 2006). An over-
expression of H2A.Z is also seen in a number of different tumours and has, therefore, been 
associated with the process of oncogenesis (Rhodes et al., 2004). The differences in the roles of 
histone H2A.Z could be attributed to the post-translational modifications of these variants and/or 
the existence of multiple H2A.Z subtypes (Ausio, 2006). Evidence for the latter explanation was 
recently discovered with the identification of two H2A.Z isoforms in vertebrates, H2A.Z1 and 
H2A.Z2 (Eirin-Lopez et al., 2009). Existence of both of these isoforms has been reported in a wide 
range of human tissues (Dryhurst et al., 2009) and also in chicken cells (Matsuda et al., 2010). In 
the human tissues, the expression of H2A.Z1 and H2A.Z2 varied depending on the tissue and 
developmental stage, though both were observed in similar regions of chromatin (Dryhurst et al., 
2009). Knockout of either H2A.Z isoform in chicken cells caused changes in cell growth and gene 
expression (Matsuda et al., 2010).  
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The macro-H2A isoforms, mH2A1 and mH2A2, are nearly three times larger than the other 
histone H2A variants at approximately 40kDa, since these histone variants have an extended C-
terminal region called the macro domain that comprises around two thirds of the proteins mass 
(Pehrson and Fried, 1992). The mH2A isoforms were identified as being almost exclusively present 
in the chromatin of the inactive X chromosome in female mammals (Costanzi and Pehrson, 1998) 
and, to date, these histone variants have only been identified in vertebrates (Malik and Henikoff, 
2003). The macro-H2A variants are likely to be involved in transcriptional repression, since it has 
been suggested that the large macro domain blocks access of transcription factors and other 
regulatory proteins to the DNA (Angelov et al., 2003). Both the mH2A1 and mH2A2 proteins were 
found at high levels in liver and kidney tissues from adults but were only present at low levels in 
these tissues from foetuses. Furthermore, both of these H2A variants were absent from mouse 
embryonic stem cells, however, their expression increased when differentiation was induced 
(Pehrson et al., 1997). Macro-H2A was shown to be a strong transcriptional repressor, since the 
macro domain of this histone variant was able to block the initiation of RNA polymerase II 
transcription and histone acetylation (Doyen et al., 2006). A recent study in zebrafish has found 
that mH2A1 and mH2A2 are involved in the repression of genes during differentiation and 
development (Buschbeck et al., 2009). 
 
Unlike the macro-H2A variant, H2A.Bbd was originally identified as being absent from the inactive 
X chromosome. This histone variant has a shortened C-terminal region and only shares 48% 
identity with the major H2A histone (Chadwick and Willard, 2001). Nucleosomes containing 
H2A.Bbd only organise approximately 118bp of DNA, and the interactions of both the histones 
and the DNA associated with the nucleosome are weakened, which is consistent with the 
proposed role of this histone variant in transcriptional activation (Bao et al., 2004). Furthermore, 
H2A.Bbd has also been found to be incorporated into nucleosomes that have acetylated histones, 
suggesting both these modifications act together to produce chromatin regions that are more 
open to transcription (Angelov et al., 2004).  
 
1.3.2.1 Developmental Studies on Two Histone H2A Variants in X. laevis 
Loss of function experiments have been performed in X. laevis on two separate histone H2A 
variants, H2A.Z (Ridgway et al., 2004) and H2A.X (Lee et al., 2010), both of which were shown to 
be essential for early development. 
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The expression of H2A.Z was inhibited using RNAi, which caused defects in embryos during 
gastrulation, where the blastopore failed to close leading to tadpoles with shortened trunks 
(Ridgway et al., 2004). Only 35% of injected embryos showed these defects however, which could 
have been due to the RNAi only reducing H2A.Z mRNA levels by 20-30% (Ridgway et al., 2004). 
The affect of the RNAi on endogenous protein levels was not investigated, therefore, the extent of 
the knock down cannot be known for certain (Eisen and Smith, 2008). Although two RNAi controls 
were used, these still caused defects in approximately 10% of embryos (Ridgway et al., 2004), 
which could be caused by the sequence independent effects of antisense RNA (Heasman, 2002). A 
level of specificity of the knock down was suggested by a rescue experiment, whereby the co-
injection of H2A.Z mRNA was able to reduce the affected embryos to around 15% (Ridgway et al., 
2004). This indicated that the reintroduction of this histone variant was able to restore normal 
development in half of the embryos affected by the knock down. 
 
The authors of this study showed that the over-expression of H2A.Z slowed the progression of 
gastrulation (Ridgway et al., 2004), which further implicated a role of this histone variant in this 
process of development. Using in situ hybridisation, the authors also found H2A.Z expression to 
be exclusive to the notochord and otic vesicle at the tailbud stage (Ridgway et al., 2004), even 
though a previous study had shown this histone variant to be expressed in the anterior tissues 
and tailbud using the same method (Iouzalen et al., 1996). Furthermore, the authors suggested 
that mesoderm formation was affected by the decrease in H2A.Z expression (Ridgway et al., 
2004); though no expression analysis was performed to confirm this. 
 
A more recent study into the developmental role of H2A.X in X. laevis had a much more thorough 
experimental design (Lee et al., 2010). This investigation first determined the temporal and spatial 
expression of H2A.X, using RT-PCR and in situ hybridisation, respectively, and found the H2A.X 
transcript was expressed throughout early development and localised to the tissues of the head in 
tadpoles (Lee et al., 2010). Since the expression of genes can give an indication of the tissues in 
which the encoded protein functions, the authors suggested that H2A.X could play a role in 
anterior neural development. This was confirmed through a loss of function analysis using 
morpholino oligonucleotides, which have been shown to be more efficient and less toxic than 
RNAi in X. laevis (Heasman, 2002). The knock down of H2A.X also caused a decrease in neural-
specific markers as determined by RT-PCR, which was further confirmed by using an animal cap 
assay (Lee et al., 2010).  
 
19 
 
The specificity of the H2A.X knock down was confirmed through experiments as set out by Eisen 
and Smith (Eisen and Smith, 2008), whereby a five base-mismatched control oligonucleotide was 
used to control for off-target effects, and the reintroduction of H2A.X mRNA was performed to 
rescue the normal phenotype. The knock down was only shown to inhibit exogenous H2A.X mRNA 
(Lee et al., 2010), therefore the affect on endogenous expression cannot be stated for certain. 
 
The authors of this investigation identified a novel phosphorylation site in the N-terminal tail of 
H2A.X, which was shown to be specifically phosphorylated by Chk1 using in vitro kinase assays on 
wild-type and mutant proteins (Lee et al., 2010). Although the phosphorylation of this threonine 
residue was shown to be important for the developmental function of H2A.X, since the mutant 
protein could not rescue the expression of neural markers in H2A.X knock down embryos (Lee et 
al., 2010), no explanation was given about how this histone variant affects neural development. 
Since α-H2A.X antibodies are commercially available (Lee et al., 2009), it would be possible to 
perform chromatin immunoprecipitation experiments to determine if this histone variant is 
located at the neural genes it affects. 
 
Together, these two studies show that histone H2A variants are crucial for vertebrate 
development. The numbers of developmental investigations on histone variants are still relatively 
low however. Therefore, more work is needed to characterise the roles of additional histone 
variants during early X. laevis development and, furthermore, to determine the separate 
functions of the two H2A.Z isoforms, H2A.Z1 and H2A.Z2. 
 
1.3.3 H2B and H3 Histone Variants 
In contrast to histones H1 and H2A, very few sequence variants have been identified for histone 
H2B, and those that have appear to posses specialised functions in male gamete development, in 
both animals (Churikov et al., 2004b) and plants (Ueda et al., 2000). Three testis-specific H2B 
variants have been identified in humans, TH2B (Shires et al., 1976), hTSH2B (Zalensky et al., 2002) 
and H2BFWT (Churikov et al., 2004a).  These H2B subtypes completely replace the canonical H2B 
histones and are involved in the condensation of chromatin, and therefore, repress transcription 
(Poccia and Green, 1992). Unlike the canonical H2B histone, the H2B variant identified in sea 
urchins has a long, highly charged N-terminal tail that is involved in interactions between 
nucleosomes, which has been proposed to cause chromatin compaction (Strickland et al., 1977).  
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Four somatic histone H3 variants have been identified in mammals; H3.1, H3.2, H3.3 and 
centromeric protein A (CENPA) (Ahmad and Henikoff, 2002, Malik and Henikoff, 2003). H3.1 and 
H3.2 differ by one amino acid (Franklin and Zweidler, 1977) and are only expressed during S-
phase, whereas H3.3 and CENPA are expressed independently of DNA replication (Wu et al., 
1982). During differentiation, the expression levels of H3.1 and H3.2 decrease and H3.3 becomes 
the major histone H3 protein (Urban and Zweidler, 1983). A testis-specific histone H3 variant, 
H3.4, has also been identified in mammals (Witt et al., 1996).  
 
The histone H3 variant, H3.3, predominantly differs at four positions; one residue in the N-
terminal tail and three in the histone-fold domain (Malik and Henikoff, 2003). Unlike the canonical 
H3, H3.3 is found in regions of open chromatin that contain actively transcribed genes and genes 
poised for transcription (Ahmad and Henikoff, 2002). During development, H3.3 has been shown 
to accumulate in certain tissues in humans and mice (Wu et al., 1982). In X. laevis, H3.3 was found 
to be expressed in the regenerating tails of tadpoles during cell proliferation (Tazaki et al., 2005). 
It has been suggested that H3.3 is involved in marking active genes for future transcription, since 
the presence of this histone variant inhibits the association of histone H1 (Braunschweig et al., 
2009). Recently, H3.3 was found to co-localise with the histone H2A variant, H2A.Z, in 
nucleosomes at the promoters of active genes, which were observed to be less stable than 
nucleosomes containing either of these histone variants separately. The authors of this study 
suggested that the instability of the double variant-containing nucleosomes facilitates the access 
of transcription factors to the DNA regulatory sequences in these regions (Jin et al., 2009). Histone 
H3.3 is also able to stabilise active gene expression after several mitotic divisions in X. laevis, 
indicating a further role of this H3 variant in epigenetic inheritance (Ng and Gurdon, 2008). H3.3 
also plays an important role in spermatogenesis (Lewis et al., 2003).  
 
As with H2A.Z, CENPA is essential for survival in mice (Howman et al., 2000). All known 
homologues of this histone H3 variant have a conserved C-terminal region and a highly divergent 
N-terminal tail, though both are essential for the function of CENPA (Chen et al., 2000). CENPA is a 
hallmark of centromeric DNA, where it replaces the canonical histone H3, and plays a crucial role 
in genomic stability (Palmer et al., 1987). The X. laevis homologue of CENPA is localised to 
centromeric DNA through a 174bp repeating sequence, which was identified in the majority of 
chromosomes examined (Edwards and Murray, 2005). Although CENPA is essential for 
kinetochore function (Oegema et al., 2001), it is not sufficient for kinetochore assembly (Van 
Hooser et al., 2001), and is only present at active centromeres (Warburton et al., 1997).  
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As with the canonical histones, the N-terminal tails of the histone variant proteins can also 
undergo post-translational modifications, which provide a further level of regulation on chromatin 
structure and gene expression (Ausio, 2006). 
 
1.4 Histone Acetylation 
 
Several residues within each of the histone N- and C-terminal tails can be covalently modified. 
Numerous post-translational modifications (PTMs) can occur at these histone tails, including 
methylation, phosphorylation, acetylation and ubiquitination (Figure 1.5). These modifications, 
usually in combination, generate a ‘histone code’ that directly alters the chromatin structure or 
mark regions of chromatin to be read by regulatory proteins (Strahl and Allis, 2000).  
 
Histone acetylation occurs at conserved lysine residues and, of the numerous post-translational 
modifications that can occur at histone tails, acetylation is one of the most studied. This 
modification was originally identified in 1964 (Allfrey et al., 1964), however, it wasn’t until over 
twenty years later that a direct link with transcriptional activation was established (Hebbes et al., 
1988). This transcriptional activation is thought to occur since acetylated histones alter the 
structure of chromatin, resulting in a more open conformation hypothesised through two 
mechanisms. 
 
The first hypothesis is that the acetyl groups neutralise the positive charges of the lysine residues, 
weakening the electrostatic interactions between histones and the negatively charged DNA, 
which would make the DNA more accessible (Davie and Chadee, 1998, Winter and Fischle, 2010). 
The other hypothesis is that histone acetylation acts as a docking site for downstream regulatory 
protein interactions, such as those containing the acetyl-lysine binding bromodomain, which then 
remodel the chromatin (Roth et al., 2001, Hargreaves et al., 2009). Although it is most likely that a 
combination of both of these two mechanisms occurs in vivo to alter the conformation of 
chromatin (Clayton et al., 2006). In X. laevis, histone acetylation is developmentally regulated. 
Histone H4 is present in the oocyte in its di-acetylated form, which causes the chromatin to be 
less stable to facilitate more efficient chromatin assembly during cleavage (Dimitrov et al., 1993). 
Proteins that catalyse the transfer of an acetyl group from acetyl-coenzyme A (AcCoA) to the 
lysine residues of histone tails are known as histone acetyltransferases (Roth et al., 2001).  
 
 
22 
 
 
 
 
Figure 1.5 – Core histone post-translational modifications. 
The identified post-translational modifications (PTMs), which occur at the amino acid residues 
indicated, include methylation, acetylation and phosphorylation (A.). These modifications occur at 
specific residues in the N-terminal tails of the core histones (B.). The PTMs are usually found in 
certain combinations; however, two or more modifications cannot occupy the same residue at the 
same time (Latham and Dent, 2007).  
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1.4.1 Histone Acetyltransferases 
Histone acetyltransferase (HAT) proteins provide a link between chromatin modifications and 
gene expression. Most HATs exhibit histone substrate and site specificity that are thought to give 
rise to the precise acetylation patterns involved in different nuclear processes (Brownell and Allis, 
1996). Since certain HAT proteins have different substrate preferences and functions, they can be 
divided into distinct families, which include the GNAT (Gcn5-related N-acetyltransferase) family 
that contain up to four conserved motifs, A, B, C and D; and the p300/CBP family that only contain 
motifs A, B and D (Marmorstein and Roth, 2001). Of particular interest is the highly conserved 
motif A, which contains the sequence, R/Q-X-X-G-X-G/A, and is required for the AcCoA recognition 
and binding that is essential for HAT activity (Figure 1.6) (Dutnall et al., 1998). Since acetylation is 
linked with gene activation, HAT proteins need to be targeted to specific regions of the genome. 
This is accomplished through their interaction with large protein complexes, which contain DNA-
binding proteins with sequence-specific recognition domains (Montminy, 1997). 
 
Although most HATs have ubiquitous expression patterns, certain HAT proteins appear to play 
specific roles during development (Roth et al., 2001). HAT activity has been determined to be 
essential for normal mammalian proliferation and development, since the knockout of p300 
causes mouse embryos to die early on in development through defects in neurulation, cell 
proliferation, and heart development (Yao et al., 1998). These defects are likely to occur as the 
changing gene expression patterns required for the rapid proliferation and differentiation seen in 
embryogenesis requires specific histone acetylation patterns for gene activation (Roth et al., 
2001). Since it has been established that HAT proteins are important for normal cell growth and 
differentiation, it is logical that mutations in HAT genes are associated with certain tumour types 
in humans (Davie et al., 1999).  
 
1.5 Heterogeneous Nuclear Ribonucleoproteins 
 
In experiments to identify novel HATs, two proteins were identified that bound to the 
transcriptionally active chicken β-globin gene with acetyltransferase activity towards histones H2A 
and H4 (Hebbes and Allen, 2000). Further experiments revealed that these two proteins were 
heterogeneous nuclear ribonucleoproteins, hnRNP AB and hnRNP D. These hnRNP proteins were 
originally identified as chromatin bound mRNA binding proteins involved in processing, protecting 
and transporting mRNA transcripts (Dreyfuss et al., 1993). 
 
24 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 – Histone acetyltransferase motifs.  
HAT proteins (e.g. Gcn5) can contain up to four conserved motifs; A, B, C and D. Motif A (R/Q-X-X-
G-X-G/A) is found in all HAT proteins and is required for the recognition and binding of acetyl 
coenzyme A (AcCoA). The glutamic acid (E) and cysteine (C) residues are involved in the catalysis 
of the acetyl group to the lysine residue of the histone tail (T. Hebbes, personal communication).  
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The X. laevis homologue of hnRNP AB was identified as 40LoVe, an hnRNP D-family protein 
(Czaplinski et al., 2005). A later study however, correctly classified hnRNP AB as part of the 
subgroup AB, of the hnRNP subfamily, AB-D, which contains vertebrate specific proteins (Kroll et 
al., 2009). HnRNP AB was found to bind specifically to the vegetal localisation element of Vg1 
mRNA and was able to localise this mRNA vegetally in oocytes. The authors of this study also 
identified the X. tropicalis homologue of hnRNP D, X-AUF, through sequence homology with 
hnRNP AB cDNA (Czaplinski et al., 2005). The X. laevis homologue of hnRNP D was cloned and 
found to bind cyclin B2 mRNA at the MBT (Guo et al., 2008). The expression of hnRNP AB was 
found at increasing levels over the course of oogenesis, and was found at varying levels in all adult 
tissues, with the highest expression in the brain and eye. Interestingly, a novel interaction was 
also found through immunoprecipitation from oocyte extract, which identified hnRNP D as a 
binding partner of hnRNP AB (Czaplinski and Mattaj, 2006). HnRNP AB was further found to have 
high affinity for mRNA but required other factors to increase binding specificity (Kroll et al., 2009).  
 
After further investigation of the hnRNP AB and hnRNP D protein sequences, a motif A and the 
catalytic residues required for functional HAT activity were found in the primary sequence of both 
these proteins, which are conserved throughout vertebrate evolution (Figure 1.7). Although 
hnRNPs were originally thought to be mRNA processing factors, these findings indicate additional 
functions. A literature search identified accumulating evidence for a role of these two subtypes in 
transcriptional regulation, potentially as histone acetyltransferases. 
 
1.5.1 HnRNP AB and hnRNP D in Transcription Regulation 
HnRNP D, also known as AUF1 (AU-rich RNA binding factor), is encoded by a single gene that is 
highly conserved throughout evolution, suggesting an important function (Wagner et al., 1998). 
The hnRNP D protein was thought to display little DNA sequence specificity; however, it has been 
shown to bind to specific regulatory response elements at the promoters of the CR2 (Tolnay et al., 
1999), KLF2 (Ahmad and Lingrel, 2005), and ENK (Dobi et al., 2006) genes. The binding affinity of 
hnRNP D for single stranded DNA was significantly higher than for double stranded DNA and, 
therefore, it has been suggested that this protein is involved in melting the double helical 
structure of DNA to facilitate transcription factor binding (Tolnay et al., 1999). Furthermore, the 
over-expression of hnRNP D stimulated gene expression through promoter binding, in a 
sequence-specific manner (Lau et al., 2000). The authors of these studies therefore suggested 
that hnRNP D plays a role in the transcriptional regulation of the genes investigated (Tolnay et al., 
1999, Lau et al., 2000, Ahmad and Lingrel, 2005, Dobi et al., 2006).  
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Figure 1.7 – Conserved HAT motifs in hnRNP AB and hnRNP D.  
Partial alignments of hnRNP AB (A.) and hnRNP D (B.) proteins reveal the important glutamic acid 
(E) and cysteine (C) residues (highlighted in red), and the motif A (highlighted in orange) required 
for HAT activity. These residues are conserved throughout vertebrate evolution, suggesting a 
conserved function. Dark shading indicates identical residues, light shading indicates similar 
residues. Hs – Homo sapiens (Human), Mm – Mus musculus (Mouse), Gg – Gallus gallus (Chicken) 
Xt – Xenopus tropicalis (Western clawed frog), Xl – Xenopus laevis (South African clawed frog), Dr 
– Danio rerio (Zebrafish) (T. Hebbes, personal communication).  
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Although the hnRNP D protein is ubiquitously expressed, its primary structure contains several 
potential post-translational modifications sites, which could be involved in regulating the different 
functions of this protein (Zhang et al., 1993). It has since been discovered that hnRNP D contains a 
transactivator domain and a DNA-binding domain (Tolnay et al., 2000), the former being either 
positively or negatively regulated by the phosphorylation of two different serine residues (Tolnay 
et al., 2002). Recently, it was found that hnRNP D is able to recruit chromatin modifiers to specific 
DNA sequences in order to facilitate gene expression in rat neurones. It has, therefore, been 
suggested that hnRNP D is involved in the integration of genetic and epigenetic signals during 
development (Lee et al., 2008). 
 
Less work has been published regarding the functions of hnRNP AB, also known as CBF-A (CArG 
box-binding factor A), in transcriptional regulation but the evidence that has been published 
indicates that this protein can influence gene expression through promoter binding (Bemark et al., 
1998, Leverrier et al., 2000, Mikheev et al., 2000). The hnRNP D and hnRNP AB proteins display a 
high degree of sequence similarity and it has also been suggested that hnRNP AB plays an 
important role in transcriptional regulation (Tolnay et al., 2000). The hnRNP AB protein is able to 
bind to double-stranded DNA at the response elements of the Ha-ras (Mikheev et al., 2000) and 
immunoglobulin kappa (Aranburu et al., 2006) promoters, and to single-stranded DNA at the 
control elements of the SP6 (Bemark et al., 1998) and spi2 (Leverrier et al., 2000) promoters. 
Furthermore, hnRNP AB has been shown to be essential, but not sufficient, for the transcriptional 
activation of spi2 (Leverrier et al., 2000) and Ha-ras (Mikheev et al., 2000). In contradiction, the 
association of hnRNP AB with promoter regions has also been shown to repress transcription (Gao 
et al., 2004, Zhao et al., 2008). Evidence for a potential role of hnRNP AB as a HAT comes from the 
findings that hnRNP AB forms part of a nuclear multiprotein complex that interacts with free core 
histones in the nucleoplasm, which may be related to post-translational modifications (Covelo et 
al., 2006). 
 
Other hnRNP proteins, such as hnRNP G (Takemoto et al., 2007), hnRNP C (Mahajan et al., 2005) 
and hnRNP K (Michelotti et al., 1996, Ostrowski et al., 2003, Lynch et al., 2005), also function as 
transcription factors. HnRNP C is part of a chromatin remodelling complex and is essential for 
transcription (Mahajan et al., 2005), whereas the transcriptional regulation activity of hnRNP K is 
regulated by PTMs (Chen et al., 2008). Both hnRNP G and hnRNP K also contain a motif A. 
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1.6 Aims 
 
The structure of chromatin provides a fundamental control mechanism for the regulation of all 
nuclear processes involving DNA, including transcription. Histone variants and post-translational 
modifications provide two different methods of altering the structure of chromatin in order to 
determine access of transcription factors, therefore, regulating gene expression (Wolffe, 1998, 
Cockerill, 2011). 
 
Although work on histone variants in X. laevis has previously been performed, the majority of 
these studies were concerned with identifying the sequence variants and elucidating their mRNA 
and protein expression patterns through Northern blot and immunohistochemical analysis, 
respectively (Moorman et al., 1986, Smith et al., 1988). Other studies have shown that histone 
variants in various organisms are important for normal development, for example mH2A1 and 
mH2A2 in zebrafish (Buschbeck et al., 2009) and H2A.X in X. laevis (Lee et al., 2010).  
 
Since the majority of histone variants are known to alter chromatin structure and, therefore, 
potentially influence transcriptional regulation (Kamakaka and Biggins, 2005, Ausio, 2006), 
studying which genes are affected by these variants during early X. laevis development would 
further the understanding of the roles of chromatin structure on gene expression and, ultimately, 
the mechanisms that drive normal development of the organism. 
 
Both hnRNP AB and hnRNP D proteins have been implicated in transcriptional regulation (Covelo 
et al., 2006, Lee et al., 2008), possibly through histone acetyltransferase activity (Hebbes and 
Allen, 2000). Since the small numbers of studies on these two proteins in X. laevis have 
concentrated on their roles in very early development, characterising these proteins during X. 
laevis embryogenesis could provide further insight into the roles of these proteins in gene 
regulation, as well as in development.  
 
This project will help to understand gene regulation through modulation of chromatin structure in 
vertebrates. In particular, it will add to the understanding of how specific histone variants affect 
gene expression at specific loci during early Xenopus laevis development, and it will further serve 
to characterise the developmental roles of hnRNP AB and hnRNP D. The work presented here 
sought to achieve these aims by: 
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 Using bioinformatics to identify any remaining histone variants in X. laevis that have not 
previously been reported in the literature. 
 Amplify unique regions of mRNA from all of the identified histone variants, and hnRNP AB 
and hnRNP D by RT-PCR, and generate antisense RNA probes. 
 Using these probes, determine the mRNA expression patterns of the histone variants and 
hnRNPs through wholemount in situ hybridisation. 
 Knockdown the expression of specific histone variants and both hnRNPs with morpholino 
oligonucleotides, and analyse the phenotypes observed. 
 Identify important developmental genes that are regulated, in part, by histone variants in 
order to further understand gene expression at the chromatin level, and by hnRNP AB and 
hnRNP D to determine their roles during development. 
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2. Materials and Methods 
 
2.1 Suppliers 
All chemicals and reagents were acquired from BioRad, Fisher Scientific, Flowgen, GE Healthcare, 
Greiner, Invitrogen, Macherey-Nagel, National Diagnostics, Promega, Qiagen, Roche and Sigma-
Aldrich, unless otherwise stated. Restriction endonucleases were obtained from New England 
Biolabs (NEB), oligonucleotide primers from Invitrogen, dual-labelled TaqMan probes from MWG 
Operon and morpholino oligonucleotides from Gene Tools LLC. Protease inhibitor cocktail tablets 
were from Roche. 
 
2.2 Solutions 
 
Alkaline Phosphatase (AP) Buffer: 0.1M Tris-HCl (pH9.0), 50mM MgCl2, 0.1M NaCl, 0.1% Tween-
20 
 
β-Gal Staining Buffer: 1x PBS, 2mM MgCl2, 0.01% Sodium Deoxycholate, 0.02% NP40, 30mM 
Potassium Ferricyanide, 30mM Potassium Ferrocyanide 
 
β-Gal Wash Buffer: 1x PBS, 2mM MgCl2, 0.01% Sodium Deoxycholate, 0.02% NP40 
 
Bleaching Solution: 5% Formamide, 0.5x SSC, 10% H2O2 
 
Buffer B: 1.5M Tris-HCl (pH8.8), 0.6% SDS 
 
Buffer C: 0.5M Tris-HCl (pH6.8), 0.4% SDS 
 
Blunt-ended Ligation Buffer (10x): 250mM Tris-HCl (pH7.5), 50mM MgCl2, 5mM DTT, 25% 
Polyethylene Glycol-8000 
 
Cell/Nuclei Lysis (C/N) Buffer: 10mM Tris-HCl (pH8.0), 10mM NaCl, 0.5% NP40, 10mM EDTA, 
Protease Inhibitor Cocktail tablet (1 in 10ml) 
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ChIP Buffer 1: 50mM Tris-HCl (pH8.0), 100mM NaCl, 2mM EDTA, 1mM DTT, 1% NP40, 0.1% 
Sodium Deoxycholate, Protease Inhibitor Cocktail tablet (1 in 10ml) 
 
ChIP Buffer 2: 50mM Tris-HCl (pH8.0), 500mM NaCl, 2mM EDTA, 1mM DTT, 1% NP40, 0.1% 
Sodium Deoxycholate, Protease Inhibitor Cocktail tablet (1 in 10ml) 
 
ChIP Buffer 3: 50mM Tris-HCl (pH8.0), 100mM NaCl, 2mM EDTA, 1mM DTT, 1% NP40, 250mM 
LiCl, 0.1% Sodium Deoxycholate, Protease Inhibitor Cocktail tablet (1 in 10ml) 
 
ChIP Elution Buffer: 0.1M NaHCO3 (pH8.8), 1% SDS 
 
Denhardt’s Solution: 0.02% BSA, 2% PVP-20, 2% Ficoll-400 
 
ECL Solution I: 100mM Tris-HCl (pH8.0), 1.1mM Luminol, 0.9mM p-Coumaric Acid 
 
ECL Solution II: 100mM Tris-HCl (pH8.0), 0.06% Hydrogen Peroxide 
 
Hybridisation Mix: 50% Formamide, 5x SSC, 1mg/ml tRNA (from E. coli MRE600), 100µg/ml 
Heparin, 1x Denhart’s Solution, 0.1% Tween-20, 5mM EDTA 
 
IP Buffer: 50mM Tris-HCl (pH8.0), 100mM NaCl, 2mM EDTA, 1mM DTT, 1% NP40, Protease 
Inhibitor Cocktail tablet (1 in 10ml) 
 
LB Agar (Miller): 1% Tryptone, 0.5% Yeast Extract, 1% NaCl, 1.5% Agar 
 
LB Broth (Miller): 1% Tryptone, 0.5% Yeast Extract, 1% NaCl 
 
Maleic Acid Buffer (MAB): 100mM Maleic Acid, 150mM NaCl (pH7.5) 
 
MEMFA: 0.1M MOPS (pH7.4), 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde 
 
Modified Barth’s Saline (1x MBS): 88mM NaCl (pH7.6), 10mM HEPES, 1mM KCl, 1mM MgSO4, 
2.5mM NaHCO3, 0.82mM MgSO4.7H2O, 0.33mM Ca(NO3)2.2H2O, 0.41mM CaCl2.6H2O, 100 
units/ml Penicillin, 100µg/ml Streptomycin Sulphate 
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Murray’s Clear: 1 volume Benzyl Alcohol, 2 volumes Benzyl Benzoate 
 
NETS Buffer: 300mM NaCl, 1mM EDTA, 20mM Tris-HCl (pH 7.6), 1% SDS 
 
Orange G Loading Buffer (6x): 0.25% Orange G, 15% Ficoll-400 
 
Phosphate Buffered Saline (PBS): 10mM Phosphate Buffer, 2.7mM KCl, 137mM NaCl (pH 7.4) 
 
PBSTw: 1x PBS, 0.1% Tween-20 
 
PBT: 1x PBS, 0.1% Triton X-100, 2mg/ml BSA 
 
Saline-Sodium Citrate (SSC) Buffer (20x): 3M NaCl, 300mM Trisodium Citrate (pH7.0) 
 
SDS-PAGE Loading Buffer (3x): 150mM Tris-HCl (pH6.8), 300mM DTT, 6% SDS, 30% Glycerol, 0.3% 
Bromophenol Blue 
 
SDS-PAGE Running Buffer (10x): 250mM Tris-HCl (pH8.3), 2M Glycine, 1% SDS 
 
Sonication Buffer: 20mM Tris-HCl (pH8.0), 70mM KCl, 1mM EDTA, 10% Glycerol, 5mM DTT, 
0.125% NP40, Protease Inhibitor Cocktail tablet (1 in 10ml) 
 
TBE (10x): 1.1M Tris-HCl (pH8.0), 0.9M Borate, 25mM EDTA 
 
TBSTw (10x): 100mM Tris-HCl (pH8.0), 1.5M NaCl, 10% Tween-20 
 
TE Buffer: 10mM Tris-HCl (pH7.5), 1mM EDTA 
 
TES Buffer: 50mM Tris-HCl (pH8.0), 10mM EDTA, 1% SDS 
 
Transfer Buffer: 20mM Tris-HCl (pH7.5), 150mM Glycine, 20% Methanol, 0.1% SDS 
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2.3 Molecular Biology Techniques 
 
2.3.1 Agarose Gel Electrophoresis 
Depending on the size of DNA or RNA to be resolved, an agarose solution of 1-2% (w/v) was 
prepared in 1x TBE buffer. The agarose powder was dissolved by heating the solution in a 
microwave. The gel was allowed to cool to touch before ethidium bromide was added to a final 
concentration of 0.5µg/ml. The gel was poured into the casting plate and allowed to solidify at 
room temperature. The tank was filled with 1x TBE. 0.2 volumes of 6x Orange G loading buffer 
was added to each sample, which was loaded into each well. Each gel also separated a 1kb Plus 
DNA Ladder (Invitrogen). Gels were run between 80V and 120V until the Orange G was 
approximately 2/3 of the way down. The samples were visualised on a G.Box transilluminator 
system (SynGene) and images captured with GeneSnap software (SynGene). 
 
2.3.2 Reverse Transcription using SuperScript II 
To synthesise cDNA from purified mRNA, a reverse transcription reaction was prepared containing 
1x First Strand buffer (Invitrogen), 10mM DTT, 1mM dNTP mix (New England Biolabs), 40 units 
RNaseOUT recombinant RNase inhibitor (Invitrogen), 10mM pd(N)6 Random Hexamer primers (GE 
Healthcare), 1ng-5µg total RNA, 600 units SuperScript II reverse transcriptase (Invitrogen) and 
made up to 25µl with nuclease-free water. A negative control reaction was set up replacing the 
reverse transcriptase with nuclease-free water, and both reactions were incubated at 55oC for 45 
minutes. This cDNA was either used immediately or stored at -70oC for future use. 
 
2.3.3 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
PCR reactions were set up in 0.2ml tubes containing 1x PCR buffer + MgCl2 (Roche), 200µM dNTP 
mix (NEB), 1µM forward/reverse primer, 1 unit Taq DNA polymerase (NEB), 2µl cDNA/negative 
control (see 2.3.2) and nuclease-free water up to 25µl. For problematic PCR reactions, 13µl 
Platinum HiFi Supermix (Invitrogen), 1µM forward/reverse primer and 1µl cDNA/negative control 
(see 2.3.2) were used. The tubes were placed in a thermal cycler, under the following conditions: 
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94oC  3 minutes 
94oC  0.5-1 minute 
50-68oC 0.5-1 minute  x35 cycles 
72oC  0.5-1 minute 
72oC  5 minutes 
 
PCR products were analysed on an agarose gel (see 2.3.1) to ensure correct amplification. 
 
2.3.4 PCR-based Site Directed Mutagenesis 
For the targeted mutation of a base using PCR, two pairs of oligonucleotide primers were used; 
the first pair were complementary to the 5’ (forward primer) and 3’ (reverse primer) ends of the 
coding sequence to be mutated. The second pair were complementary to the – (mutation forward 
primer) and + (mutation reverse primer) strands at the mutation target site and contained the 
base change necessary for the mutation. Two reactions were set up for the first PCR (see 2.3.3), 
using the forward and mutation reverse primers, and the mutation forward and reverse primers 
to amplify the upstream and downstream fragments, respectively. The products of each reaction 
were run on an agarose gel (see 2.3.1) to check if the correct size fragments had been amplified 
before being gel purified (see 2.3.9) and the concentrations estimated using a small volume 
spectrophotometer. To anneal the two fragments, 100ng of combined upstream and downstream 
fragments at eqimolar concentrations were combined with 2.5 units of Taq DNA polymerase 
(NEB), 1x Taq buffer (NEB) and 2mM dNTPs (NEB), and the reaction made up to 50µl using 
nuclease-free water. For the second stage PCR, this reaction was put in a thermal cycler under the 
following conditions: 
 
94oC 3 minutes 
94oC 2.5 minutes 
65oC 45 minutes  x10 cycles 
72oC 45 minutes 
72oC 5 minutes 
 
The third stage PCR was performed as a standard PCR, using 10µl of the second stage reaction, 
and the forward and reverse primers to amplify the full length sequence containing the mutated 
base. The product of this reaction was run on an agarose gel to check that the correct size 
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sequence was amplified before being gel purified and ligated into the pGEM-T Easy vector (see 
2.3.5) and the mutation was then confirmed by sequencing. 
 
2.3.5 Ligation into pGEM-T Easy 
DNA sequences amplified using Taq DNA polymerase were T-A cloned into pGEM-T Easy using the 
pGEM-T East Vector System (Promega) according to the manufacturer’s protocol.  
 
2.3.6 Transformation of DNA into Chemically Competent E. coli 
A ligation reaction or 500ng of plasmid DNA was added to 50µl of chemically competent DH5α E. 
coli cells, gently mixed and incubated on ice for 30 minutes. The cells were then heat-shocked at 
42oC for 45 seconds and incubated on ice for a further 2 minutes, before LB broth without 
selection was added up to 500µl and the suspension was incubated at 37oC for 1 hour. After this 
incubation, 100µl of the suspension was plated onto LB agar containing the appropriate selection 
and incubated for a 16 hours at 37oC. 
 
2.3.7 Plasmid Purification 
To purify plasmid DNA from bacterial cultures, depending on the yield required, either a 
NucleoSpin Plasmid QuickPure kit (average yield - 15µg) or a NucleoBond Plasmid Midi kit 
(average yield - 250µg) were used. Plasmids were purified according to the manufacturer’s 
(Macherey-Nagel) instructions. 
 
2.3.8 Restriction Digests 
Restriction digests were performed according to the manufacturer’s (NEB) instructions, using the 
correct buffer and, if required, supplemented with 100µg/ml BSA. Small-scale digests were 
incubated at the indicated temperature for 1-2 hours, and large-scale digests were incubated 
overnight. 
 
2.3.9 Gel Extraction of DNA 
To purify excised DNA fragments after restriction digest (see 2.3.8), the DNA was resolved on a 1% 
agarose gel (see 2.3.1). A long wave UV transilluminator was used to visualise the DNA, to avoid 
damage, and the correct band was cut out of the gel using a clean scalpel. The DNA was then 
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purified from the gel using a QIAquick Gel Extraction kit (Qiagen), following the manufacturer’s 
instructions. 
 
2.3.10 Phenol/Chloroform Extraction  
If the sample was less than 400µl, nuclease-free water was used to make it up to this volume to 
make handling the volumes easier. An equal volume of phenol/chlororform/isoamyl alcohol 
(25:24:1) was added to the sample, voretexed for 30 seconds and centrifuged at 16000 xg for 5 
minutes. The upper aqueous phase was transferred to a clean 1.5ml tube, without disturbing the 
interface, and an equal volume of chloroform was added to remove residual phenol. The sample 
was vortexed again for 30 seconds and centrifuged at 16000 xg for 5 minutes, after which the 
upper aqueous phase was transferred to a clean 1.5ml tube. The nucleic acid was then 
precipitated using ethanol (see 2.3.11). 
 
2.3.11 Ethanol Precipitation of RNA/DNA 
To precipitate nucleic acids, 2 volumes of absolute ethanol and 0.1 volumes of 3M sodium acetate 
were added to the sample, which was mixed and incubated at -20oC for at least 30 minutes. The 
nucleic acid was then pelleted by centrifugation at 16000 xg for 15 minutes at 4oC. The 
supernatant was discarded and the pellet was washed by adding 500µl 70% ethanol and spinning 
at 16000 xg for 5 minutes at 4oC. The supernatant was carefully removed and the pellet was 
allowed to dry at room temperature before being resuspended in an appropriate amount of 
nuclease-free water or TE. 
 
2.3.12 Antarctic Phosphatase Treatment of Digested Plasmid 
To prevent re-circularisation of plasmids, the phosphate groups from the 5’ ends of the DNA were 
removed. To the completed digest reaction, 1x Antarctic Phosphatase Buffer (NEB) and 1 unit of 
Antarctic Phosphatase (NEB) were added and the solution was incubated at 37oC for 30 minutes. 
The reaction was then incubated at 65oC for 5 minutes to inactivate the enzyme. 
 
2.3.13 Complimentary-ended Ligation 
DNA fragments, with complementary ends to the vector, were ligated into the destination 
plasmid in a 15µl reaction containing 1x T4 DNA Ligase Buffer (NEB), 400U of T4 DNA Ligase (NEB) 
and an approximate 3:1 molar ratio of fragment to vector DNA. The reactions were incubated at 
room temperature for 4 hours or at 4oC overnight. 
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2.3.14 Blunt-ended Ligation 
DNA fragments with blunt-ends were ligated into the destination plasmid in a 15µl reaction, 
containing 1x Blunt-ended Ligase Buffer, 3mM ATP (Roche), 400U T4 DNA Ligase (NEB) and an 
approximate 9:1 molar ratio of fragment to vector DNA. The reactions were incubated at room 
temperature for 4 hours. 
 
2.3.15 Preparation of DNA for in vitro Transcription 
For efficient transcription to take place, the plasmid containing the sequence to be transcribed 
was linearised to prevent the RNA polymerase transcribing the plasmid DNA. 10µg of plasmid was 
digested with the appropriate restriction enzyme in a 50µl reaction according to the 
manufacturer’s instructions. The linearised template was purified by phenol/chloroform 
extraction (see 2.3.10) and ethanol precipitation (see 2.3.11), resuspended in 10µl of nuclease 
free water and stored at -20oC. 
 
2.3.16 Transcription of DIG-Labelled RNA Probes 
The template cDNA was first prepared for in vitro transcription (see 2.3.15). To synthesise the 
RNA probe, a reaction was set up at room temperature containing 1µg linearised template, 1x 
transcription buffer (Roche), 1x DIG-11-UTP labelling mix (Roche), 40U RNaseOUT (Invitrogen), 
40U T3/T7/SP6 RNA polymerase and made up to 20µl with nuclease-free water. This reaction was 
incubated at 37oC for 2 hours, after which, a 1µl sample was taken to run on an agarose gel to 
check that the transcript had been synthesised. To remove the cDNA template, 1x DNaseI Buffer 
(Roche) and 5U RNase-free DNase I (Roche) were added to the reaction and the solution 
incubated at 37oC for 30 minutes. To purify the probe, the reaction was centrifuged through an 
illustra MicroSpin G-50 column (GE Healthcare), the concentration was estimated using a small 
volume spectrophotometer and the probe was then stored at -70oC. 
 
2.3.17 In vitro Transcription of Synthetic mRNA 
The plasmid template was first prepared for in vitro transcription (see 2.3.15). To synthesise the 
synthetic mRNA, a reaction was prepared at room temperature as follows; 2µg linearised 
template, 1x transcription buffer (Roche), 10mM DTT, 80U RNase OUT (Invitrogen), 2.5mM ATP, 
CTP and UTP (Roche), 0.5mM GTP (Roche), 2mM m7G(5’)ppp(5’)G RNA cap analog (NEB), 80U 
T3/SP6 RNA polymerase and made up to 50µl with nuclease-free water. This reaction was then 
incubated at 37oC for 2 hours, after which, a 1µl sample was taken to run on an agarose gel to 
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check that the mRNA had been synthesised. To remove the plasmid template, 1x DNaseI Buffer 
(Roche) and 5U RNase-free DNase I (Roche) were added to the reaction and it was incubated at 
37oC for 30 minutes. To purify the transcript, the reaction was purified through an illustra 
MicroSpin G-25 column (GE Healthcare). The concentration was estimated using a small volume 
spectrophotometer and the mRNA was then stored at -70oC in small aliquots. 
 
2.3.18 Primer and Probe Design for Quantitative RT-PCR 
Primers and probes to be used in quantitative RT-PCR experiments were designed according to 
Applied Biosciences’ guidelines. Primers were designed to be 15-30 bases in length, with 30-80% 
GC content, and no more than two C or G bases in the last five bases at the 3’ end of each primer. 
The primers were also designed so that the melting temperatures (Tm) were between 58oC and 
60oC, with less than 2oC difference between any primer pair, and to produce amplicons of 50-
150bp. Probes were designed to be 15-30 bases in length, with 30-80% GC content, and neither to 
have runs of identical nucleotides nor a G at the 5’ end. The probes were also designed with a Tm 
10oC higher than that of the primers, and to be dual-labelled with a 5’-FAM (fluorophore) and a 3’-
TAMRA (quencher). 
 
2.3.19 Quantitative PCR 
Real-time PCR reactions were performed using either cDNA (qRT-PCR) or gDNA obtained from a 
ChIP (ChIP-qPCR) as the template material. The reactions were set-up as a 40µl mix in 1.5ml tubes 
containing 900nM forward/reverse primer (Invitrogen), 200nM TaqMan probe (MWG Operon), 
4µl cDNA/-RT control (see 2.3.2) or 20ng ChIP DNA (see 2.5.4), 1x TaqMan Fast Universal PCR 
Master Mix (Applied Biosciences) and nuclease-free water (Sigma). This was vortexed thoroughly 
and then aliquoted as 10µl triplicate reactions on a 96-well plate. The plate was sealed and briefly 
centrifuged for 30 seconds at 3000 xg, before being placed in a Prism 7900HT Fast Real-Time PCR 
System (Applied Biosciences) and run under the following conditions: 
 
95oC 20 seconds 
95oC 1 second  40 cycles 
60oC 20 seconds 
 
Data were collected at the 60oC point of each cycle. The results of the qRT-PCR were analysed 
using the comparative Ct method, with ODC as the reference in each experiment. The results for 
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the ChIP-qPCR were calculated as enrichments or depletions by comparing input samples with 
bound samples. 
 
2.3.20 Sonication of Embryonic Chromatin 
Prior to sonication, embryonic chromatin was crosslinked (see 2.4.13) and then 100 embryos were 
homogenised in 1ml of Sonication Buffer using a plastic pestle. The homogenate, cooled by ice 
water, was then sonicated at 15% amplitude, for 3 seconds on and 10 seconds off using a Vibra-
Cell (Jencons), until the DNA fragments were an average size of 0.5-1kb (see 2.3.21). The sample 
was then centrifuged at 16000 xg for 5 minutes at 4oC and the supernatant was stored as 200µl 
aliquots (20 embryos equivalents) at -70oC until required for ChIP experiments (see 2.5.4). 
 
2.3.21 Checking the Size of Sonicated Chromatin 
A 30µl sample of sonicated homogenate was taken and centrifuged at 16000 xg for 5 minutes at 
4oC. The supernatant was transferred to a clean 1.5ml tube and 170µl TES Buffer, 200mM NaCl 
and 5µg Proteinase K were added. The sample was vortexed and incubated at 65oC overnight. The 
sample was then phenol/chloroform extracted (see 2.3.10) and ethanol precipitated (see 2.3.11) 
before being resuspended in 20µl TE with 40µg RNase A. This was incubated at 37oC for 1.5 hours, 
before being run on a 1.5% agarose gel (see 2.3.1) to determine the average size of the 
chromatin.  
 
2.4 Embryological Techniques 
 
In accordance with Home Office regulations regarding the use of animals in scientific research, all 
procedures were carried out by appropriately trained and licensed staff where required. Embryos 
for all experiments were staged following the Normal Table of Nieuwkoop and Faber (Nieuwkoop 
and Faber, 1967). Experiments involving embryos were repeated at least twice with embryos from 
separate females. 
 
2.4.1 Fertilisation and Preparation of Xenopus laevis Embryos 
The day before embryos were required, two adult female frogs were injected with 600-800 units 
of human chorionic gonadotrophin (depending on the size of the female) into their dorsal lymph 
sacs and were kept at 19-21oC overnight. Adult male frogs were killed by tricane anaesthesia, 
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before the testes were dissected and kept in 1x MBS at 4oC. The next morning, the female frogs 
were gently squeezed so that the eggs were laid into 90mm petri dishes. One quarter of a 
dissected testis was then crushed in 0.4ml 0.1x MBS, pipetted over the eggs and left for 5-10 
minutes to allow fertilisation to occur. The embryos were flushed and incubated in 0.1x MBS until 
the eggs had turned so that the animal pole was uppermost. The 0.1x MBS was then replaced 
with 2% cysteine in 1x MBS (pH8.0) in order to remove the jelly coat. The petri dish was shaken to 
remove the eggs from the bottom of the plate, which were then transferred to a 50ml centrifuge 
tube and gently agitated. The eggs were allowed to settle at the bottom of the tube occasionally 
to check whether they were in direct contact with one another, indicating that the jelly coat had 
been completely removed. Once removed, the embryos were washed 5 times in 1x MBS, 
transferred to a clean petri dish, and allowed to develop to the desired stage at 14-23oC. When 
the embryos reached around stage 6, the buffer was changed to 0.1x MBS, since high salt 
concentrations inhibit gastrulation. The embryos were checked regularly to remove any dead or 
unhealthy embryos, and the buffer was changed at least once a day. 
 
2.4.2 Total RNA Extraction from Xenopus laevis Embryos 
To purify RNA, 400µl TRIzol reagent (Invitrogen) was added to 10 frozen embryos, which were 
homogenised by pipetting and vortexing. 80µl of chloroform was added and the sample was 
vortexed for 15 seconds, before being centrifuged at 16000 xg for 5 minutes. The top phase was 
transferred to a clean 1.5ml tube, to which, 200µl of isopropanol was added and mixed by 
inverting the tube. The sample was incubated for 15 minutes at room temperature, before being 
centrifuged at 16000 xg for 10 minutes at 4oC. The supernatant was carefully removed, without 
disturbing the pellet, 500µl 70% ethanol was added and the sample was centrifuged at 16000 xg 
for 5 minutes at 4oC. Again, the supernatant was carefully removed and the pellet was air-dried 
for 10 minutes. When dry, the pellet was resuspended in 150µl nuclease-free water and heated at 
56oC for 10 minutes. A 3µl sample of the RNA was run on an agarose gel to check the preparation. 
The RNA was split into 30µl aliquots and stored at -70oC. 
 
2.4.3 Total RNA Extraction for Quantitative RT-PCR 
To purify RNA without using TRIzol, 600µl of NETS Buffer was added to 10 embryos that had been 
stored at -70oC. The embryos were homogenised by pipetting, and 600µl of phenol was added 
straight away, vortexed for 30 seconds and centrifuged at 16000 xg for 5 minutes. The upper, 
aqueous phase was transferred to a clean 1.5ml tube and was phenol/chloroform extracted (see 
2.3.10) three times. The nucleic acids were then precipitated (see 2.3.11) and the resulting pellet 
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was dissolved in 100µl of nuclease-free water. Half of this sample was transferred to a separate 
tube and 1x DNaseI Buffer (Roche) and 5U RNase-free DNaseI (Roche) was added. The sample was 
incubated at 37oC for 30 minutes to remove any DNA. The RNA was then phenol/chloroform 
extracted (see 2.3.10) and ethanol precipitated (see 2.3.11). The pellet was dissolved in 50µl of 
nuclease-free water and stored at -70oC.  
 
2.4.4 Preparation of Total Protein from Xenopus laevis Embryos 
Frozen embryos were lysed in C/N buffer (4µl per embryo). The egg yolk was then removed by 
adding 200µl Freon to the lysate, vortexing for 20 seconds and spinning at 16000 xg for 3 minutes. 
The top phase was transferred to a clean 1.5ml tube, avoiding the interface. SDS-GSB was added 
to a 1x final concentration, and either heated to 95oC for 5 minutes before being loaded onto an 
SDS-PAGE gel, or stored at -20oC. 
 
2.4.5 Microinjection into Embryos 
A glass capillary (Harvard Apparatus GC100-10) was pulled into a needle using a micropipette 
puller (Sutter Instrument Co. P-87) and placed into the holder of a micromanipulator (Sutter MM-
33) connected to a microinjector (Medical Systems Corp. PLI-100). Using fine watchmakers 
forceps and looking down the microscope, the very end of the needle was cut off. To calibrate the 
needle it was first filled with nuclease-free water, and then a 30mm glass capillary with a volume 
of 1µl was injected into 10 times for 1 second each until the water reached a length of 3mm, 
giving an injection volume of 10nls-1. The morpholino oligonucleotide or RNA to be injected was 
centrifuged at 16000 xg for 5 minutes to pellet any particles that could block the needle, and then 
a few microlitres of the sample was transferred to a square of parafilm. This was placed under the 
microscope with the tip of the needle well into the droplet, and the needle was filled. The 
embryos to be injected were placed in 3% ficoll in 1x MBS on a nylon mesh grid in a 55mm petri 
dish. The excess buffer was removed until the top of the embryos were just below the surface, 
stopping the embryos from moving around when under pressure from the needle. The volume 
required was injected into each embryo on the grid, injecting into the air occasionally to ensure 
the needle wasn’t blocked. When the batch had been injected, the embryos were transferred to a 
clean 55mm petri dish with fresh 3% ficoll in 1x MBS using a Pasteur pipette. The embryos were 
then incubated at 14-18oC until around stage 6 when the embryos were transferred to a 90mm 
dish and the buffer was replaced with 0.1x MBS. Any dead or unhealthy embryos were removed, 
and the embryos were incubated at 14-21oC until at the stage required. 
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2.4.6 Fixation of Embryos in MEMFA 
Embryos at the required stage were transferred into MEMFA in glass scintillation vials and were 
fixed for 30-90 minutes. The MEMFA was then replaced twice with methanol and the embryos 
were then left to dehydrate for 30 minutes in methanol. This was replaced with fresh methanol 
and the embryos were stored at -20oC. 
 
2.4.7 Rehydrating and Bleaching Embryos 
All washes were performed in 1ml, unless otherwise stated. Fixed embryos were transferred 
carefully into 1.5ml tubes using a Pasteur pipette and rehydrated by washing in 75%, 50% and 
25% methanol in PBSTw and PBSTw alone for 5 minutes each. To remove the pigment from the 
embryos, the PBSTw was replaced with Bleaching Solution and the tubes were placed on a light 
box for 10-20 minutes, inverting occasionally to mix. The Bleaching Solution was removed by 
three washes in PBSTw for 5 minutes each. 
 
2.4.8 Wholemount in situ Hybridisation (WISH)  
All washes were performed in 1ml, unless otherwise stated. Fixed embryos were rehydrated and 
bleached (see 2.4.7), and were then acetylated by washing twice in 0.1M triethanolamine for 5 
minutes each. 2.5µl acetic anhydride was added to the second wash and a further 2.5µl was 
added after 5 minutes. The embryos were then washed twice with PBSTw for 5 minutes each, 
which was replaced with 0.5ml hybridisation mix twice and left to prehybridise for 6 hours at 
60oC. After prehybridisation, the buffer was replaced with fresh hybridisation buffer containing 
0.2-1µg/ml of RNA probe and hybridisation was allowed to proceed overnight at 60oC, protected 
from light. Following hybridisation, the buffer containing the probe was removed and stored at -
20oC for further use. The embryos were washed at 60oC with 50% formamide/5x SSC for 10 
minutes, 25% formamide/2x SSC for 10 minutes, 12.5% formamide/2x SSC for 10 minutes, 2x 
SSC/0.1% Tween for 10 minutes and 0.2x SSC/0.1% Tween for 30 minutes. The buffer was 
replaced three times with PBSTw for 5 minutes each at room temperature, and then once with 
MAB for 10 minutes. The embryos were blocked with 2% blocking reagent in MAB for 4-5 hours 
before being incubated with a 1:2000 dilution of anti-digoxygenin Fab antibody fragments 
conjugated to alkaline phosphatase (Roche) in MAB blocking solution overnight at 4oC. To remove 
the unbound and excess antibody, the embryos were washed with MAB at least five times for an 
hour each at room temperature. The MAB was replaced twice with AP buffer for 5 minutes each 
before the embryos were transferred to a 55mm petri dish and the SigmaFast BCIP/NBT (Sigma-
Aldrich) solution (1 tablet dissolved in 10ml H2O) was added. The dish was wrapped in foil and the 
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colour was allowed to develop at room temperature. Once the colour had developed to a 
satisfactory level, the embryos were washed in PBSTw several times, and then washed with 
methanol for at least 5 minutes to leach out any non-specific background staining. The methanol 
was replaced with AP buffer for 5 minutes and the embryos were refixed in MEMFA for at least 20 
minutes, before replacing with methanol for 30 minutes. This was replaced with fresh methanol 
and the embryos were stored at -20oC. Staining patterns were analysed using a SteREO Lumar.V12 
microscope (Zeiss) and captured using AxioVision software (Zeiss). If required, the embryos were 
cleared by transferring them into Murray’s Clear, which has the same refractive index as the yolk 
platelets to allow the visualisation of internal staining. 
 
2.4.9 Wholemount Immunohistochemistry 
All washes were performed in 1ml, unless otherwise stated. Fixed embryos were rehydrated and 
bleached (see 2.4.7), and then equilibrated in PBT by washing twice for 15 minutes. The embryos 
were blocked by incubating in PBT containing 10% normal sheep serum for 2 hours at room 
temperature. The embryos were then incubated with the primary antibody at an appropriate 
dilution in 0.5ml PBT containing 10% normal sheep serum overnight at 4oC. The primary antibody 
was removed by washing the embryos five times in PBT for 45 minutes each at room 
temperature. The embryos were blocked again, as before and incubated with the HRP-linked 
secondary antibody at a dilution of 1:500 in 0.5ml PBT containing 10% normal sheep serum 
overnight at 4oC. The secondary antibody was removed by washing the embryos five times in PBT 
for 45 minutes each at room temperature. The staining reaction was carried out using DAB with 
metal enhancer tablets (Sigma). Once stained, the embryos were washed several times in PBSTw 
and stored in methanol. Staining patterns were analysed using a SteREO Lumar.V12 microscope 
(Zeiss) and captured using AxioVision software (Zeiss). To view internal staining, embryos were 
cleared using Murray’s Clear. 
 
2.4.10 Mesoderm Induction Assay 
To remove animal caps from embryos, stage 9 embryos were transferred to a glass petri dish 
containing 1x MBS and the vitelline membranes were removed. Using Dumont No.5 jeweller’s 
forceps, cuts were made around the region of the animal cap until the cap could be lifted out. Any 
marginal zone cells were removed to ensure only animal cells were isolated. Using a glass Pasteur 
pipette, the caps were immediately transferred to a 48-well plate lined with 1% agarose 
containing 1x MBS, 1x MBS + 20ng/ml Activin A or 1x MBS + 50ng/ml Activin A. Caps were left to 
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develop, alongside undissected embryos, to around the end of neurulation (St.18) and were then 
fixed (see 2.4.6). 
 
2.4.11 Nieuwkoop Conjugates  
Nieuwkoop conjugates were formed from animal caps and vegetal poles dissected from stage 9 
embryos with Dumont No.5 jeweller’s forceps. Embryos were transferred to a glass petri dish 
containing 1x MBS and the vitelline membranes were removed. Animal caps were dissected as in 
section 2.4.10 and vegetal poles were isolated from the same embryos by removing the marginal 
cells around the equator of the embryos. Animal caps were placed on top of the vegetal poles and 
were left to fuse for 10 minutes before being transferred to a 48-well plate lined with agarose 
containing 1x MBS. The conjugates were left to develop, alongside undissected embryos, to 
around the end of gastrulation (St.13) and were then fixed (see 2.4.6). 
 
2.4.12 β-Galactosidase Staining of Embryos 
To stain for β-galactosidase, embryos at the required stage were transferred into glass 
scintillation vials. MEMFA was added and the embryos were fixed for 30-40 minutes. The MEMFA 
was replaced with two 5 minute washes of β-Gal Wash Buffer and then with β-Gal Staining Buffer, 
to which, X-gal was added to 2mg/ml. Embryos were incubated at room temperature until colour 
development could just about be seen over the pigment (earlier embryos required longer 
incubations). Embryos were then washed three times for 5 minutes in β-Gal Wash Buffer, fixed in 
MEMFA for 30-40 minutes and then stored in methanol at -20oC. 
 
2.4.13 Crosslinking Embryonic Chromatin 
Embryos at the desired stage were transferred to a scintillation vial and rinsed with distilled 
water. The embryos were then incubated in distilled water with 1% formaldehyde for 20 minutes 
at room temperature, before being transferred into 0.25x MBS with 125mM glycine for 30 
minutes. After this, embryos were washed twice for 15 minutes each in 0.25x MBS. Batches of 
100 embryos were transferred into 1.5ml tubes and these were stored at -70oC. 
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2.5 Biochemical Techniques 
 
2.5.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE gels were set up in ATTO mini-gel casts, using a 30% acrylamide: 0.8% bis-acrylamide 
stock solution (37.5:1) acrylamide mix (National Diagnostics), following the recipes below: 
                     
 
Resolving Gel (10ml) Stacking Gel 
(5ml) 4% 15% 12% 10% 
Acrylamide Mix 5ml 4ml 3.4ml 0.65ml 
Buffer B 2.5ml 2.5ml 2.5ml - 
Buffer C - - - 1.25ml 
Water 2.5ml 3.5ml 4.1ml 3ml 
10% APS 100µl 100µl 100µl 50µl 
TEMED 10µl 10µl 10µl 5µl 
 
The resolving gel was poured into the cast up to around ¾ of the volume, overlaid with 0.5ml 
isopropanol and left to polymerise. The isopropanol was thoroughly washed off with distilled 
water and the stacking gel was poured on top of the resolving gel, and left to polymerise with a 12 
well comb inserted. Protein samples to be run on the gel had half a volume of 3x SDS-PAGE 
Loading Buffer added before being heated to 95oC for 5 minutes, and then centrifuged for 30 
seconds at 16000 xg. 
 
Once set, the gel was placed in the running tank, which was then filled with 1x SDS-PAGE Running 
Buffer, and the wells were rinsed to ensure they were free from excess acrylamide. Samples were 
loaded into the wells, along with 5µl of SeeBlue Plus2 Prestained Protein Standards (Invitrogen), 
and run at 80V through the stacking gel and then 140V until the dye front reached the bottom of 
the gel.  
 
2.5.2 Western Blot 
Proteins to be analysed were resolved using SDS-PAGE (see 2.5.1), but instead of staining with 
Coomassie Blue Stain, proteins were transferred to HyBond-ECL 0.2µm nitrocellulose membrane 
(GE Healthcare). The SDS-PAGE gel, blotting paper and nitrocellulose membrane were soaked in 
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Transfer Buffer for 30 minutes, before a gel sandwich was set up from cathode to anode as 
follows: 
 
 Fibre Pad 
 Whatman 3M Filter Paper (x2) 
 Nitrocellulose Membrane 
 SDS-PAGE Gel 
 Whatman 3M Filter Paper (x2) 
 Fibre Pad 
 
Any air bubbles were rolled out and the sandwich was transferred to a western blot tank filled 
with Transfer Buffer. The proteins were transferred at 300mA for 2-3 hours. The prestained 
protein standards gave an estimate of the transfer efficiency. 
 
The membrane was blocked in the desired blocking solution (TBSTw/PBSTw-5% Milk/BSA) for 1 
hour at room temperature or overnight at 4oC. Primary antibody was diluted in blocking solution 
at the desired concentration, and incubated with the blot for 2 hours at room temperature or 
overnight at 4oC. The primary antibody was then removed and stored with 0.05% sodium azide at 
4oC, and the membrane was washed three times in blocking solution for 15 minutes each. The 
secondary antibody was diluted to 1:5000 in blocking solution, added to the membrane and 
incubated for 1 hour at room temperature. The membrane was then washed three times in 
blocking solution for 15 minutes each, twice in TBSTw for 5 minutes each and twice in PBS for 5 
minutes each. The membrane was developed by mixing together ELC Solution I and ECL Solution 
II, then adding this to the membrane for 1 minute. The chemiluminescence from the blot was 
captured using a FujiFilm LAS-3000. 
 
2.5.3 In vitro Translation of Synthetic mRNA 
To ensure the recovery mRNA transcripts (see 2.3.17) were able to be translated into protein, the 
Wheat Germ Extract Plus system (Promega) was used. Reactions were set up on ice as follows; 
30µl Wheat Germ Extract Plus, 6-12µg mRNA, 2µl FluroTect GreenLYS tRNA (Promega) and 
nuclease-free H2O up to 50µl. A control reaction was also set up, where the mRNA was replaced 
with water. Reactions were incubated at 25oC for 2 hours. After incubation, half a volume of 3x 
SDS-PAGE Loading Buffer was added to the reactions and these were heated at 68oC for 3 
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minutes. The proteins were resolved by SDS-PAGE (see 2.5.1) and analysed using a FujiFilm FLA-
5000. 
 
2.5.4 Chromatin Immunoprecipitation (ChIP) 
For each chromatin sample (see 2.3.20), 10mg of Protein G Agarose beads (Sigma) were added to 
a 1.5ml tube and washed 5 times with 0.5ml IP Buffer, centrifuging at 1000 xg for 1 minute at 4oC 
between washes. The beads were then blocked in 1ml IP Buffer containing 1mg/ml BSA for at 
least 1 hour with shaking at 4oC, before being washed twice with 1ml IP Buffer. Each 200µl aliquot 
of chromatin (20 embryo equivalent) was diluted with 200µl IP Buffer and 60µl was removed for 
an Input sample. The remaining chromatin was pre-cleared by adding each sample to a tube 
containing beads and incubating at 4oC for 1 hour with shaking. After this incubation, the samples 
were centrifuged at 3000 xg for 1 minute at 4oC and the chromatin transferred to a clean 1.5ml 
tube, taking care to avoid the beads. Either 50µg of pre-immune IgG, 50µg of α-AcH2A.Z or 25µg 
of α-H3K3me2 antibodies were added to each chromatin sample and incubated overnight at 4oC 
with shaking. Whilst the antibody-chromatin mix was incubating, 20mg Protein G Agarose beads 
were washed and blocked as previously for each sample. The antibody-chromatin mix was then 
added to the beads and incubated at 4oC for 3 hours with shaking. The beads were collected by 
centrifugation and 200µl of the supernatant was removed for an Unbound sample. The remainder 
of the supernatant was then removed and the beads were washed once with 1ml of ChIP Buffer 1, 
ChIP Buffer 2, ChIP Buffer 3 and ChIP Buffer 1, and then once with 0.5ml TE, with everything on 
ice. The antibody-DNA complexes were eluted from the beads using two washes of 200µl ChIP 
Elution Buffer for 15 minutes each with shaking and the supernatants were collected in clean 
1.5ml tubes. All samples, including Input, Unbound and Bound, were then made up to 400µl with 
water (if not already at this volume) and 200mM NaCl, 10µg Proteinase K and 100µg RNase A 
were added. These were vortexed and incubated at 65oC overnight. Each sample was then 
phenol/chloroform extracted (see 2.3.10) and ethanol precipitated (see 2.3.11). The resulting 
pellets from the Input and Unbound samples were resuspended in 100µl TE and the Bound pellets 
in 50µl TE. The concentrations of these samples were determined using a small volume 
spectrophotometer and quantitative PCR (see 2.3.19) was then performed on these samples to 
determine the enrichments or depletions at specific loci. 
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3. Expression Analysis of Histone Variants and hnRNPs 
 
3.1 Introduction 
 
Histone variants have been reported to be involved in a number of diverse nuclear functions, 
including transcriptional activation and/or repression, DNA repair, kinetochore formation, and 
chromosome packaging and segregation (Wolffe, 1998, Ausio, 2006). Both hnRNP AB and hnRNP 
D have also been shown to be important for the transcriptional regulation of a number of genes 
(Tolnay et al., 1999, Leverrier et al., 2000, Mikheev et al., 2000, Ahmad and Lingrel, 2005). Many 
of the described properties of these proteins, however, are based on in vitro work. Previous 
functional studies on histone variants have, however, been performed in a wide range of 
organisms, including work on H2A.Z in Tetrahymena thermophilia (Liu et al., 1996) and Drosophila 
melanogaster (van Daal and Elgin, 1992), H2A.X-F in Xenopus laevis (Shechter et al., 2009a), and 
mH2A1 and mH2A2 in Danio rerio (Buschbeck et al., 2009). All of which determined that these 
histone variants were crucial for the normal development of these organisms. Both hnRNP AB 
(Czaplinski et al., 2005) and hnRNP D (Czaplinski et al., 2005, Guo et al., 2008) have previously 
been identified in X. laevis; however, no previous developmental studies have been published 
regarding these proteins. Though other hnRNP proteins, such as hnRNP G (Dichmann et al., 2008) 
and hnRNP K (Liu et al., 2008), have been shown to be required for normal development in X. 
laevis. 
 
A number of histone variants have previously been identified in X. laevis. The linker histone 
variants, B4 (Smith et al., 1988), H1A, H1B, H1C (Risley and Eckhardt, 1981), H1o-1 and H1o-2 
(Risley and Eckhardt, 1981, Brocard et al., 1997); the H2A variants, H2A.X (Lee et al., 2010) and 
H2A.Z (Iouzalen et al., 1996); and the histone H3 variants, CENPA (Edwards and Murray, 2005) and 
H3.3 (Tazaki et al., 2005), have all previously been reported. Although the expression patterns of 
some of these histone variants were also published, a temporal and spatial analysis of all of the 
histone variants and both hnRNPs during early X. laevis development had previously never been 
performed. 
 
It can take considerable time and effort to raise and characterise antibodies against a protein of 
interest to determine its localisation within an embryo and throughout development. After 
identifying the gene of interest however, the mRNA expression can be determined quickly using 
wholemount in situ hybridisation (WISH). The patterns of mRNA expression can give an indication 
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of where the protein is expressed and can also indicate that a gene may have an important 
developmental role if this expression is restricted to a particular tissue or embryonic stage. This 
type of analysis has contributed to the understanding of a number of important X. laevis genes. 
Therefore, the timing and location of a gene’s mRNA expression can provide some insight to the 
purpose it serves in a developing organism. 
 
Defining the expression pattern of a gene allows us to speculate about the functions the protein 
may have due to tissue specificity and its changes during development. Therefore, the spatial and 
temporal expression of the histone variants and both hnRNP AB and hnRNP D were determined in 
X. laevis. Before the expression patterns of all of the histone variants could be performed 
however, histone variants that had not previously been described in X. laevis were identified 
through database searches. The identities of these proteins were confirmed through multiple 
sequence alignments with the known histone variants from other species. Having identified these 
sequences, it was then possible to sub-clone unique regions of the mRNAs in order to synthesise 
antisense RNA probes. These probes were used in WISH experiments to determine the mRNA 
expression patterns across a range of differently staged X. laevis embryos.  
 
3.2 Identification of Histone Variants in X. laevis 
 
Since several histone variants had previously been described in X. laevis, to identify the remaining 
histone variant sequences, a list of human histone variants was compiled from the literature 
(Kamakaka and Biggins, 2005, Ausio, 2006). Histone variants specific to mammals, i.e. H2A.Bbd 
(Chadwick and Willard, 2001) or found exclusively in the testes, i.e. H2BFWT (Churikov et al., 
2004a), were discarded since these were less applicable to this study. Once the list of human 
histone variants had been compiled, the protein sequences for variants previously unidentified in 
X. laevis were used to identify the Xenopus homologues through BLAST (Basic Local Alignment 
Search Tool) searches on the XenBase website. Consequently, these X. laevis homologues were 
named after the human histone variants used to identify them.  
 
These searches identified several histone variants that had not been identified in X. laevis before. 
In order to confirm the identity of these variants, multiple sequence alignments were performed 
against the human (Homo sapiens), mouse (Mus musculus), zebrafish (Danio rerio), and the 
closely related Western clawed frog (Xenopus tropicalis) proteins. Each X. laevis histone variant 
was also analysed using ExPASy ProSite to identify conserved protein domains and motifs. 
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Entering the sequence of the human H1X protein into a BLAST search resulted in the identification 
of the X. laevis homologue of this linker histone variant. The X. laevis H1X protein sequence was 
aligned with the same histone variant from other species (Figure 3.1) and was discovered to share 
approximately 50% homology with the human, mouse and zebrafish proteins, though the X. 
tropicalis protein shared 77%. The core histone H1 globular domain (blue underline in Figure 3.1A) 
was, however, highly conserved across all species. The N- and C-terminal domains were highly 
variable. 
 
The X. laevis homologues of H2A.1 and H2A.2 were identified through a BLAST search with the 
human protein sequences. Alignment of both of these histone H2A variants with the same 
proteins from other species revealed a high homology of over 90% across each species analysed 
for H2A.1 and H2A.2 (Figure 3.2). The H2A signature motif (red underline in Figure 3.2A) in the N-
terminal region was found to be conserved throughout all of the H2A.1 and H2A.2 proteins, 
whereas, most of the amino acid differences occurred in the C-terminal regions of both histone 
variants. 
 
Although H2A.Z had previously been identified in X. laevis (Iouzalen et al., 1996), two isoforms of 
this histone variant were recently been identified in vertebrates (Eirin-Lopez et al., 2009). A BLAST 
search with the human proteins identified H2A.Z1 (previously named H2A.Z) and H2A.Z2 
(previously named H2A.V) in X. laevis. Both of these proteins were found to be extremely well 
conserved throughout evolution when aligned with the same histone variants from other species 
(Figure 3.3) and both contained the H2A signature motif (red underline in Figure 3.3A) in their N-
terminal regions. When the X. laevis homologues of H2A.Z1 and H2A.Z2 were aligned (Figure 3.4), 
these proteins were seen to share 89% sequence identity. Together with the high conservation of 
both of these isoforms throughout evolution, this result suggested that H2A.Z1 and H2A.Z2 are 
not alloalleles of the same gene, but are separate proteins, potentially with distinct functions. 
 
BLAST searching with the human macro-H2A variants, mH2A1 and mH2A2, identified the X. laevis 
homologues of these proteins, which were previously named H2A.Y and H2A.Y2, respectively. 
When aligned with the same histone variants from other species (Figure 3.5), it was found that 
both proteins were well conserved, although mH2A1 had higher sequence identity across species 
than mH2A2. Both of these histone variants were seen to have a highly conserved macro domain 
(green underline in Figure 3.5) in their C-terminal regions, indicating the correct identity for both 
of these homologues. 
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Figure 3.1 – Multiple sequence alignment of histone H1 variant, H1X. 
The H1X homologues were aligned with ClustalW 2.1 and processed using BoxShade 3.21 to 
identify regions of homology clearly (A.). ExPASy ProSite was used to identify the highly conserved 
histone H1 globular domain (blue underline in A.). The percentage sequence identities of the H1X 
proteins from other species compared to the X. laevis homologue were recorded (B.). Dark 
shading indicates identical residues, light shading indicates similar residues. Hs – Homo sapiens 
(Human), Mm – Mus musculus (Mouse), Xt – Xenopus tropicalis (Western clawed frog), Xl – 
Xenopus laevis (South African clawed frog), Dr – Danio rerio (Zebrafish) 
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Figure 3.2 – Multiple sequence alignment of histone H2A variants, H2A.1 and H2A.2. 
The H2A.1 (A.) and H2A.2 (B.) homologues were aligned with ClustalW 2.1 and processed using 
BoxShade 3.21 to identify regions of homology clearly. ExPASy ProSite was used to identify the 
highly conserved histone H2A signature motif (red underline in A. and B.). The percentage 
sequence identities of the H2A.1 and H2A.2 proteins from other species compared to the X. laevis 
homologues were recorded (C.). Dark shading indicates identical residues, light shading indicates 
similar residues. Hs – Homo sapiens (Human), Mm – Mus musculus (Mouse), Xt – Xenopus 
tropicalis (Western clawed frog), Xl – Xenopus laevis (South African clawed frog), Dr – Danio rerio 
(Zebrafish) 
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Figure 3.3 – Multiple sequence alignment of histone H2A variants, H2A.Z1 and H2A.Z2. 
The H2A.Z1 (A.) and H2A.Z2 (B.) homologues were aligned with ClustalW 2.1 and processed using 
BoxShade 3.21 to identify regions of homology clearly. ExPASy ProSite was used to identify the 
highly conserved histone H2A signature motif (red underline in A. and B.). The percentage 
sequence identities of the H2A.Z1 and H2A.Z2 proteins from other species compared to the X. 
laevis homologues were recorded (C.). Dark shading indicates identical residues, light shading 
indicates similar residues. Hs – Homo sapiens (Human), Mm – Mus musculus (Mouse), Xt – 
Xenopus tropicalis (Western clawed frog), Xl – Xenopus laevis (South African clawed frog), Dr – 
Danio rerio (Zebrafish) 
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Figure 3.4 – Comparison of the X. laevis histone H2A.Z isoforms, H2A.Z1 and H2A.Z2. 
The X. laevis H2A.Z1 and H2A.Z2 protein sequences were aligned with ClustalW 2.1 and processed 
using BoxShade 3.21 to identify regions of homology clearly. These two H2A.Z isoforms were 
found to share 89% sequence identity. Dark shading indicates identical residues, light shading 
indicates similar residues.  
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Figure 3.5 – Multiple sequence alignment of histone H2A variants, mH2A1 and mH2A2. 
The mH2A1 (A.) and mH2A2 (B.) homologues were aligned with ClustalW 2.1 and processed using 
BoxShade 3.21 to identify regions of homology clearly. ExPASy ProSite was used to identify the 
highly conserved macro domain (green underline in A. and B.). The percentage sequence 
identities of the mH2A1 and mH2A2 proteins from other species compared to the X. laevis 
homologues were recorded (C.). Dark shading indicates identical residues, light shading indicates 
similar residues. Hs – Homo sapiens (Human), Mm – Mus musculus (Mouse), Xt – Xenopus 
tropicalis (Western clawed frog), Xl – Xenopus laevis (South African clawed frog), Dr – Danio rerio 
(Zebrafish) 
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After identifying the sequences, fragments of each of the mRNAs were sub-cloned into a suitable 
vector and antisense RNA probes were synthesised. These probes were used to determine the 
spatial and temporal patterns of each gene’s expression using wholemount in situ hybridisation.  
 
3.3 Expression Analysis of Histone Variants and hnRNPs 
 
3.3.1 Cloning and RNA Probe Synthesis 
Before the expression patterns of the histone variants and hnRNPs could be determined, primers 
were designed to amplify 300-600bp regions of each histone variant and both hnRNP mRNAs that 
shared as little homology as possible. Since some of the histone variants, such as H1o-1 and H1o-2, 
and H2A.Z1 and H2A.Z2, share significant homology in their ORFs, sequences from either the 3’ or 
5’UTR of these transcripts were used to generate probes. 
 
Reverse transcription-PCR (RT-PCR) was used to amplify these regions from a X. laevis RNA pool, 
generated by combining RNA purified from stage 6, 11, 17, 24, 35 and 41 embryos to provide a 
wide coverage of the mRNAs expressed throughout development. The successfully amplified 
fragments were ligated into the pGEM-T Easy vector (see 9.2.1). To confirm the sequence and 
determine the orientation of each fragment, each clone was sent for DNA sequencing. 
 
The pGEM-T Easy vector was chosen since the insert site is flanked by SP6 and T7 RNA polymerase 
promoters. Therefore, once the orientation of each fragment was known, separate restriction 
digests were performed to linearise the plasmids at either the 3’ or 5’ end of each fragment. An in 
vitro transcription reaction was then carried out with the 3’ and 5’ linearised plasmids for each 
clone, using a digoxygenin-labelled uridine-5’-triphosphate (DIG-UTP) RNA labelling mix, in order 
to synthesise sense (control) and anti-sense RNA probes, respectively (Figure 3.6).  
 
3.3.2 Wholemount in situ Hybridisation  
Wholemount in situ hybridisation is a technique widely used to investigate mRNA expression 
patterns throughout development. This method uses RNA probes that are complementary to part 
of the endogenous mRNA that have been labelled with a particular tag, in this case DIG-UTP. 
These antisense DIG-labelled probes are hybridised to the mRNA they were generated from 
within the embryos, which are then probed with α-DIG antibodies conjugated to alkaline 
phosphatise to indicate the sites of mRNA expression (Hemmati-Brivanlou et al., 1990). 
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Figure 3.6 – Schematic of sense and anti-sense RNA probe synthesis. 
To synthesise the sense (A.) and anti-sense (B.) RNA probes required for WISH, a region of the 
histone variant or hnRNP mRNA (blue) was cloned into the pGEM-T Easy vector. In separate 
restriction digest reactions, the plasmids were cut at the 3’ (A.) or 5’ (B.) ends of these sequences. 
An in vitro transcription reaction was then performed from either the T7 or SP6 promoters (red), 
which labelled the RNA probes with DIG-UTP (yellow triangles).  
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Using the RNA probes synthesised for each clone, WISH was used to determine the expression 
patterns of the histone variants and hnRNPs throughout early X. laevis development. Since a 
number of important developmental processes take place across embryogenesis, a range of 
differently staged X. laevis embryos were used to ensure coverage throughout early development; 
stage 9 (mid-blastula transition), stage 11 (gastrulation), stage 16 (neurulation), stage 22 (tailbud), 
stage 28 (late tailbud) and stage 38 (swimming tadpole) (Figure 3.7). All of the embryos hybridised 
with each of the sense probes were clear from any specific staining, indicating the specificity of 
the anti-sense probes and therefore, the expression patterns.  
 
3.3.3 Expression Analysis of H1 Histone Variants 
The majority of the histone variants investigated displayed one of two general patterns of 
expression; a ubiquitous expression throughout development, or a restricted pattern of 
expression in anterior and neural tissues. One histone variant that did not exhibit either of these 
patterns was the maternal H1 linker variant, B4 (Figure 3.8A). Northern blot analysis had 
previously shown B4 to be an oocyte specific variant that is only expressed until the mid-blastula 
transition (MBT) (Smith et al., 1988). The expression of B4, as determined by WISH, mirrored this 
result since the B4 mRNA was only detected in the animal hemisphere of stage 9 embryos, with 
the later stage embryos clear from staining. The three somatic linker histone variants, H1A, H1B 
and H1C, were all seen to be highly expressed throughout embryos from at least stage 9 up until 
stage 38 (Figure 3.8B, C and D). Since these histone variants replace B4 at the MBT (Khochbin and 
Wolffe, 1994), these expression patterns correlated with previous data.  
 
In X. laevis, the previously uncharacterised linker histone variant, H1X, was also seen to be 
expressed throughout early development (Figure 3.8E). The expression of H1X was observed at a 
low level in the animal hemisphere at stage 9 but was increased in the animal pole and marginal 
zone at gastrulation. No expression was detected in the vegetal region at either stage. During 
neurulation, H1X expression became restricted to the neural plate. In later embryonic 
development, this expression continued to be localised to the tissues derived from the neural 
plate, such as the eye and brain, up until at least stage 38.  
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Figure 3.7 – Developmental stages during X. laevis life cycle. 
Early X. laevis development occurs from the point of fertilisation (stage 1) to the development of a 
swimming tadpole (stage 40). These embryos undergo several important processes (labelled in 
bold text) at particular stages of development (stages shown labelled), before metamorphosing 
and becoming adults (F – female, M – male).  
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Figure 3.8 – Wholemount in situ hybridisation analysis of histone H1 variant expression patterns 
in X. laevis. 
WISH was performed on embryos from a single X. laevis female at approximately stage 9, stage 
11, stage 16, stage 22, stage 28 and stage 38. These were hybridised with the anti-sense or sense 
(Controls) RNA probes for B4 (A.), H1A (B.), H1B (C.), H1C (D.), and H1X (E.). B4 expression was 
only seen at stage 9, whereas H1A, H1B and H1C were expressed ubiquitously from stage 9 
throughout early development to stage 38. H1X was also expressed from stage 9 through to stage 
38 but was restricted to the anterior neural tissues. No specific staining was observed in any of 
the embryos hybridised with the control probes. Stage 9 – animal (left) and vegetal (right) views, 
stage 11 – vegetal view, stage 16 – anterior view (dorsal top), stages 22, 28 and 38 – lateral views 
(anterior right). 
 65 
 
 
 66 
 
Unfortunately, expression of neither H1o-1 nor H1o-2 could be detected in any of the embryos 
assayed. Although this could be a problem with the probes themselves it has previously been 
reported that both H1o mRNAs are expressed at very low levels throughout development, only 
rising after stage 36, through Northern blot analysis (Khochbin and Wolffe, 1993). Therefore, the 
expression levels of these genes may have been too low to detect using WISH. 
 
3.3.4 Expression Analysis of H2A Histone Variants 
The expression of the H2A histone variants were primarily observed in the anterior and neural-
derived tissues (Figure 3.9). Two H2A variants that were expressed more widely, however, were 
H2A.1 and H2A.2 (Figure 3.9A and B). Expression of both H2A.1 and H2A.2 were detected in the 
animal hemisphere of embryos at the MBT and this expression continued through gastrulation. 
Although expression of both of these H2A variants were still detected throughout neurula stage 
embryos, a higher expression level was observed in the neural plate. From neurulation onwards, 
the expression of H2A.2 appeared to be higher than that of H2A.1. During later embryogenesis, 
the mRNAs of both histone variants were detected in similar tissues; being highly expressed in the 
anterior neural tissue with lower levels of expression throughout the rest of the embryos.  
 
The recently characterised H2A.X was observed to have a similar pattern of expression (Figure 
3.9C). The expression of this histone variant was restricted to neural and neural-derived tissue 
later in embryonic development. These observations correlate with a previous study in X. laevis, 
since the authors also observed the same expression patterns for H2A.X (Lee et al., 2010). 
Although the expression of H2A.Z had also been previously characterised in X. laevis (Iouzalen et 
al., 1996, Ridgway et al., 2004), recently, two isoforms of this histone variant were discovered in 
vertebrates (Eirin-Lopez et al., 2009) that had not been characterised separately.  
 
The expression patterns observed for H2A.Z1 and H2A.Z2 were very similar in later 
embryogenesis; however, the onset of expression of each gene was markedly different (Figure 
3.9D and E). H2A.Z1 expression was detected throughout early development. During the MBT and 
gastrulation, H2A.Z1 was seen to be expressed in the animal region and was absent from the 
vegetal tissue. This expression became restricted to the neural plate and neural crest during 
neurulation. In later embryonic development, H2A.Z1 continued to be expressed in neural tissues 
and those derived from the neural crest, such as the brain, eye, neural tube and branchial arches, 
as well as in the tailbud. H2A.Z2 was similarly expressed in these neural and neural-derived tissues 
at these later stages of embryogenesis.  
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Figure 3.9 – Wholemount in situ hybridisation analysis of histone H2A variant expression 
patterns in X. laevis. 
WISH was performed on embryos from a single X. laevis female at approximately stage 9, stage 
11, stage 16, stage 22, stage 28 and stage 38. These were hybridised with the anti-sense or sense 
(Controls) RNA probes for H2A.1 (A.), H2A.2 (B.), H2A.X (C.), H2A.Z1 (D.), H2A.Z2 (E.), mH2A1 (F.) 
and mH2A2 (G.). H2A.1, H2A.2, H2A.X and H2A.Z1 were all expressed from stage 9 throughout 
development up until stage 38, whereas H2A.Z2, mH2A1 and mH2A2 expression was only 
observed from stage 16 onwards. At stages 28 and 38, all of the H2A variants were expressed in 
the anterior neural tissues and neural-derived tissues. H2A.1, H2A.2, H2A.X and H2A.Z1 were also 
expressed in the tailbud. No specific staining was observed in any of the embryos hybridised with 
the control probes. Stage 9 – animal (left) and vegetal (right) views, stage 11 – vegetal view, stage 
16 – anterior view (dorsal top), stages 22, 28 and 38 – lateral views (anterior right).  
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No H2A.Z2 expression could however be detected at MBT or gastrulation, and only a small 
amount of expression was observed at the neurula stage, which was restricted to a smaller area 
of the neural plate. 
 
Neither mH2A1 nor mH2A2 had previously been characterised in X. laevis. As determined by 
WISH, both genes were expressed at a low level during later embryonic development (Figure 3.9F 
and G). No expression was detected for either of these H2A variants at the MBT or gastrulation. 
During neurulation, low levels of mH2A1 and mH2A2 expression were detected in the neural 
plate, though mH2A1 expression was seen at a higher level than that of mH2A2. Both macro-H2A 
variants were observed at low levels in anterior neural tissues at stage 22 and this expression 
continued in later embryogenesis, being localised to the neural tissues of the head, such as the 
eye and brain. 
 
3.3.5 Expression Analysis of H3 Histone Variants and Histone H4 
The two X. laevis histone H3 variants, H3.3 (Tazaki et al., 2005) and CENPA (Edwards and Murray, 
2005) had previously been identified, though the expression patterns of neither gene were 
characterised. Using WISH, both H3.3 and CENPA were seen to be expressed throughout early 
development and both showed similar expression patterns (Figure 3.10). Staining for both mRNAs 
was observed in the animal hemisphere, but not the vegetal hemisphere, of embryos at the MBT. 
During gastrulation, expression of H3.3 and CENPA were seen in the animal region and the 
marginal zone, though not in the blastoporal endoderm. The expression of both H3 variants 
became restricted to the neural plate at neurulation and was seen in the anterior neural tissues of 
stage 22 embryos. Most of the H3.3 and CENPA expression at the later stages of embryogenesis 
were observed in the neural tissues of the head, though slight expression was also seen in the 
neural tube.  
 
Since histone H4 is expressed throughout early X. laevis development (Sindelka et al., 2006), the 
expression pattern of this histone was used as a positive control for ubiquitous histone expression 
(Figure 3.11). As expected, H4 was expressed in all of the embryos assayed. At the MBT and 
gastrulation however, only slight expression was observed in the endodermal tissue. In later 
embryogenesis, the expression of H4 was seen throughout the embryos, with more intense 
staining in the anterior tissues.  
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Figure 3.10 – Wholemount in situ hybridisation analysis of histone H3 variant expression 
patterns in X. laevis. 
WISH was performed on embryos from a single X. laevis female at approximately stage 9, stage 
11, stage 16, stage 22, stage 28 and stage 38. These were hybridised with the anti-sense or sense 
(Controls) RNA probes for H3.3 (A.) and CENPA (B.). Both H3.3 and CENPA were expressed from 
stage 9 throughout development to stage 38. At stage 16, both H3 variants were restricted to the 
neural plate. Expression of H3.3 and CENPA were detected in the anterior neural tissues at stages 
22, 28 and 38. No specific staining was observed in any of the embryos hybridised with the control 
probes. Stage 9 – animal (left) and vegetal (right) views, stage 11 – vegetal view, stage 16 – 
anterior view (dorsal top), stages 22, 28 and 38 – lateral views (anterior right). 
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Figure 3.11 – Wholemount in situ hybridisation analysis of histone H4 expression in X. laevis. 
WISH was performed on embryos from a single X. laevis female at approximately stage 9, stage 
11, stage 16, stage 22, stage 28 and stage 38. These were hybridised with the anti-sense or sense 
(Controls) RNA probes for histone H4. Expression was detected from stage 9 throughout 
development up until stage 38. At stage 9 and stage 11, no expression was detected in the vegetal 
tissues. H4 expression was observed throughout the embryos at stages 16, 22, 28 and 38, with an 
increased level of expression in the anterior neural tissues of these embryos. No specific staining 
was observed in any of the embryos hybridised with the control probes. Stage 9 – animal (left) 
and vegetal (right) views, stage 11 – vegetal view, stage 16 – anterior view (dorsal top), stages 22, 
28 and 38 – lateral views (anterior right). 
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3.3.6 Expression Analysis of hnRNP AB and hnRNP D 
The expression patterns of neither hnRNP AB nor hnRNP D had been investigated throughout X. 
laevis early development, however, both proteins had previously been observed in oocytes and 
hnRNP AB protein was detected in several adult tissues (Czaplinski and Mattaj, 2006). The 
expression patterns determined here confirmed that both hnRNP mRNAs were expressed 
throughout early development, until at least the swimming tadpole stage (Figure 3.12). 
 
Both hnRNP AB and hnRNP D were detected at low levels in the animal hemisphere of embryos at 
the MBT, though no expression was detected in the vegetal pole of these embryos. This 
expression increased at gastrulation and was still absent from the endoderm. At the neurula 
stage, the expression of both transcripts became more restricted and was observed in the neural 
plate and neural crest. The expression of hnRNP AB and hnRNP D at stage 22 remained in neural 
tissues. HnRNP AB was also expressed in the tailbud region of these embryos and appeared to be 
expressed at a higher level than hnRNP D up until this point of development. In later embryonic 
development, both hnRNP mRNAs were still detected in these neural tissues, such as the brain, 
eye, neural tube and branchial arches. Expression of hnRNP AB and hnRNP D was also observed in 
the ventral blood islands of the stage 28 and stage 38 embryos, though more so in hnRNP D than 
in hnRNP AB. 
 
3.4 Discussion 
 
3.4.1 Histone Variants 
The histone variants identified here, together with the previously identified X. laevis histone 
variants all have homologues in higher eukaryotes (Kamakaka and Biggins, 2005). It would 
therefore appear that Xenopus laevis has a similar number of somatic histone variants to humans. 
Though humans also have an additional histone H2A variant, H2A.Bbd (Chadwick and Willard, 
2001) and have five replication-dependent somatic H1 variants, H1.1-H1.5 (Happel and Doenecke, 
2009), whereas X. laevis only has three, H1A, H1B and H1C (Risley and Eckhardt, 1981).  
 
Together with those identified in this study, the most histone variants have been identified for 
histones H1 and H2A in X. laevis, whilst only two have been identified for histone H3. These 
numbers correlate with the known histone variants in other species (Kamakaka and Biggins, 
2005). 
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Figure 3.12 – Wholemount in situ hybridisation analysis of hnRNP AB and hnRNP D expression 
patterns in X. laevis. 
WISH was performed on embryos from a single X. laevis female at approximately stage 9, stage 
11, stage 16, stage 22, stage 28 and stage 38. These were hybridised with the anti-sense or sense 
(Controls) RNA probes for hnRNP AB (A.) and hnRNP D (B.). Both hnRNPs were expressed from 
stage 9 throughout development to stage 38. At stages 9, 11 and 16, the expression of hnRNP AB 
appeared to be at a higher level than that of hnRNP D. Expression of both of these hnRNP genes 
were detected in neural and neural-derived tissues at stages 16, 22, 28 and 38. No specific 
staining was observed in any of the embryos hybridised with the control probes. Stage 9 – animal 
(left) and vegetal (right) views, stage 11 – vegetal view, stage 16 – anterior view (dorsal top), 
stages 22, 28 and 38 – lateral views (anterior right). 
 74 
 
As expected, no histone H4 variants were identified, so this histone was used as a control of 
ubiquitous histone expression. 
 
3.4.1.1 B4, H1A, H1B and H1C 
It had previously been reported that expression of the linker histone variant, B4, is restricted to 
oogenesis and early embryogenesis (Smith et al., 1988), and disappears from the embryo by 
gastrulation (Cho and Wolffe, 1994). This Northern blot analysis correlated with the results 
generated by WISH in this study since B4 expression was only observed at stage 9 and was absent 
from older embryos (Figure 3.8A). During X. laevis development, B4 is replaced by the three 
somatic linker histone variants, H1A, H1B and H1C, just after the MBT (Khochbin and Wolffe, 
1994), which then become the predominant linker histones (Kandolf, 1994, Khochbin and Wolffe, 
1994). H1A, H1B and H1C are replication-dependent histone variants and have previously been 
found to be expressed in both embryonic and adult tissues (Risley and Eckhardt, 1981). Therefore 
these H1 variants are considered to be the canonical X. laevis histone H1 proteins (Khochbin and 
Wolffe, 1994). The expression patterns determined here back up these findings since H1A, H1B 
and H1C are all expressed at high levels throughout embryos from stage 9 up until at least stage 
38 (Figure 3.8B, C and D). 
 
3.4.1.2 H1X 
The X. laevis homologue of H1X was found to exhibit a tripartite structure, characteristic of higher 
eukaryote histone H1 proteins (Wolffe, 1998), that display a highly conserved core globular 
domain and highly variable N- and C-terminal tails (Figure 3.1A). Previous Northern blot analysis 
showed that this replication-independent linker histone variant was expressed in a wide range of 
adult human tissues (Yamamoto and Horikoshi, 1996). Using WISH, the expression of H1X in X. 
laevis embryos was seen to occur throughout early development, though localised to anterior 
neural tissues (Figure 3.8E). Together these results suggest H1X is expressed throughout an 
organism’s life but may have a specialised function during embryogenesis due to its specific 
expression pattern. 
 
3.4.1.3 H1o-1 and H1o-2 
The X. laevis H1o-1 and H1o-2 proteins were originally found to occur only in adult tissues, similar 
to the mammalian H1o variant (Risley and Eckhardt, 1981). A more in depth analysis determined 
that the H1o proteins only appeared after stage 42 during embryogenesis (Moorman et al., 1986). 
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Although the H1o-1 and H1o-2 mRNAs have been detected at low levels during early development 
using Northern blotting (Khochbin and Wolffe, 1993), this expression was likely to be too low to 
detect with the less sensitive WISH assay.  
 
3.4.1.4 H2A.1 and H2A.2 
The mammalian H2A.1 and H2A.2 histone variants are replication-dependent and together 
account for 40% of the total histone mRNA in mice (Hurt et al., 1989, Fecker et al., 1990). 
Therefore, the highly conserved X. laevis homologues of H2A.1 and H2A.2 (Figure 3.2A and B) can 
be considered to be the canonical histone H2A proteins. The expression patterns determined for 
both transcripts correlated with this, since both genes were expressed throughout embryos at the 
developmental stages tested, though an increase in expression was observed in neural tissues 
(Figure 3.9A and B).  
 
3.4.1.5 H2A.X 
Since performing expression analysis on H2A.X (Figure 3.9C), another study documenting the 
expression of this histone variant in X. laevis was published (Lee et al., 2010). In the published 
study, H2A.X was only found in the neural tissues of the head. In this study, H2A.X expression was 
also observed the tailbud region. Inhibition of H2A.X expression in X. laevis caused defects in 
anterior neural development (Lee et al., 2010), which demonstrates the important link between 
the expression and function of a gene. 
 
3.4.1.6 H2A.Z1 and H2A.Z2 
The X. laevis H2A.Z homologue was previously identified and its expression was observed in the 
head and tailbud of stage 26 embryos (Iouzalen et al., 1996). Two isoforms of H2A.Z were recently 
discovered in vertebrates however, named H2A.Z1 and H2A.Z2 (Eirin-Lopez et al., 2009). The 
homologues of these proteins were identified in X. laevis and were found to be very highly 
conserved throughout vertebrate evolution (Figure 3.3A and B). Both H2A.Z1 (previously H2A.Z) 
and H2A.Z2 (previously H2A.V) displayed expression patterns similar to each other in later 
embryogenesis (Figure 3.9D and E) and also to the published expression pattern for H2A.Z1 
(Iouzalen et al., 1996). The initiation of expression of each gene was significantly different, since 
H2A.Z1 was expressed from at least stage 9, whereas H2A.Z2 was expressed from neurulation. 
These results suggest that although these H2A.Z isoforms and their expression patterns are 
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similar, H2A.Z1 and H2A.Z2 could have separate developmental functions. This is investigated in 
Chapters 5 and 6. 
 
3.4.1.7 mH2A1 and mH2A2 
The macro-H2A variants, mH2A1 and mH2A2, identified in X. laevis were found to be highly 
conserved (Figure 3.5A and B). No expression of either of these genes was detected before 
neurulation, though the expression of mH2A1 and mH2A2 remained low until the later stages of 
embryonic development (Figure 3.9F and G). Previous studies in zebrafish have found that mH2A1 
and mH2A2 are involved in the repression of genes during differentiation (Buschbeck et al., 2009). 
Therefore, the later onset of the expression of these histone variants could be due to their 
involvement in the differentiation of tissues at these later stages of development. 
 
3.4.1.8 H3.3 and CENPA 
The expression patterns of neither histone H3 variant in X. laevis had previously been 
characterised, although both H3.3 (Tazaki et al., 2005) and CENPA (Edwards and Murray, 2005) 
have been reported in this organism. In this study, H3.3 and CENPA expression was seen 
throughout early development, in the neural and anterior tissues of the embryos assayed (Figure 
3.10). These expression patterns could indicate a requirement of both of these histone variants 
throughout embryogenesis, since in X. laevis, H3.3 is involved in transcriptional activation (Ng and 
Gurdon, 2008) and CENPA is involved in kinetochore formation (Edwards and Murray, 2005). 
 
3.4.2 HnRNP AB and hnRNP D 
Previous studies in X. laevis have shown that both hnRNP AB and hnRNP D are initially expressed 
as maternal proteins in oocytes (Czaplinski and Mattaj, 2006, Kroll et al., 2009). Using WISH, it was 
shown that both of these hnRNP genes continue to be expressed throughout early embryonic 
development, until at least the swimming tadpole stage (Figure 3.12). HnRNP AB and hnRNP D 
both exhibited elevated expression in the neural plate and neural crest at neurulation. At the 
tailbud and swimming tadpole stages, this expression was maintained in neural tissues, such as 
the eye, brain, branchial arches and the neural tube. Previous studies on the expression of several 
other hnRNP genes, including hnRNP G (Dichmann et al., 2008), hnRNP K (Liu et al., 2008), and 
Samba, which is closely related to hnRNP AB (Yan et al., 2009), found that although the expression 
of each of these mRNAs differed slightly, each transcript was found in the same tissues as hnRNP 
AB and hnRNP D were. Inhibiting the translation of these hnRNP mRNAs resulted in problems in 
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neural development (Dichmann et al., 2008, Liu et al., 2008, Yan et al., 2009). It is therefore 
possible that hnRNP AB and hnRNP D are also important for early X. laevis development; this is 
investigated in Chapter 4. 
 
Although analysing mRNA expression patterns can prove informative, it is important to note that 
expression of the mRNA and the protein it encodes do not necessarily correlate. Furthermore, 
although the potential tissues a particular gene functions in can be indicated by localisation of its 
mRNA, these expression patterns, ultimately, only give limited knowledge about the function of a 
gene. To gain more insight into gene function, the expression of a protein of interest can be 
inhibited. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 78 
 
4. Loss of Function Studies on hnRNP AB and hnRNP D 
 
4.1 Introduction 
 
Although mRNA expression patterns can give some indication about the possible roles of hnRNP 
AB and hnRNP D during development due to their locations, this information is limited to the 
potential target tissues. To further understand a protein’s role, one of the most informative 
methods is to knock down its expression. This is done relatively simply in Xenopus through 
microinjection of antisense nucleic acid analogues, morpholino oligonucleotides (MO).  
 
Morpholino oligonucleotides were first used in Xenopus laevis at the start of this century 
(Heasman et al., 2000) and have since become a powerful tool due to their ease of use and long-
lasting effects. MOs are most often composed of 25 base-like subunits, but unlike DNA and RNA, 
these subunits have morpholine rings (hexameric sugar backbone) instead of ribose rings 
(pentameric sugar backbone). This allows the MO to go undetected by nucleases in the cell that 
would normally digest other antisense nucleic acids, but still allows normal Watson-Crick base 
pairing. Morpholino oligonucleotides can be used to block translation of an mRNA, modify pre-
mRNA splicing or block other mRNA sites, such as preventing micro RNA activity (Summerton and 
Weller, 1997). MOs that are targeted to the 5’ UTR and/or translational start site of an mRNA 
work through steric blocking. This occurs when the MO binds to the mRNA at the target region 
and interferes with the progression of the ribosome, thereby inhibiting protein synthesis 
(Summerton and Weller, 1997).  
 
HnRNP proteins are known to regulate the expression of genes at the post-transcriptional level, 
where they are involved in RNA splicing, stability, export and localisation (Dreyfuss et al., 1993). In 
X. laevis, hnRNP AB was identified as being involved in the vegetal localisation of Vg1 mRNA in 
oocytes (Czaplinski et al., 2005), and hnRNP D was discovered to destabilise cyclin B2 mRNA at the 
MBT (Guo et al., 2008). An over-expression of hnRNP AB in X. laevis has also been previously 
performed, which caused embryos to develop a kinked axis and anterior defects (Dichmann et al., 
2008). No further characterisation of this protein was however performed. In other systems it has 
been suggested that both of these proteins have further roles as transcription cofactors (Tolnay et 
al., 1999, Leverrier et al., 2000, Mikheev et al., 2000, Ahmad and Lingrel, 2005), potentially as 
histone acetyltransferases (Hebbes and Allen, 2000, Covelo et al., 2006). Therefore, the aim of this 
study was to determine the roles of these hnRNP proteins during early development in X. laevis. 
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Using in situ hybridisation, the expression patterns of hnRNP AB and hnRNP D were determined. 
Both mRNAs were expressed up until the tadpole stage. This expression was mainly localised in 
neural tissue and tissues derived from the neural crest/plate throughout development (Figure 
3.12). Studies on hnRNP proteins in X. laevis have previously been performed where it was found 
that the mRNA of these proteins was expressed in very similar patterns to that of hnRNP AB and 
hnRNP D (Dichmann et al., 2008, Liu et al., 2008, Yan et al., 2009). These studies have also shown 
that MO-mediated knock down and gain of function experiments on these proteins correlates 
with primary neuron development and axonal growth (Dichmann et al., 2008, Liu et al., 2008, Yan 
et al., 2009), suggesting that this group of proteins plays a significant role in early development, 
especially in neurogenesis. 
 
In this chapter, the expression of hnRNP AB and hnRNP D was suppressed using distinct MOs in 
separate loss of function studies. After microinjection of the MOs targeted to hnRNP AB and 
hnRNP D into embryos, phenotypic analysis gave an indication of the developmental processes 
that were affected by the loss of either protein, suggesting their potential roles during 
development. In order to gain a deeper understanding of these processes, and more importantly, 
the genes that are affected by these knockdowns; WISH experiments were performed using 
molecular markers of tissues that were affected by the loss of either of the hnRNP proteins. 
 
4.2 HnRNP AB 
 
4.2.1 Knockdown of hnRNP AB Results in Embryo Paralysis 
In an attempt to determine the requirement for hnRNP AB during early X. laevis development, a 
loss of function study was performed (Figure 4.1). Although X. laevis has a pseudotetraploid 
genome (Hughes and Hughes, 1993), only one hnRNP AB mRNA sequence could be identified. 
Therefore, a MO was designed to target the 5’ UTR and the first 4 bases of the coding region of 
this mRNA (Figure 4.1A), and was used to study the effect on development. A BLAST search, 
restricted to Xenopus nucleic acids, was performed on XenBase to ensure the MO would not bind 
to sequences other than that of hnRNP AB. This search revealed no other targets of this MO in X. 
laevis and that it should specifically bind to the intended mRNA (Figure 4.1B). To ensure no off-
target effects were caused by the morpholine backbone, a standard control (SC) MO was injected 
alongside (Figure 4.2). This SC MO is targeted against a splice-generating mutation in the β-globin 
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mRNA from thallasemic humans (Figure 4.2A) and should, therefore, have no target or biological 
activity in Xenopus cells. 
 
Since the required dose of MOs can vary with different targets, it was necessary to titrate the 
hnRNP AB MO to determine the appropriate amount required to induce an effect. The hnRNP AB 
MO was diluted to 0.25mM, 0.5mM and 1mM; 5nl were injected from 0.25mM, 5nl and 10nl were 
injected from 0.5mM and 10nl were injected from 1mM, which gave 10ng, 20ng, 40ng or 80ng of 
MO per embryo (Figure 4.1C). The same dilutions of the SC MO were also made and the same 
amounts were injected into the same batch of fertilised eggs to control for any slight differences 
that could occur between eggs from different females (Figure 4.2B). These embryos were allowed 
to develop until early tadpole stage, being monitored closely throughout development. Nearly all 
embryos injected with up to 40ng of the SC MO developed up to stage 35/36 normally, with only 
10% or less dying, a rate that has experimentally been seen to be normal (Figure 4.2C). The 
mortality rate in embryos injected with 80ng of SC MO increased to just over 30%, indicating 
some off target effects were occurring at this amount. All of the embryos injected with 10ng of 
hnRNP AB MO developed up to stage 33/34 normally, as did the majority of embryos injected 
with 20ng. When embryos were injected with 40ng of this MO however, around 75% of the 
embryos injected were incapable of swimming at stage 33/34. These embryos developed 
normally through to the tailbud stages, when embryos start moving. Approximately 75% of the 
hnRNP AB morphants did not respond to stimuli, such as shaking the dish or prodding the 
embryos with forceps. Some of these embryos also exhibited defects in anterior-posterior axis 
patterning and a reduction of pigmentation in the eye (arrowed in Figure 4.1D). Embryos injected 
with 80ng of MO were also paralysed, however, around half of these embryos died during early 
tailbud stage with only a few surviving to stage 33/34.  
 
Since embryos injected with 10ng and 20ng of hnRNP AB MO showed no obvious effect and those 
injected with 80ng of either MO had increased mortality rates. It was decided that 40ng of hnRNP 
AB MO would be used for all loss of function experiments since this amount of MO resulted in a 
clear phenotype in the majority of embryos but did not lead to early death.  
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Figure 4.1 – Microinjection of hnRNP AB MO into X. laevis embryos. 
X. laevis embryos from a single female were injected with the hnRNP AB MO (A.) recognising the 
5’ UTR and translation start site of the hnRNP AB mRNA (B.). Embryos were injected with 
increasing amounts of MO and monitored throughout development. Movement and death were 
scored and plotted as percentages (C.). Embryos injected with 40ng of hnRNP AB MO were 
photographed at stage 33/34 to show the kinked axis (blue arrows) and reduced eye pigment (red 
arrows) morphologies (D.). 
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Figure 4.2 – Microinjection of Standard Control (SC) MO into X. laevis embryos.  
X. laevis embryos from a single female were injected with the SC MO (A.) using increasing 
amounts. Injected embryos were monitored throughout development, and the numbers of 
normal and dead embryos were recorded and plotted as percentages (B.). An embryo injected 
with 40ng of SC MO was photographed at stage 35/36 to show the normal morphology of a 
swimming tadpole stage embryo (C.).  
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The phenotypes observed with the loss of hnRNP AB only give an initial indication of an important 
role for this protein, but without additional data, reveal nothing about the specific genes or 
potential processes that were affected. To assess the function of this protein in greater detail, 
gene specific probes were used in WISH experiments. 
 
4.2.2 Loss of hnRNP AB Results in Decreased Axon Length  
The loss of hnRNP AB caused embryos to lose the ability to move and rendered them unable to 
respond to stimuli. It was therefore thought that either neural or muscle development could be 
affected by the loss of this protein, so markers of these tissues were probed using WISH 
experiments. 
 
A connexin protein, gja3 (gap junction protein α3), expressed solely in the somites of X. laevis 
embryos at the tailbud and tadpole stages (De Boer et al., 2005), was used to identify if muscle 
development was normal in embryos lacking hnRNP AB (Figure 4.3). A WISH experiment was 
performed on ten embryos that had been injected with SC and hnRNP AB MOs and then fixed at 
the late tailbud stage. After staining, the embryos were cleared to better visualise the expression 
of gja3 in the somites for easier comparison between the two sets of embryos (Figure 4.3C and 
D). All of the SC MO-injected embryos, as expected, expressed gja3 specifically in the somites 
(Figure 4.3A and C). When these control embryos were compared to those injected with the 
hnRNP AB MO (Figure 4.3B and D), the relative expression of this gene was similar in both. The 
distinct patterning of the chevron-shaped somites could also be distinguished in both sets of 
embryos; however, the somites in the morphant embryos were consistently shorter in the 
dorsoventral plane than those in control embryos (arrowed in Figure 4.3A and B). This was not 
likely to be caused by a difference in the age of the embryos either, since they were very close 
together in developmental staging. The results of this experiment were not conclusive enough to 
state that a defect in muscle development was the cause of paralysis in these morphant embryos. 
These results did identify a decrease in size of the somites, which could however contribute to 
axis deformation in some of these morphant embryos.  
 
Since hnRNP AB is expressed in neural tissue up to the tadpole stage, the effect of the loss of this 
protein on neural markers was analysed to determine if defects in these cells could have led to 
the paralysis of morphant embryos. A marker of neural progenitors, Sox2 (Graham et al., 2003), 
and a marker of terminally differentiated neurons, NST (neural-specific β-tubulin) (Oschwald et 
al., 1991), were assayed using WISH in ten of the same set of embryos at late tailbud stage.  
 84 
 
Figure 4.3 – Wholemount in situ hybridisation analysis of gja3 expression in SC and hnRNP AB 
MO-injected embryos. 
Embryos from a single female X. laevis were injected with either the SC MO (A. and C.) or the 
hnRNP AB MO (B. and D.). The embryos were allowed to develop to the late tailbud stage and 
were then fixed. WISH was performed on these embryos using a gja3 probe. The expression of 
gja3 was seen in the somites of stage 31 control (A. and C.) and stage 29/30 morphant (B. and D.) 
embryos at similar levels. The lengths of the somites in morphant embryos were shorter in the 
dorsoventral plane than those of the controls (compare arrowed structures in A. and B.). The 
average length of somite 8 in the morphant embryos was approximately 20% shorter than the 
same somite in the controls. The stained embryos were cleared using Murray’s clear to better 
visualise the structure of the somites (C. and D.), which were found to occur in the same discrete 
patterning in control (C.) and morphant (D.) embryos. The numbers A and B indicate how many 
embryos looked like those in the pictures. 
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Figure 4.4 – Wholemount in situ hybridisation analysis of Sox2 and NST expression in SC and 
hnRNP AB MO-injected embryos. 
Embryos from a single female X. laevis were injected with either the SC MO (A., C. and E.) or the 
hnRNP AB MO (B., D. and F.). The embryos were allowed to develop to the late tailbud stage and 
were then fixed. WISH was performed on these embryos using either a Sox2 probe (A. and B.) or 
an NST probe (C.-F.). The expression of Sox2 in stage 31 control embryos (A.) was seen in the eye 
(e), brain (b) and otic vesicle (ov). In stage 29/30 morphant embryos (B.), Sox2 was seen at an 
increased level in these tissues but was also expressed in the neural tube (nt) (compare arrowed 
structures in A. and B.). The expression of NST in stage 28 embryos injected with SC MO (C. and E.) 
was observed in the neural tube and the dorsal tissues of the head. As was the expression of NST 
in hnRNP AB MO injected embryos at stage 27 (D. and F.). The NST-stained embryos were cleared 
using Murray’s clear to better visualise the patterning of the inter-somitic neurons (E. and F.). 
Even though the patterning was the same in control and morphant embryos (indicated by the 
arrows in E. and F.), the expression of NST in the morphants was slightly reduced. The numbers A, 
B, C and D indicate how many embryos looked like those in the pictures. 
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These embryos had been injected either with SC or hnRNP AB MOs (Figure 4.4). The expression of 
Sox2 in all of the control embryos was restricted to the eye, brain and otic vesicle at a low 
expression level (Figure 4.4A). In all of the morphant embryos, Sox2 was also expressed in these 
regions but these embryos always had additional staining through the entire length of the neural 
tube (Figure 4.4B). This expression was not seen in any of the control embryos even when slightly 
over developed. The expression of Sox2 in the anterior regions of embryos lacking hnRNP AB was 
also consistently increased when compared to the controls (compare arrowed structures in Figure 
4.4A and B). With the NST in situ hybridisation, the expression in inter-somitic neurons could be 
seen clearly in both control and morphant embryos when cleared (arrowed in Figure 4.4E and F). 
There seemed to always be a slight decrease in the intensity of the staining in the morphant 
embryos, however, this could be due to developmental timing differences since the staging of the 
embryos was not exactly the same. 
 
Since the loss of hnRNP AB caused an increase in the staining of Sox2 in neural progenitors but the 
effects were unclear on terminally differentiated neurons, an expanded set of markers was tested 
on neurula stage embryos in an attempt to dissect the pathway of neural development (Figure 
4.5). During neurulation, Sox2 is expressed in the region of the neural plate (Graham et al., 2003), 
as well as Slug, a gene that is involved in neural crest migration (Carl et al., 1999). Neurogenin is 
expressed in three distinct areas at the start of neurulation, where it is involved in defining the 
regions of primary neurogenesis (Ma et al., 1996). Later during neurulation, NST is expressed in 
terminally differentiated neurons in two stripes either side of the invaginating neural tube 
(Oschwald et al., 1991). Runx1 is expressed in a similar region to that of NST, but its expression is 
restricted to neuroblasts (Tracey et al., 1998). Runx1 is also expressed in haematopoietic 
precursors and is one of the earliest markers of blood development in X. laevis (Tracey et al., 
1998). No change was observed in the majority of the morphant embryos probed for Neurogenin 
(Figure 4.5C) or Slug (Figure 4.5B), suggesting early primary neurogenesis and neural crest were 
unaffected. Early blood development was also seen to be unaffected, indicated by the ventral 
staining of Runx1 (Figure 4.5F). As expected, a consistent increase in Sox2 expression was seen in 
morphant embryos (Figure 4.5A); however, there was no change in the size or shape of the neural 
plate as indicated by this expression. Though what was clearer at this stage was that the number 
of terminally differentiated neurons were always decreased with the loss of hnRNP AB, as 
indicated by the decrease in NST staining (compare black and red arrows in Figure 4.5D). The 
staining of Runx1 in the neuroblasts was also consistently decreased (Figure 4.5E). 
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Figure 4.5 – Wholemount in situ hybridisation analysis of Sox2, Slug, Neurogenin, NST and 
Runx1 expression in SC and hnRNP AB MO-injected embryos. 
Embryos from a single female X. laevis were injected with either the SC or hnRNP AB MO. The 
embryos were allowed to develop to various stages during neurulation and were then fixed. WISH 
was performed on these embryos using Sox2 (A.), Slug (B.), Neurogenin (C.), NST (D.) or Runx1 (E. 
and F.) probes. The expression of Sox2 in stage 15 control and morphants embryos was restricted 
to the neural plate and neural crest; however, the staining in the morphants was slightly 
increased over that of the controls (A.). Both sets of embryos displayed the same levels and 
patterning of Slug expression at stage 15 (B.), and Neurogenin at stage 12.5 (C.). The patterning of 
NST expression was the same in SC MO and hnRNP AB MO injected embryos at stage 17 (D.), 
however, the intensity of the staining was reduced in the morphants (compare black arrows to 
red arrows in D.). Runx1 expression in the morphant embryos at stage 17 was decreased in the 
dorsal region (E.) but was the same as the controls in the ventral (F.) regions. The numbers in A, B, 
C, D, and E and F indicate how many embryos looked like those in the pictures. 
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Figure 4.6 – Wholemount immunohistochemistry using the HNK1 antibody in SC and hnRNP AB 
MO-injected embryos. 
Embryos from a single female X. laevis were injected with either the SC MO (A.) or the hnRNP AB 
MO (B.). The embryos were allowed to develop to the late tailbud stage and were then fixed. 
Immunohistochemistry was performed on these embryos using a HNK1 antibody (A. and B.). 
These embryos were then cleared using Murray’s clear to better visualise the internal staining of 
the neurons. In stage 29/30 SC MO injected embryos; HNK1 staining could be seen in neurons 
throughout the embryo; most noticeably in the head, inter-somitic neurons and the ventral 
extension of the axons (A.). The hnRNP AB MO injected embryos at the same stage also displayed 
staining in the inter-somitic neurons (B.), however, in the morphants there was a decrease in the 
overall number of neurons and a decrease in staining in the head. The lengths of the axonal 
projections were also shorter, as indicated by the length of the arrows in A and B. The numbers A 
and B indicate how many embryos looked like those in the pictures. 
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In order to examine the differentiated neurons in greater detail, immunohistochemistry was used 
with an antibody called HNK1 (Figure 4.6), which detects the cell bodies and axons of neurons 
during a period of axonal growth during the tadpole stage (Nordlander, 1989). The patterning of 
HNK1-stained neurons between the somites was the same in both control and hnRNP AB knock 
down embryos, as with the NST expression patterns determined by WISH. A definite decrease in 
neuron numbers could be seen in the morphant embryos (compare Figure 4.6A and B), however, 
these were not quantified. It can also be seen that the axons do not descend as far ventrally when 
compared to those of the control embryos and this is likely to be a cause of paralysis observed in 
the morphants (arrowed in Figure 4.6A and B). 
 
4.3 HnRNP D 
 
4.3.1 Loss of hnRNP D Leads to Embryo Paralysis 
As with hnRNP AB, the function of hnRNP D during early development in X. laevis was investigated 
using a loss of function study (Figure 4.7). Although X. laevis has a pseudotetraploid genome 
(Hughes and Hughes, 1993), only one hnRNP D mRNA sequence could be identified. Therefore, a 
morpholino oligonucleotide was designed to target the first 25 bases of the coding region of this 
mRNA in order to inhibit protein synthesis and used to determine the effects on development 
(Figure 4.7A). To check that the MO would not bind to any other sequences, a BLAST search was 
performed on XenBase using the same parameters as for the hnRNP AB MO search. The results of 
this search revealed no other targets of this MO in X. laevis other than the single hnRNP D mRNA 
(Figure 4.7B). 
 
It was again necessary to titrate the amount of MO to test its effect. So, both the SC and hnRNP D 
MOs were diluted to 0.25mM, 0.5mM and 1mM; 5nl were injected from 0.25mM, 5nl and 10nl 
were injected from 0.5mM and 10nl were injected from 1mM, which gave 10ng, 20ng, 40ng or 
80ng of MO per embryo (Figure 4.7C). Fertilised eggs were injected with these increasing amounts 
of hnRNP D MO as they were with the hnRNP AB MO. Since these loss of function experiments 
were performed alongside each other the same set of embryos acted as controls for both hnRNP 
knock downs (Figure 4.2). Again, the embryos were allowed to develop until the swimming 
tadpole stage and were monitored for any change in normal development.  
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Figure 4.7 – Microinjection of hnRNP D MO into X. laevis embryos.  
X. laevis embryos from a single female were injected with the hnRNP D MO (A.) recognising the 
translation start site of the hnRNP D mRNA (B.). Embryos were injected with increasing amounts 
of MO and monitored throughout development. Movement and death were scored and plotted 
as percentages (C.). Embryos injected with 40ng of hnRNP D MO were photographed at stage 
33/34 to show the kinked axis (blue arrows), lack of eye pigment (red arrows), and oedema (green 
arrows) morphologies (D.). 
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As with the loss of hnRNP AB, the vast majority of embryos injected with 10ng or 20ng of hnRNP D 
MO survived through to tadpole stage with no apparent differences in morphology or phenotype 
compared to control embryos. When embryos were injected with 40ng of MO, around 15% of 
embryos died, as also seen with the knock down of hnRNP AB. Unlike hnRNP AB morphants 
however, all of the remaining embryos were unable to move or respond to stimuli. These 
embryos were morphologically normal through to the tailbud stages when the morphants 
exhibited more dramatic morphological changes, such as deformation of the anterior-posterior 
axis and defects in head morphology, such as smaller heads and decreased eye pigmentation 
(arrowed in Figure 4.7D). Also, to a lesser extent enlarged fins and oedema were observed in 
some of the morphant embryos. Embryos injected with 80ng of hnRNP D MO all died during early 
tailbud stage with no embryos surviving to tadpole, suggesting this morpholino oligonucleotide 
was either more potent or less specific than the hnRNP AB MO, or that hnRNP D is more 
important for development. 
 
It was again decided that 40ng of hnRNP D MO would be used for all loss of function experiments. 
This amount was chosen since less MO gave no obvious phenotype and more resulted in the 
death of all embryos injected. Also, this amount resulted in a clear phenotype that occurred in all 
surviving embryos and it did not dramatically increase mortality rates.  
 
This MO-mediated knock down of hnRNP D resulted in paralysis, kinking of the axis and defects in 
head morphology. Though these results show this protein is important for the normal 
development of X. laevis embryos, they do not provide information on the genes and 
developmental processes affected, which can be elucidated through the use of gene-specific 
probes in WISH experiments. 
 
4.3.2 Knockdown of hnRNP D Results in Loss of Differentiated Neural and Blood Tissue  
A loss of hnRNP D protein resulted in the paralysis of tadpole stage embryos and the deformation 
of the anterior-posterior axis. Since hnRNP D is expressed in the neural plate at neurogenesis and 
remains in neural tissue up to the tadpole stage, the effect of the loss of this protein on neural 
plate patterning and primary neurogenesis was analysed. Therefore, WISH experiments were 
conducted on SC MO and hnRNP D MO injected embryos at neurula stages using the markers of 
the various neural and neural crest tissues, Sox2, Neurogenin, Slug, NST and Runx1 (Figure 4.8).  
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Figure 4.8 – Wholemount in situ hybridisation analysis of Sox2, Slug, Neurogenin, NST and 
Runx1 expression in SC and hnRNP D MO-injected embryos.  
Embryos from a single female X. laevis were injected with either the SC or hnRNP D MO. The 
embryos were allowed to develop to various stages during neurulation and were then fixed. WISH 
was performed on these embryos using Sox2 (A.), Slug (B.), Neurogenin (C.), NST (D.) or Runx1 (E. 
and F.) probes. The expression of Sox2 in stage 15 control and morphants embryos was restricted 
to the neural plate and neural crest, however, the staining in the morphants was decreased 
compared to that of the controls (A.). Both sets of embryos at stage 15 displayed the same levels 
and patterning of Slug expression (B.). Both SC MO and hnRNP D MO injected embryos at stage 
12.5 showed the same staining patterns of Neurogenin expression (C.). The expression in the 
trigeminal ganglia of the morphant embryos however was stronger than the expression in the 
same regions of the controls (compare black and red arrowed structures in C.). In stage 17 
embryos, the patterning of NST expression in the differentiated neurons of morphants was more 
widespread than the expression of NST in the controls (compare black and red arrows in D.). At 
stage 17, the dorsal expression of Runx1 was slightly decreased in embryos injected with hnRNP D 
MO compared to the expression in the controls (E.), whereas, the ventral staining of Runx1 was 
the same in both sets of embryos (F.). The numbers in A, B, C, D, and E and F indicate how many 
embryos looked like those in the pictures. 
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Figure 4.9 – Wholemount in situ hybridisation analysis of NST expression in SC and hnRNP D 
MO-injected embryos. 
Embryos from a single female X. laevis were injected with either the SC (A. and C.) or hnRNP D (B. 
and D.) MO. The embryos were allowed to develop to the late tailbud stage and were then fixed. 
WISH was performed on these embryos using an NST probe. The expression of NST in control 
embryos at stage 28 was observed in the neural tube and the dorsal tissues of the head (A. and 
C.); as was the expression of NST in the morphant embryos at stage 26, though at a lower level (B. 
and D.). The NST-stained embryos were cleared using Murray’s clear to better visualise the 
patterning of the neurons (C. and D.). The patterning of the neurons in the embryos injected with 
SC MO could clearly be seen (indicated by the arrows in C.), though this patterning was far less 
distinct in embryos lacking hnRNP D (D.). The numbers in A and B indicate how many embryos 
looked like those in the pictures. 
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The formation of the neural crest was always unaffected by the loss of hnRNP D as shown by 
expression of Slug being the same in all of the morphant embryos as they were for the controls 
(Figure 4.8B). Neurogenin in morphant embryos was expressed in the same pattern as in the 
controls but there was a consistent increase in expression in the morphants, most noticeably in 
the trigeminal ganglia (compare black and red arrows in Figure 4.8C). The staining for Sox2 in the 
neural plate of all the embryos injected with hnRNP D MO was slightly less intense than the 
staining seen in the SC MO injected embryos, indicating that the size and shape of the neural 
plate aren’t affected but that there may be an overall loss of neural tissue (Figure 4.8A). The 
expression level of NST in primary neurons was similar between both sets of embryos but the 
patterning of the neurons appeared to be more dispersed in the majority of embryos lacking 
hnRNP D (compare black and red arrows in Figure 4.8D). Dorsal staining of Runx1 also showed a 
slight reduction in neuroblasts in the majority of the embryos probed, however, staining in the 
VBI was very similar compared to the control embryos (Figure 4.8E and F).  
 
To determine how the loss of primary neurons at the neurula stage caused by the knock down of 
hnRNP D affected neural patterning at later stages, an in situ hybridisation was carried out using 
the same NST probe on SC and hnRNP D MO injected embryos at the late tailbud stage to test 
whether this effect was also visible in later development (Figure 4.9). Although the control and 
morphant embryos were at slightly different developmental stages, the lack of patterning in 
hnRNP D depleted embryos could always be seen (Figure 4.9C and D). 
 
For a more in depth analysis of neural patterning in embryos with knocked down hnRNP D 
expression, antibody staining with HNK1 was carried out on tadpole stage embryos (Figure 4.10). 
The organised patterning of the inter-somitic neurons could be seen in control embryos but this 
patterning was consistently lost when embryos were injected with the hnRNP D MO (compare 
insets in Figure 4.10A and B), as also seen with the NST WISH experiments. Although the axons 
project dorsally in the morphant embryos, these projections are sporadic and are not as organised 
as in the control embryos. Most noticeable in these embryos was the lack of neurons in the 
morphants when compared to the controls. Staining in the head region of the morphants was 
however much more intense than the staining seen in control embryos, which could be an effect 
of the increase of Neurogenin expression in the trigeminal ganglia. 
 
To determine a quantitative measurement of the number of neurons in morphant embryos, an 
antibody generated against Islet1 was used to stain the cells bodies of sensory and motor neurons 
(Figure 4.11). These were counted and statistical analysis was performed.  
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Figure 4.10 – Wholemount immunohistochemistry using the HNK1 antibody in SC and hnRNP D 
MO-injected embryos. 
Embryos from a single female X. laevis were injected with either the SC MO (A.) or the hnRNP D 
MO (B.). The embryos were allowed to develop to the late tailbud stage and were then fixed. 
Immunohistochemistry was performed on these embryos using a HNK1 antibody (A. and B.). 
These embryos were then cleared using Murray’s clear to better visualise the internal staining of 
neurons. In the control embryos at stage 31 (A.), HNK1 staining could be seen in neurons 
throughout the embryo, however, the morphant embryos at stage 31 displayed a loss of neuron 
patterning (B.), as well as an overall loss of neurons (highlighted inset in A. and B.). The ventral 
axon projections were sporadic and slightly shorter than those of the control embryos, and there 
was also a noticeable increase in HNK1 staining the head of morphant embryos compared to the 
controls. The numbers in A and B indicate how many embryos looked like those in the pictures. 
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Figure 4.11 – Wholemount immunohistochemistry analysis of Islet1 in SC and hnRNP D MO-
injected embryos, and statistical analysis of neuron numbers. 
Embryos from a single female X. laevis were injected with either the SC MO (A.) or the hnRNP D 
MO (B.). The embryos were allowed to develop to stage 22 and were then fixed. 
Immunohistochemistry was performed on these embryos using an Islet1 antibody (A. and B.). 
These embryos were then cleared using Murray’s clear to better visualise the internal staining of 
the neuron nuclei. The neuronal nuclei were counted in ten embryos injected with either SC MO 
or hnRNP D MO. Nuclei on either side of the neural tube were treated as separate counts. The 
mean and standard deviations were calculated and plotted (C.). Morphant embryos were found to 
have approximately 40% less neurons than controls. An unpaired t-test was performed, where p < 
0.0001 (indicated by *** in C.), suggesting a high statistical significance.  
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The antibody staining was performed on embryos at the end of neurogenesis when the numbers 
of neurons plateau (Sharpe and Goldstone, 2000), in order to get more accurate numbers. Since 
both sides of the embryo show little variation in the numbers of neurons (Sharpe and Goldstone, 
2000), each side was counted separately for ten embryos of both control and morphants. Even 
before counting it was clear that the numbers had decreased and it was also easier to see that the 
neurons weren’t patterned correctly since they were not in neat lines as in the control embryos 
(compare Figure 4.11A and B). After counting the neurons, the mean and standard deviations 
were calculated for both sets of results and were plotted on a graph (Figure 4.11C). Since these 
samples were independent, an unpaired t-test was performed. When compared to the control 
embryos, those lacking hnRNP D had around a 40% decrease in neuron numbers, which was 
deemed to be statistically significant by the t-test (p < 0.0001). These results indicate that hnRNP 
D is required for the normal development and patterning of at least these two types of neuron. 
 
Although the significant decrease in neuron numbers and the disorganised patterning of those 
remaining could explain the lack of motility in hnRNP D morphant embryos, there could have 
been other effects in different tissues in these embryos. To test this, markers of muscle (gja3), 
liver and blood (Hex), and heart (Tbx20) were used in WISH experiments (Figure 4.12). The gja3 
staining in the somites of morphants was similar to that of the controls; however, the somites 
consistently looked less differentiated, which could be due to the small differences in 
developmental staging (arrowed in Figure 4.12A and B). The expression of both Hex and Tbx20 
exhibited increased staining in regions around the liver (Figure 4.12C and D) and heart (Figure 
4.12E and F), respectively, however, in these areas the expression of these genes appeared 
diffuse. There was also a consistent increase in the cement gland staining of Tbx20, and a loss of 
expression of Hex in both the VBI and dorsal lateral plate mesoderm (DLP). The changes in 
expression in these regions could be due to the maternal (Czaplinski and Mattaj, 2006) or VBI 
(Figure 3.12B) expression of hnRNP D. 
 
Since a decrease in expression of Hex staining in blood vessels and adult blood precursors was 
observed, markers of early and late haematopoiesis were investigated using WISH (Figure 4.13). 
Fli1 and SCL, markers of early blood development, had slightly decreased expression in the VBI at 
neurula stage but there the expression patterns remained in a similar region to that of the 
controls in the majority of the morphant embryos (Figure 4.13A and B). At the tailbud and tadpole 
stages, the expression of LMO2 and globin, respectively, was nearly completely abolished in VBI 
(Figure 4.13C and D). 
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Figure 4.12 – Wholemount in situ hybridisation analysis of gja3, Hex and Tbx20 expression in SC 
and hnRNP D MO-injected embryos.  
Embryos from a single female X. laevis were injected with either the SC MO (A., C. and E.) or the 
hnRNP D MO (B., D. and F.). The embryos were allowed to develop to the late tailbud stage and 
were then fixed. WISH was performed on these embryos using either a gja3 (A. and B.), Hex (C. 
and D.) or Tbx20 (E. and F.) probe. The expression of gja3 in stage 31 control embryos was seen in 
the discrete patterning as expected (A.). Morphant embryos at stage 28 also showed expression in 
the somites to a similar level (B.). The somites at the posterior end of the morphant embryos 
lacked definition (compare arrowed structures in A. and B.). In stage 29/30 control embryos, Hex 
expression was primarily located in the liver (l), ventral blood islands (vbi) and the dorsal-lateral 
plate mesoderm (dlp) (C.). In morphant embryos at stage 29/30 (D.), the majority of Hex staining 
was lost from the VBI and DLP (compare black arrows in C. and D.). The expression of Hex was still 
present in the liver of morphant embryos but was seen over an expanded region (compare red 
arrows in C. and D.). The expression of Tbx20 in control embryos at stage 29/30 was seen in the 
heart (h) and cement gland (cg) (E.). Hex expression was also observed in these structures in the 
same stage embryos injected with hnRNP D MO (F.). This expression occurred over an expanded 
region (compare arrowed structures in E. and F.). The numbers in A, B, C, D, E and F indicate how 
many embryos looked like those in the pictures. 
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Figure 4.13 – Wholemount in situ hybridisation analysis of Fli1, SCL, LMO2 and globin expression 
in SC and hnRNP D MO-injected embryos. 
Embryos from a single female X. laevis were injected with either SC MO or hnRNP D MO. The 
embryos were allowed to develop to the desired stage and were then fixed. WISH was performed 
on these embryos using Fli1 (A.), SCL (B.), LMO2 (C.) and globin (D.) probes. The expression of Fli1 
in stage 15 control and morphant embryos occurred in the early VBI, though at a lower level in 
morphants (A.), as did the expression of SCL in stage 17 embryos (B.). In stage 24 embryos 
injected with SC MO, the expression of LMO2 was seen in the VBI, DLP and the extending tailbud 
(tb). In the embryos injected with hnRNP D MO however, the majority of the VBI and DLP 
expression was absent, although the expression of LMO2 in the tailbud region was still present 
(compare black arrows to red arrows in C.). Globin expression was observed in control embryos at 
stage 29/30 in the VBI, however, the majority of this expression was lost in morphant embryos at 
the same stage (compare black arrow to red arrow in D.). The numbers in A, B, C and D indicate 
how many embryos looked like those in the pictures. 
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Even though blood development was effected in the morphants, the decrease in neurons was 
likely to be the primary cause of paralysis in embryos lacking the hnRNP D protein. Also, there 
appeared to be a lack of terminal differentiation, at least in certain tissues, occurring in these 
morphant embryos. This would require further investigation to fully understand. 
 
4.4 Discussion 
 
4.4.1 Loss of Function 
A level of specificity for each hnRNP MO was indicated since the phenotypes for both knock 
downs were different. In addition, the MOs were injected at levels that had no effect in the 
control embryos.  
 
Both hnRNP MOs generated the best results when 40ng was injected per embryo. The same 
amount of MO was found to be effective for the suppression of hnRNP G expression, in previous 
loss of function studies in X. laevis (Dichmann et al., 2008). Both loss of function experiments 
resulted in paralysed embryos, though the morphology of hnRNP D morphants was more severely 
abnormal compared to that of the hnRNP AB morphants. The kinked axis, paralysis and head 
defects were also seen in a previous study of X. laevis hnRNP proteins (Dichmann et al., 2008), 
indicating a related and/or overlapping roles for this group of proteins. Neither MO had any 
noticeable effect at 10ng or 20ng injections. Whereas, embryos injected with 80ng of hnRNP AB 
MO resulted in around 50% of all embryos dying, the same amount of hnRNP D MO caused all of 
the morphants to die. With these results it would seem that either the hnRNP D MO caused off 
target effects, that hnRNP D is critical for development or that the hnRNP D MO is more potent 
than the hnRNP AB MO. Additional experiments could answer these questions. A rescue 
experiment (see below) would determine a lack of specificity, and a western blot for the hnRNP D 
protein in morphant embryos would test whether they require at least a small amount of hnRNP 
D in order to survive. The increased potency of the hnRNP D MO over the hnRNP AB MO could be 
explained by an increased level of expression of hnRNP AB over that of hnRNP D, causing less 
inhibition of hnRNP AB protein synthesis. The higher expression of hnRNP AB above the level of 
hnRNP D can be seen in the expression patterns determined by WISH in Chapter 3, which was also 
corroborated with the expression profiles for both genes that can be found on XenBase (Figure 
4.14).  
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Figure 4.14 – mRNA expression levels of hnRNP AB and hnRNP D.  
The developmental mRNA levels of hnRNP AB (A.) and hnRNP D (B.) have previously been 
quantified by spiking RNA extracted from X. laevis and X. tropicalis with heterologous RNA at 
known concentrations, and then hybridising these samples to microarrays. The expression data 
are given in log10 units of relative mRNA expression (Yanai et al., 2011). These data indicate an 
increase in hnRNP AB mRNA levels at gastrulation (stages 10-14), whereas hnRNP D mRNA levels 
steadily increase during development. 
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When using morpholino oligonucleotides to generate data, many false positives can be observed, 
therefore, it is necessary to include controls to ensure the specificity of each result (Eisen and 
Smith, 2008). To ensure the specificity and, therefore, the effects of each knock down, extra 
controls would have to be performed and so the results here must be considered preliminary. 
These could include using a second MO designed to a different non-overlapping part of the 5’UTR 
of both mRNAs and using a mismatched MO where five or more of the bases in the original 
morpholino oligonucleotide are modified. A rescue experiment could also be performed, where 
the MO is injected into the embryos along with a synthetic mRNA encoding the hnRNP protein 
being investigated (for example, see Chapter 6). 
 
Some progress has been made with the third option above; rescue constructs have been prepared 
and sequenced, where the third base of each codon in the MO binding region was altered to 
prevent binding but to retain amino acid identity. Since both hnRNP proteins have the conserved 
motif A and amino acids required for HAT activity, constructs were also cloned alongside these 
that contained a point mutation that caused the glutamic acid necessary for this activity to be 
changed to an alanine. Future experiments could be performed where either MO is injected into 
one-cell embryos, then the corresponding rescue mRNA (with or without the glutamic acid) would 
be injected into two of the four blastomeres of a stage 3 embryo, along with a lineage tracer. One 
half of the embryo would then act as a knock down and the other as a rescue. These experiments 
could determine if any part of the knock down phenotypes seen are due to a loss of HAT activity, 
further suggesting additional roles of hnRNP AB and hnRNP D.  
 
4.4.2 Phenotypic Analysis 
The loss of hnRNP AB and hnRNP D from X. laevis embryos both caused defects in neural 
development. The differences between the knock downs observed using in situ hybridisation and 
immunohistochemistry suggest a level of specificity in their functions, though additional analysis 
is still required. 
 
Neural crest migration and the onset of primary neurogenesis were found to be unaffected by the 
loss of hnRNP AB. Whereas, there was an increase in neural stem cells and a loss of neuroblasts, 
and a decrease in differentiated neurons at neurula and tailbud stages. It is likely that the increase 
in Sox2 expression, caused by the knockdown of hnRNP AB (Figure 4.5A), maintains the neural 
stem cell population and prevents differentiation (Archer et al., 2011).  In turn, this causes the 
loss of terminally differentiated neurons as seen with the NST (Figure 4.5D) and HNK1 staining 
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(Figure 4.6). Since these experiments were only semi-quantitative it would be necessary to 
quantify these decreases using quantitative RT-PCR. It would also be possible to quantify the loss 
of the primary neurons using the Islet1 nuclei counting assay. 
 
Neural crest migration was also unaffected by the loss of hnRNP D, however, neural stem cells, 
neuroblasts and differentiated neurons were all affected by the knock down. The loss of neural 
stem cells as indicated by the decreased expression of Sox2 probably caused the decrease seen in 
neuroblasts and differentiated neurons (Figure 4.8). Furthermore, the presence of HNK1-stained 
neurons that had extended their axons would agree with this hypothesis (Figure 4.10). 
 
These observations show that both hnRNP AB and hnRNP D are required for normal neurogenesis, 
which correlates with the expression of both these hnRNPs (Figure 3.12). The results generated 
here also show similarities with the morphant phenotypes of other X. laevis hnRNPs (Dichmann et 
al., 2008, Liu et al., 2008, Yan et al., 2009). The misexpression of each hnRNP appears to have 
different effects on neural development, such as impaired neural crest migration (Yan et al., 
2009), disorganisation of microtubules and neurofilaments (Liu et al., 2008), and defects in 
primary and secondary neural differentiation (Dichmann et al., 2008). The abundance of hnRNPs 
found with activity in the various processes of neurogenesis in previous studies (Dichmann et al., 
2008, Liu et al., 2008, Yan et al., 2009), together with the results generated here; suggest that this 
group of proteins plays an important role in early neural development. To ensure there were no 
other effects of hnRNP AB and hnRNP D knock down on neural development, markers of other 
regions of the neural plate, secondary neurogenesis and brain regions could be investigated. 
 
Muscle development in both loss of function studies appeared to be affected in subtly different 
ways. Though previous work has also implicated several hnRNPs in muscle development 
(Dichmann et al., 2008), it would be necessary to investigate the muscle development pathway in 
greater detail. Markers of early muscle development, such as MyoD and Myf5, could be used with 
in situ hybridisation, and the antibody 12/101 could be used to look at skeletal muscle. 
 
Previous studies on X. laevis hnRNP proteins have only focused on neural (Dichmann et al., 2008, 
Liu et al., 2008, Yan et al., 2009) and muscle (Dichmann et al., 2008) development. Therefore, 
there are no known affects of hnRNPs on haematopoiesis during early development except the 
results found for the loss of hnRNP D in this study (Figure 4.13). It appears that the loss of hnRNP 
D causes a loss of blood in later development possibly through a lack of differentiation, which 
correlates with the expression of hnRNP D in the VBI (Figure 3.12B). In addition to the potential 
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inhibition of differentiation in neural, muscle and blood in embryos lacking hnRNP D, it also 
appears that liver and heart are affected by the loss of hnRNP D (Figure 4.12), which could be due 
to the maternal expression of this protein (Czaplinski and Mattaj, 2006). To fully explore this 
theory, it would be essential to look at the terminal differentiation markers of other tissues in the 
embryo.  
 
HnRNPs are involved in splicing, nuclear export and controlling stability of mRNAs (Dreyfuss et al., 
1993), therefore, it could be possible that any one of these functions, or perhaps a currently 
unknown function, is the molecular mechanism behind the effects seen with these knock downs. 
Although this would require biochemical analysis, rescue constructs lacking HAT activity may go 
some way to answering this question. To fully understand the biological roles of hnRNP AB and 
hnRNP D during early development, it would be necessary to determine the direct target genes of 
both these proteins. 
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5. H2A.Z2 Loss of Function Analysis 
 
5.1 Introduction 
 
The histone H2A family contains the largest number of histone variants identified within the four 
core histones (Malik and Henikoff, 2003). The histone variant H2A.Z is one such member of this 
family and is also one of the most heavily studied histone variants. Within chromatin, H2A.Z has 
been reported as having diverse nuclear functions in a number of species. In chicken, H2A.Z is 
present at the promoters of active genes in its acetylated form and is completely absent from 
inactive genes (Bruce et al., 2005), indicating a role in transcriptional activation. In mammalian 
cell lines, H2A.Z is essential for normal chromosome segregation (Rangasamy et al., 2004), and is 
required for heterochromatin silencing in mice (Rangasamy et al., 2003) and fruit flies 
(Swaminathan et al., 2005).  
 
Although the proposed roles of H2A.Z are numerous and varied, how this histone variant exerts 
its effects is not fully understood. It has been suggested that post-translational modifications, 
such as acetylation, ubiquitination and SUMOylation, could account for the molecular 
mechanisms underlying the structural and functional variability of the roles of H2A.Z (Dryhurst et 
al., 2009). While these past studies referred to H2A.Z as a single protein, it was recently 
discovered that two protein isoforms of H2A.Z exist in vertebrates, H2A.Z1 (previously named 
H2A.Z) and H2A.Z2 (previously named H2A.F/Z or H2A.V) (Eirin-Lopez et al., 2009). This group also 
discovered that the H2A.Z2 isoform is more evolutionary constrained than H2A.Z1 (Eirin-Lopez et 
al., 2009); therefore, some of the previously described multiple functions of H2A.Z in vertebrates 
could be attributed to the existence of these two distinct isoforms. 
 
Only two previous studies have been published that characterise the two H2A.Z isoforms 
separately. The first, reported that both H2A.Z1 and H2A.Z2 are expressed in a wide range of 
human tissues, though the two transcripts were expressed at varying levels depending on the 
tissue and developmental stage (Dryhurst et al., 2009). Both H2A.Z1 and H2A.Z2 were also found 
to occupy similar but non-identical regions within chromatin, and both are acetylated at lysine 
residues in their N-terminal tails (Dryhurst et al., 2009). Dryhurst and colleagues suggested that 
the differences in the spatial and temporal expression of these two genes could be due to the 
highly divergent promoters of H2A.Z1 and H2A.Z2 (Dryhurst et al., 2009). The second study 
generated knockouts of either the H2A.Z1 or H2A.Z2 gene in a chicken cell line, and it was 
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possible to detect separate proteins for either isoforms via immunoblotting from these individual 
knockouts (Matsuda et al., 2010). The cell lines lacking either H2A.Z1 or H2A.Z2 showed differing 
phenotypes and changes in cell growth and gene expression (Matsuda et al., 2010), suggesting 
that the two isoforms of H2A.Z have separate functions. 
 
Though the existence of two separate isoforms of H2A.Z has been confirmed in most vertebrate 
genomes (Eirin-Lopez et al., 2009) and chicken, mouse and human tissues (Dryhurst et al., 2009, 
Matsuda et al., 2010), it is still unknown whether the existence of these two isoforms is 
significant. It is likely that, in the majority of previous studies, H2A.Z1 was under investigation. 
Since these two isoforms only differ by three amino acids in most vertebrates (Eirin-Lopez et al., 
2009), it is possible that some of the functions characterised for this protein may have been due 
to the presence of H2A.Z2. The functional significance of H2A.Z2, therefore, is still unclear. In an 
attempt to characterise the roles of both H2A.Z isoforms and to determine if they have separate 
roles during early X. laevis development, loss of function analysis was performed on H2A.Z1 (see 
Chapter 6) and H2A.Z2 (described here). 
 
In order to gain a better understanding of the processes H2A.Z2 is involved in, the expression of 
this isoform was knocked down using a morpholino oligonucleotide and the effects on 
development were investigated. The inhibition of H2A.Z2 translation was confirmed through 
Western blotting. Phenotypic analysis of the embryos injected with the H2A.Z2 MO was 
performed during development, which gave an indication of the developmental processes that 
were affected by the loss of this protein due to the morphologies observed. A standard control 
(SC MO) was also injected into embryos to ensure that no off-target effects were caused by the 
morpholine backbone. To determine the genes responsible for the morphologies seen in H2A.Z2-
deficient embryos, WISH was performed with a variety of cell-type-specific markers. Rescue 
experiments were performed by co-injecting the H2A.Z2 MO with an mRNA encoding the coding 
region of the H2A.Z2 open reading frame (ORF), to test whether normal development was 
recovered by the reintroduction of the H2A.Z2 protein. 
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5.2 Knockdown of H2A.Z2 Using a Morpholino Oligonucleotide 
 
5.2.1 Embryos Lacking H2A.Z2 Exhibit Movement Defects 
To determine the requirement for H2A.Z2 during early development, a loss of function study was 
performed (Figure 5.1). A morpholino oligonucletoide was designed to target the 5’UTR of the 
H2A.Z2 mRNA of both alloalleles in X. laevis (Figure 5.1A). Although there was one base difference 
between the MO and either alloallele (Figure 5.1B), this would not have affected the binding 
capacity of the MO to either H2A.Z2-1 or H2A.Z2-2 (personal communication, Dr. P. A. Morcos – 
GeneTools). The 5’UTR sequence was chosen since it was necessary for the MO only to bind to 
and inhibit the translation of both H2A.Z2 mRNAs, and not the highly similar H2A.Z1. A BLAST 
search was performed on XenBase, restricted to Xenopus nucleic acids, to ensure the H2A.Z2 MO 
was specific for its intended target sequences. The search revealed no other targets of the H2A.Z2 
MO, apart from the H2A.Z2-1 and H2A.Z2-2 mRNAs from X. laevis.  
 
The H2A.Z2 MO was titrated into X. laevis embryos to determine the amount of morpholino 
oligonucleotide required to elicit an effect. Therefore, the H2A.Z2 MO was diluted to 0.25mM, 
0.5mM and 1mM; 5nl were injected from 0.25mM, 5nl and 10nl were injected from 0.5mM and 
10nl were injected from 1mM, which gave 10ng, 20ng, 40ng or 80ng of MO per embryo (Figure 
5.1C). Since these injections were performed alongside the hnRNP AB and hnRNP D knock downs 
(see Chapter 4), the same SC MO injected embryos (Figure 4.2) were used as controls for the 
initial titration experiments with the H2A.Z2 MO (Figure 5.1E).  
 
Embryos injected with the H2A.Z2 MO were monitored throughout development and were 
allowed to reach the swimming tadpole stage. The embryos injected with either 10ng or 20ng of 
H2A.Z2 MO showed no apparent differences in morphology compared to control embryos 
injected with the same amounts of SC MO. Furthermore, no increase in the number of dead 
embryos was observed at these amounts of H2A.Z2 MO. Injections of 40ng H2A.Z2 MO, however, 
resulted in 70% of the morphant embryos having severely impaired movement or being 
completely paralysed. In addition, these morphant embryos displayed kinked anteroposterior axis 
(blue arrows in Figure 5.1D) and reduced pigmentation in the eyes (red arrows in Figure 5.1D), 
despite showing normal morphology throughout the majority of development. Injection of 40ng 
H2A.Z2 MO caused an increase in the number of dead embryos, 20% in the morphants compared 
to less than 5% in the controls. All embryos injected with 80ng of H2A.Z2 MO became abnormal at 
neurula stages and went on to die during the early tailbud stage. 
 114 
 
Figure 5.1 – Microinjection of H2A.Z2 MO into X. laevis embryos. 
X. laevis embryos from a single female were injected with the H2A.Z2 MO (A.), which targeted the 
5’ UTR of both the H2A.Z2 mRNAs (B.). Embryos were injected with increasing amounts of MO 
and were then monitored throughout development. Movement and death were scored and 
plotted as percentages (C.). Embryos injected with 40ng of H2A.Z2 MO were photographed at 
stage 33/34 to show the kinked axis (blue arrows) and reduced eye pigment (red arrows) 
morphologies (D.). An embryo injected with 40ng SC MO to show the normal morphology of a 
swimming tadpole stage embryo (E.). 
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For gene expression analysis in the H2A.Z2 loss of function embryos, it was decided that 40ng of 
H2A.Z2 MO would be used since this amount of morpholino oligonucleotide resulted in the most 
obvious phenotype. In addition, embryos injected with less MO displayed no phenotype and more 
MO killed all of the embryos injected. Since injections of 40ng H2A.Z2 MO resulted in an increased 
mortality rate and 80ng caused all of the injected embryos to die, Western blot analysis was 
performed to test whether the H2A.Z2 MO inhibited the production of H2A.Z2 protein. 
 
5.2.2 The H2A.Z2 MO Suppresses Recombinant H2A.Z2 Protein Expression 
To confirm the ability of the H2A.Z2 MO to knockdown H2A.Z2 protein expression and, therefore, 
ensuring the MO works, immunoblotting was performed on proteins purified from morphant 
embryos. Since it has been previously reported that no commercial antibodies raised against 
H2A.Z proteins are able to distinguish between H2A.Z1 and H2A.Z2 (Matsuda et al., 2010), which 
was further confirmed with the use of an in-house mouse α-H2A.Z antibody, it was decided that 
FLAG-tagged proteins would be used to determine the efficacy of the H2A.Z2 MO (Figure 5.2). 
 
Given that the H2A.Z2 MO was designed to target the 5’UTR of both H2A.Z2 mRNAs, it was 
necessary to include this sequence prior to the FLAG-tag encoding sequence, which would be 
linked to the H2A.Z2 ORF (Figure 5.2A). To do this, primers were designed to amplify the 5’UTR 
from H2A.Z2-1 and the FLAG-tag sequence, and another set of primers were designed to amplify 
the H2A.Z2-1 ORF. These two sequences were then ligated together and cloned into the pCS2+ 
vector (see 9.2.3). The construct was confirmed as correct by DNA sequencing before being 
linearised using Not1. An in vitro transcription reaction was then performed to synthesise the 
FLAG-H2A.Z2 mRNA. To determine whether the H2A.Z2 MO was able to bind to the target 
sequence, increasing amounts of the FLAG-H2A.Z2 mRNA were injected into the fertilised eggs of 
a single female frog; half of these embryos were then injected with 40ng H2A.Z2 MO. The other 
half of the embryos were left without MO to ensure the FLAG-H2A.Z2 mRNA was translated 
within the embryos. These embryos were allowed to develop to late gastrulation before being 
collected for protein purification. The proteins extracted from each set of embryos were 
separated on an SDS-PAGE gel, transferred to nitrocellulose and a Western blot was performed 
with an α-FLAG-HRP antibody (Figure 5.2B). An increasing amount of FLAG-H2A.Z2 protein was 
seen from embryos injected with increasing amounts of mRNA, showing this mRNA was 
successfully translated.  
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Figure 5.2 – Western blot analysis of FLAG-tagged H2A.Z2 mRNA expression and H2A.Z2 MO 
efficacy. 
Primers (grey half arrows in A.) were designed to amplify two constructs. One containing the 
H2A.Z2-1 5’UTR (blue), coupled to FLAG-tag encoding DNA (yellow) and flanked by recognition 
sites for Xho1 (purple) at the 5’ end and BamH1 (red) at the 3’ end. The other consisting of the 
H2A.Z2-1 ORF (green) flanked by BamH1 (red) at the 5’ end and Xba1 (orange) at the 3’ end. Once 
amplified, the DNA from both reactions were digested with BamH1, gel purified and the two 
sequences ligated together. The resulting construct was further amplified using the 5’UTR forward 
primer and the ORF reverse primer. The amplified DNA was digested with Xho1 and Xba1, and gel 
purified. This sequence was ligated in an Xho1/Xba1 digested pCS2+ vector, sequenced and then 
translated into mRNA in vitro (A.). Embryos from a single X. laevis female were injected with 
increasing amounts of the FLAG-H2A.Z2 mRNA. Half of these embryos were also injected with 
40ng H2A.Z2 MO. The embryos were allowed to develop to stage 13/14 and total protein was 
purified from 20 embryos for each condition. One embryo equivalent of protein from each sample 
was separated on a 15% SDS-PAGE gel and transferred to nitrocellulose. The membrane was 
probed with a mouse α-FLAG-HRP antibody (B.). The FLAG-H2A.Z2 protein (black arrow in B.) was 
detectable with injections of 100pg of mRNA and above. Co-injection of the H2A.Z2 MO 
completely inhibited the production of protein from 100pg mRNA injections, and greatly reduced 
the amount produced from 200pg, 500pg and 1ng of mRNA. A non-specific band acted as a 
loading control (red arrow in B.).  
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The samples from embryos also injected with the H2A.Z2 MO showed dramatically decreased 
amounts of FLAG-H2A.Z2 protein, indicating the MO was able to bind to the 5’UTR of the H2A.Z2 
mRNA and inhibit the synthesis of this protein. 
 
Since it was confirmed that the H2A.Z2 MO was able to knock down the production of FLAG-
H2A.Z2 in X. laevis embryos, the phenotypes of the morphant embryos might be caused by loss of 
the endogenous H2A.Z protein. Therefore, to investigate these phenotypes in greater detail, WISH 
was performed using tissue-specific markers. 
 
5.3 Phenotypic Analysis of H2A.Z2 Morphant Embryos 
 
5.3.1 Loss of H2A.Z2 Increases the Number of Primary Neurons 
Embryos injected with 40ng of H2A.Z2 MO displayed movement defects and a kinked A-P axis. 
These phenotypes were also seen for the hnRNP AB and hnRNP D knock downs, which appeared 
to be the result of defective neural development (see Chapter 4). Therefore, the H2A.Z2 MO 
injected embryos were first probed with specific markers of neural development during 
neurulation (Figure 5.3). 
 
The size and shape of the neural plate, as indicated by Sox2 staining, was found to be unchanged 
in embryos injected with the H2A.Z2 MO. The expression of Sox2 was always decreased in the 
morphants embryos compared to those injected with the SC MO however (Figure 5.3A), 
suggesting an overall loss of neural tissue (Graham et al., 2003). In spite of this, neural crest 
migration was consistently found to be unaffected by the loss of H2A.Z2 (Figure 5.3B), indicated 
by the expression of Slug in morphant embryos compared to controls. Although there appeared 
to be an overall loss of neural tissue, expression of Neurogenin in the regions of early primary 
neuron development (Ma et al., 1996) was increased in the majority of embryos injected with 
H2A.Z2 MO (Figure 5.3C). Furthermore, the expression of NST in the differentiated neurons of 
morphant embryos later in neurulation was consistently increased (Figure 5.3D). There also 
appeared to be a greater number of neurons stained than in the control embryos (compare black 
and red arrows in Figure 5.3D). This was also seen in the dorsal staining of Runx1, where an 
increase in neuroblasts was observed in the majority of the H2A.Z2 MO injected embryos (Figure 
5.3E). Conversely, the Runx1 staining in the VBI of embryos injected with H2A.Z2 MO consistently 
remained unchanged compared to the control embryos (Figure 5.3F). 
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Figure 5.3 – Wholemount in situ hybridisation analysis of Sox2, Slug, Neurogenin, NST and 
Runx1 expression in SC and H2A.Z2 MO-injected embryos.  
Embryos from a single female X. laevis were injected with either SC or H2A.Z2 MO. The embryos 
were allowed to develop to various stages during neurulation and were then fixed. WISH was 
performed on these embryos using Sox2 (A.), Slug (B.), Neurogenin (C.), NST (D.) or Runx1 (E. and 
F.) probes. Expression of Sox2 in stage 15 control and morphant embryos occurred in the neural 
plate and neural crest, however, the expression in H2A.Z2 MO injected embryos was lower (A.). 
The expression of Slug was the same in both control and morphant embryos at stage 15 (B.). At 
stage 12.5, the expression of Neurogenin was increased in embryos injected with H2A.Z2 MO 
compared to those injected with SC MO (C.). This was particularly apparent in the region of 
primary neuron development (compare black and red arrows in C.). NST expression in control and 
morphant embryos at stage 17 occurred in similar patterns (D.) but the expression was increased 
in the differentiated neurons in the morphants (compare black red arrows in D.). The dorsal 
expression of Runx1 of stage 17 embryos indicated an increased in neuroblasts in the embryos 
injected with H2A.Z2 MO compared to those injected with the SC MO (E.), whereas, the ventral 
expression of Runx1 in the early VBI was unaffected by the loss of H2A.Z2 (F.). The numbers in A, 
B, C, D, and E and F indicate how many embryos looked like those in the pictures. 
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In order to investigate the neurons in greater detail, immunohistochemistry was performed on SC 
MO and H2A.Z2 MO injected embryos at the late tailbud stage using the HNK1 antibody 
(Nordlander, 1989). In both sets of embryos, the antibody stained neurons and their axons 
throughout the embryos (Figure 5.4). The inter-somitic patterning of the neurons was unaffected 
by the loss of H2A.Z2, as was the length of the axonal projections, however, there appeared to be 
a consistently higher density of axons throughout the embryos injected with the H2A.Z2 MO 
compared to the control embryos (compare the high magnification images in Figure 5.4A and B). 
The frequency of the projection of axons was also increased in morphant embryos, which was 
especially clear when comparing the posterior regions (arrowed in Figure 5.4). 
 
To determine if the increase in neuronal staining seen in both WISH and immunohistochemistry 
experiments was significant, a quantitative neuronal nuclei counting assay was performed (Sharpe 
and Goldstone, 2000). Early tadpole stage embryos injected with either the SC MO or the H2A.Z2 
MO, were stained with the Islet1 antibody (Figure 5.5). After the embryos were cleared, it was 
apparent that there were more nuclei stained in the morphants compared to the control embryos 
(compare high magnification images in Figure 5.5A and B). Once the nuclei were counted for both 
sets of embryos and the statistical analysis was performed, it was determined that there was a 
20% increase in the number of neuronal nuclei in H2A.Z2 MO injected embryos over those 
injected with the SC MO (Figure 5.5C). This result was found to be statistically significant (p < 
0.0001) after an unpaired t-test was performed on the data collected. 
 
Together, these results suggested that H2A.Z2 MO was required for the correct differentiation of 
primary neurons during early X. laevis development. Although H2A.Z2 was only expressed in 
neural tissues, and not maternally (Figure 3.9E), the effects of the loss of this protein on other 
tissues could not be ruled out, therefore, further WISH experiments were carried out with 
markers of other tissues. 
 
5.3.2 Muscle, Liver, Heart and Blood Development Are All Unaffected by the Loss of H2A.Z2 
The increase in primary neuron development seen in embryos lacking the H2A.Z2 histone variant 
could explain the movement defects in these morphant embryos. The kinking of the 
anteroposterior axis however, was less likely to be caused by this phenotype. Therefore, in situ 
hybridisation analysis of the somites was performed on late tailbud stage embryos injected with 
SC or H2A.Z2 MO, using a probe for gja3, which is expressed specifically in the gap junctions of the 
somites at this stage of development (De Boer et al., 2005).  
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Figure 5.4 – Wholemount immunohistochemistry using the HNK1 antibody in SC and H2A.Z2 
MO-injected embryos. 
Embryos from a single female X. laevis were injected with either the SC MO (A.) or the H2A.Z2 MO 
(B.). The embryos were allowed to develop to the late tailbud stage and were then fixed. 
Immunohistochemistry was performed on these embryos using a HNK1 antibody (A. and B.). 
These embryos were then cleared using Murray’s clear to better visualise the internal staining of 
the neurons. In stage 28 embryos injected with SC MO, neurons throughout the embryo were 
stained (A.). In embryos injected with H2A.Z2 MO at the same stage (B.), an increase in the 
number of neurons stained was observed (highlighted inset in A. and B.). Although the neurons 
projected axons to the same length in both control and morphant embryos, the number of 
projections were increased, especially in the posterior (compare arrowed structures in A. and B.). 
The numbers in A and B indicate how many embryos looked like those in the pictures. 
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Figure 5.5 – Wholemount immunohistochemistry analysis of Islet1 in SC and H2A.Z2 MO-
injected embryos, and statistical analysis of neuron numbers. 
Embryos from a single female X. laevis were injected with either the SC MO (A.) or the H2A.Z2 MO 
(B.). The embryos were allowed to develop to stage 22 and were then fixed. 
Immunohistochemistry was performed on these embryos using an Islet1 antibody (A. and B.). 
These embryos were then cleared to better visualise the internal staining of the neuronal nuclei. 
The nuclei were counted from ten embryos injected with either SC MO or H2A.Z2 MO. Nuclei on 
either side of the neural tube were treated as separate counts. The mean and standard deviations 
were calculated and plotted (C.). Morphants were found to have approximately 20% more 
neurons than control embryos. An unpaired t-test was performed, where p < 0.0001 (indicated by 
*** in C.).  
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Although there was a slight developmental difference between the two sets of embryos, the 
morphants being older than the controls, it was clear to see that neither the expression nor the 
patterning of gja3 was affected by a decrease in H2A.Z2 in any of the morphant (Figure 5.6). 
 
Although the loss of H2A.Z2 had no effect on muscle development, to test whether other tissues 
were being affected, markers of the liver, heart and blood were assayed using WISH on embryos 
injected with either the SC MO or the H2A.Z2 MO (Figure 5.7). The expression of Hex in late 
tailbud stage embryos was consistently seen in the liver, ventral blood island and the dorsal 
lateral plate mesoderm at the same levels and patterns in both sets of embryos probed (Figure 
5.7A and B). The same was also seen for the expression of Tbx20 in the heart and cement gland, 
which was unaffected by the H2A.Z2 knock down (Figure 5.7C and D). Earlier in development, at 
the early tailbud stage, LMO2 expression was observed in the VBI, DLP and the elongating tailbud 
region to the same extent in embryos injected with the SC MO (Figure 5.7E) and those injected 
with the H2A.Z2 MO (Figure 5.7F). 
 
Though limited to a small number of tissues, these results suggested that the increase in primary 
neurons observed when H2A.Z2 was knocked down was likely to be a specific results of the loss of 
this histone variant since the other markers investigated here showed that most cell types were 
unaffected. To understand the role of H2A.Z2 more fully, it was, therefore, necessary to 
determine the precise point in the pathway of primary neurogenesis where H2A.Z2 functions. 
 
5.3.3 H2A.Z2 Knock Down Decreases Notch Expression 
In order to discover where H2A.Z2 acts in the normal development of primary neurons, it was first 
necessary to consider what is currently known about the pathway of primary neuron 
development and how it is thought to function (Figure 5.8).  
 
The formation of primary neurons in X. laevis development has been shown to be regulated by 
lateral inhibition through Delta/Notch signalling (Coffman et al., 1993, Chitnis et al., 1995). 
Neurogenin is first expressed in the precursors of the primary neurons during early neurulation 
(Ma et al., 1996). The downstream targets of Neurogenin then promote the expression of the 
neural differentiation marker NST (Lee et al., 1995) and the Notch ligand, Delta (Vernon et al., 
2006). The expression of Delta in the primary neurons signals and activates the Notch receptor in 
membranes of the undifferentiated neural plate cells surrounding the primary neuron cells 
(Coffman et al., 1993, Chitnis et al., 1995).  
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Figure 5.6 – Wholemount in situ hybridisation analysis of gja3 expression in SC and H2A.Z2 MO-
injected embryos. 
Embryos from a single female X. laevis were injected with either the SC MO (A. and C.) or the 
H2A.Z2 MO (B. and D.). The embryos were allowed to develop to the late tailbud stage and were 
then fixed. WISH was performed on these embryos using a gja3 probe. The expression of gja3 
occurred at the same level and pattern in stage 29/30 controls (A.) as it did in stage 31 morphants 
(B.). The stained embryos were cleared using Murray’s clear to investigate the structure of the 
somites in greater detail (C. and D.), however, no differences could be seen. The numbers in A and 
B indicate how many embryos looked like those in the pictures. 
 127 
 
 
 
 128 
 
 
 
 
 
 
Figure 5.7 – Wholemount in situ hybridisation analysis of Hex, Tbx20 and LMO2 expression in SC 
and H2A.Z2 MO-injected embryos.  
Embryos from a single female X. laevis were injected with either the SC MO (A., C. and E.) or the 
H2A.Z2 MO (B., D. and F.). The embryos were allowed to develop to the desired stage and were 
then fixed. WISH was performed on these embryos using Hex (A. and B.), Tbx20 (C. and D.) and 
LMO2 (E. and F.) probes. The expression of Hex in stage 31 embryos injected with SC MO (A.) was 
seen in the liver (l), VBI and DLP (arrowed in A.). In morphant embryos at the same stage (B.), the 
expression was also seen in these regions at a similar level (arrowed in B.). In stage 31 control (C.) 
and morphant (D.) embryos, the expression of Tbx20 occurred in the heart (h) and cement gland 
(cg) at the same levels (compare arrowed structures in C. and D.). LMO2 expression was observed 
in the VBI, DLP and tailbud (tb) regions (arrowed in E. and F.) of embryos injected with SC MO (E.) 
as well as those injected with H2A.Z2 MO (F.). The numbers in A, B, C, D, E and F indicate how 
many embryos looked like those in the pictures. 
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Figure 5.8 – A simplified schematic of primary neuron development. 
In normal primary neuron development, the expression of Neurogenin ultimately activates NST in 
cells destined to become neurons. Neurogenin also activates Delta expression. Delta then signals 
the surrounding neural plate cells, through Notch, to inhibit Neurogenin expression in these 
undifferentiated cells (Vernon et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 130 
 
Once Notch is activated the intracellular domain (ICD) initiates a signalling cascade that inhibits 
the expression of Neurogenin (Coffman et al., 1993, Chitnis et al., 1995), giving the ‘salt and 
pepper’ appearance of the neurons as seen in the NST in situ hybridisations (see Figure 5.3D). 
Since the loss of H2A.Z2 causes an increase in the number of primary neurons, it was 
hypothesised that an abnormally high number of undifferentiated neural plate cells were 
becoming differentiated neurons. One mechanism that might cause this was a defect within the 
Delta/Notch signalling system. 
 
To determine the effect of the H2A.Z2 knock down on Notch expression, embryos were injected 
with either the SC MO or the H2A.Z2 MO and were allowed to develop to late neurulation. WISH 
was performed on these embryos using a Notch probe (Figure 5.9). Notch expression was 
observed in the neural plate, neural crest and posterior region of the control embryos. A decrease 
in the level of this expression was consistently seen in the neural plate and neural crest of H2A.Z2 
MO injected embryos (compare black arrows in Figure 5.9), although the expression in the 
posterior region remained normal (compare red arrows in Figure 5.9). This result indicated that 
the decrease in Notch expression could have been the cause of the increase in Neurogenin and 
NST expression, and in the number of primary neurons seen in embryos lacking the H2A.Z2 
histone variant. Although the H2A.Z2 MO was shown to inhibit exogenous H2A.Z2 protein 
expression (Figure 5.2), before the results could be directly linked to the loss of this protein, it was 
necessary to rescue the normal phenotype through the reintroduction of H2A.Z2 into morphant 
embryos.  
 
5.4 Rescue of Morphant Embryos with H2A.Z2 mRNA 
 
5.4.1 Reintroduction of H2A.Z2 Protein Recovers Normal Morphology in Morphant Embryos 
Before the phenotype observed in embryos injected with the H2A.Z2 MO could be stated to occur 
due to a specific loss of the H2A.Z2 protein, rescue experiments where H2A.Z2 mRNA was co-
injected with the H2A.Z2 MO were performed. In order to perform these rescue experiments, the 
ORF of H2A.Z2-1 was cloned into the pβUT2-Sfi1 vector (see 9.2.2) and confirmed through DNA 
sequencing. This vector was chosen since it contains the 5’ and 3’UTRs from the X. laevis β-globin 
mRNA, and thus does not contain the MO binding site, which allows the mRNA to be translated 
efficiently in X. laevis embryos.  
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Figure 5.9 – Wholemount in situ hybridisation analysis of Notch expression in SC and H2A.Z2 
MO-injected embryos.  
Embryos from a single female X. laevis were injected with either SC or H2A.Z2 MO. The embryos 
were allowed to develop to stage 17 and were then fixed. WISH was performed on these embryos 
using a Notch probe. Notch expression in SC MO injected embryos was seen in the neural plate 
(np), neural crest (nc) and the posterior (pos) region. Whereas, the expression level of Notch in 
morphant embryos was lower in the neural plate and neural crest than that seen in the control 
embryos (compare black arrowed structures). Notch expression in the posterior region remained 
normal (compare red arrows). The numbers indicate how many embryos looked like those in the 
picture. 
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After the cloning of the H2A.Z2-1 ORF was confirmed, the plasmid was linearised using Sfi1 and an 
in vitro transcription reaction, containing T3 RNA polymerase, was performed (Figure 5.10A). The 
H2A.Z2 mRNA was successfully transcribed, so to test if this mRNA was able to be translated, 
Western blot analysis was performed on embryos injected with the H2A.Z2 mRNA. 
 
Protein purification was performed on embryos injected with 1ng of H2A.Z2 mRNA, 2ng of H2A.Z1 
mRNA and 40ng of a H2A.Z1/Z2 MO, and embryos that were left uninjected as a control for the 
endogenous protein. These proteins were separated using SDS-PAGE, transferred to nitrocellulose 
membrane and immunoblotted with a sheep α-H2A.Z antibody (Figure 5.10B). While the bands 
present in the correct location on the blot were faint, it was clear to see that much more H2A.Z 
protein was detected from embryos injected with the H2A.Z2 mRNA and the H2A.Z1 mRNA than 
there was endogenous protein. Furthermore, no H2A.Z protein was detected from embryos 
injected with the double knockdown MO. This indicated that the H2A.Z2 mRNA was successfully 
translated in X. laevis embryos, resulting in a protein recognised by the α-H2A.Z antibody. 
 
Since the H2A.Z2 mRNA was able to generate protein production in X. laevis embryos, a rescue 
experiment was performed to test whether the morphologies observed in H2A.Z2 MO injected 
embryos were caused by the specific loss of the H2A.Z2 protein (Figure 5.11). Fertilised eggs from 
a single frog were injected with 40ng of H2A.Z2 MO. Half of these embryos were allowed to 
develop to the two-cell stage and then 625pg of H2A.Z2 mRNA was injected into each cell, giving a 
total of 1.25ng mRNA per embryo (Figure 5.11A). The other half were left without mRNA, to allow 
a comparison between the morphant and rescue embryos. Both sets of embryos were monitored 
throughout development and were allowed to develop to the early tadpole stage. As expected, 
the six out of the eight surviving embryos injected with H2A.Z2 MO alone were paralysed. 
Although the mortality rate increased from 20% in the morphants to 40% in the rescue embryos, 
four out of the six surviving embryos injected with both H2A.Z2 MO and mRNA displayed normal 
morphologies and were also able to swim (Figure 5.11). 
 
These results show that, although only a small number of embryos were used, reintroduction of 
H2A.Z2 protein into morphant embryos appears to rescue the normal morphology. Therefore, a 
further rescue experiment was performed to determine if normal primary neuron development 
was regained with the injection of H2A.Z2 mRNA into H2A.Z2 MO injected embryos. 
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Figure 5.10 – In vitro transcription and in vivo translation of H2A.Z2 ORF mRNA. 
The ORF of H2A.Z2-1 was cloned into the pβUT2-Sfi1 vector and the resulting plasmid was 
linearised at the 3’ end of the sequence to be transcribed. An in vitro transcription reaction was 
performed using this template DNA to synthesise the mRNA (A.). DNaseI was added to the 
reaction to remove the DNA template and leave only the transcript. Aliquots of the reaction 
before and after incubation with DNaseI were run on a 1% agarose gel. The template DNA was 
only seen in the sample before DNaseI (red arrow in A.), whereas the H2A.Z2 mRNA was seen in 
two bands before and after incubation (black arrows in A.). Embryos from a single female X. laevis 
were injected with 1ng of the H2A.Z2 mRNA, 2ng of H2A.Z1 mRNA or 40ng of a H2A.Z1/Z2 MO 
(double knockdown). Some embryos were left uninjected as controls of endogenous protein 
expression. The embryos were allowed to develop to stage 13/14 and total protein was purified 
from 50 embryos for all conditions. Six embryos equivalent of protein from uninjected and 
injected embryos was separated on a 15% SDS-PAGE gel and transferred to nitrocellulose. The 
blot was probed with a sheep α-H2A.Z antibody (B.). The endogenous H2A.Z protein was detected 
as a very faint band (see black arrow in Uninjected). More intense bands were detected from 
embryos injected with H2A.Z2 mRNA and H2A.Z1 mRNA, whereas no H2A.Z protein was detected 
in the double knockdown. A non-specific band (red arrow) acted as a loading control. 
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Figure 5.11 – Morphological rescue of H2A.Z2 MO-mediated knock down using H2A.Z2 mRNA. 
Fertilised eggs from a single female were injected with 40ng of H2A.Z2 MO and incubated at 18oC 
for 2 hours. At the two-cell stage, half of these embryos were injected with 625pg of H2A.Z2 
mRNA into each cell (A.). The embryos were monitored throughout development and allowed to 
reach the swimming tadpole stage. The number of normal, paralysed and dead embryos were 
recorded and plotted as percentages (B.). The majority of embryos injected with only the H2A.Z2 
MO were paralysed and had kinked axis (C.). Whereas, the majority of the surviving embryos co-
injected with the H2A.Z2 MO and the H2A.Z2 mRNA showed normal morphology and were able to 
swim (D.)  
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5.4.2 Notch Expression Is Rescued by the Injection of H2A.Z2 mRNA 
The knock down of H2A.Z2 due to the injection of a morpholino oligonucleotide caused an 
increase in the number of primary neurons in these embryos, possibly through a down-regulation 
of Notch. Since normal morphology was rescued in morphant embryos by the injection of H2A.Z2 
mRNA, another rescue experiment was performed to determine if the expression of Notch was 
returned to normal levels through the reintroduction of the histone variant, H2A.Z2 (Figure 5.12). 
 
Quantitative RT-PCR was used to determine whether a sensitive quantitative approach could 
detect any change in Notch expression levels in morphant embryos, co-injected with H2A.Z2 
mRNA (Figure 5.12). Fertilised eggs from a single female were injected with SC MO or H2A.Z2 MO. 
Half of the embryos injected with H2A.Z2 MO were also injected with 625ng of H2A.Z2 mRNA into 
each cell of two-cell stage embryos. The embryos were then allowed to develop to stage 17. Ten 
embryos for each condition were collected and total RNA was purified. Quantitative RT-PCR was 
performed using primers and probe for Notch and Gata2, which acted as a control. The threshold 
cycle (Ct) values for each PCR were normalised to ODC expression and the ΔΔCt method was used 
to calculate the fold changes in expression in morphant and rescue embryos in relation to the 
controls.  
 
As expected, the expression of Notch decreased in embryos injected with H2A.Z2 MO. The 
expression of Notch in embryos also injected with H2A.Z2 mRNA however was observed to 
increase. Furthermore, the expression of Gata2 was unaffected by the loss of H2A.Z2, though 
reintroducing the H2A.Z2 protein resulted in a slight increase in expression, although the standard 
deviation was large. Therefore, adding the H2A.Z2 protein back into the morphant embryos was 
sufficient to return the expression of Notch to normal. These results suggest that the decrease in 
Notch expression was a direct result of the loss of the H2A.Z2 histone variant.  
 
5.5 Discussion 
 
5.5.1 Loss of Function 
The morpholino oligonucleotide used to knock down the expression of the H2A.Z isoform, H2A.Z2, 
was designed to specifically bind to the two H2A.Z2 mRNAs described in X. laevis (Eirin-Lopez et 
al., 2009). The H2A.Z2 MO was designed to bind to the 5’UTR of these mRNAs, to ensure that only 
this H2A.Z2 isoform and not H2A.Z1 was knocked down in the loss of function experiments.  
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Figure 5.12 – Quantitative RT-PCR analysis of Notch and Gata2 expression in morphant and 
rescue embryos. 
Fertilised eggs from a single female were injected with SC MO or H2A.Z2 MO, and incubated at 
18oC for 2 hours. Half of the embryos injected with H2A.Z2 MO were also injected with 625ng of 
H2A.Z2 mRNA into each cell of two-cell stage embryos. All of the embryos were allowed to 
develop to stage 17 and total RNA was purified from 10 embryos for all conditions. Quantitative 
RT-PCR was performed using Notch and Gata2 as amplicons. The threshold cycle (Ct) values for 
each PCR were normalised to ODC expression. The ΔΔCt method was used to calculate the fold 
changes in expression in morphant and rescue embryos relative to control embryos injected with 
the SC MO (1.0 = control expression level). The fold changes from at least three biological 
replicates were averaged and plotted with the standard deviations indicated by the error bars. 
The expression of Notch in embryos injected with H2A.Z2 MO was decreased. When the embryos 
were co-injected with H2A.Z2 mRNA, Notch expression increased. In both morphant and rescue 
embryos, the expression of Gata2 was slightly increased compared to controls.  
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This would allow us to gain some understanding of the individual functions of H2A.Z2, which so 
far have been little studied. 
 
The MO-mediated inhibition of H2A.Z2 translation resulted in abnormal morphologies in 
developing X. laevis embryos. Movement problems, kinked axes and anterior defects were all 
observed in embryos injected with 40ng of the H2A.Z2 MO. The majority of the embryos injected 
with H2A.Z2 MO that survived to the tadpole stage had severely impaired movement or were 
completely paralysed, with only around 10% of the total injected embryos displaying normal 
phenotypes. It has previously been reported that 45% of embryos injected with 40ng of a GFP MO 
displayed abnormalities (Nutt et al., 2001) but up to 200ng of SC MO has been injected without 
any affect on normal X. laevis development (Lavallee et al., 2006). Since injections of 40ng of SC 
MO had no effects on normal development here, it was therefore plausible that the observed 
morphologies in H2A.Z2 MO injected embryos were due to the specific targeting of H2A.Z2 mRNA. 
Furthermore, injections of less H2A.Z2 MO resulted in no apparent phenotype in any of the 
injected embryos, whereas, 80ng injections of H2A.Z2 MO resulted in the death of all injected 
embryos. These results suggest that either the MO was causing off target effects or the H2A.Z2 
protein is essential for X. laevis survival. The former was shown not to be the case through rescue 
experiments (see 5.3), suggesting that some level of H2A.Z2 expression is essential. To test this 
hypothesis, a rescue experiment could be performed on embryos injected with 80ng H2A.Z2 MO 
to determine if the H2A.Z2 protein is able to prevent these embryos from dying. 
 
A list of controls to be used in loss of function experiments using morpholino oligonucleotides 
were set out by Eisen and Smith (Eisen and Smith, 2008), one of which was to determine the 
effect of each morpholino on protein levels whenever possible. Using the sheep α-H2A.Z antibody 
however, the H2A.Z1 protein could not be distinguished from the H2A.Z2 protein, as had 
previously been reported (Matsuda et al., 2010). Therefore, an mRNA containing the H2A.Z2 MO 
binding site, encoding a FLAG-tagged H2A.Z2 protein was synthesised, which was used to 
determine the effectiveness of the H2A.Z2 knock down. The FLAG-H2A.Z2 protein was found to be 
expressed in a dose-dependent manner, since increased mRNA resulted in a greater amount of 
protein. This expression was dramatically decreased, however, when 40ng of H2A.Z2 MO was co-
injected with the mRNA. Although these results displayed the ability of the H2A.Z2 MO to bind to 
and inhibit the translation of exogenous mRNA, they do not indicate how effectively the 
expression of the endogenous H2A.Z2 protein is inhibited (Eisen and Smith, 2008). 
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5.5.2 Phenotypic Analysis 
The loss of the histone variant, H2A.Z2, resulted in abnormal neural development, specifically the 
over-production of primary neurons. H2A.Z2 is expressed in the embryo during primary 
neurogenesis (Figure 5.13) in the neural plate (Figure 3.9E), which is consistent with this loss of 
function result.  
 
A decrease in H2A.Z2 resulted in a decrease of Sox2 expression, suggesting an overall loss of 
undifferentiated neural precursor cells and an increase in differentiated cells at neurulation 
(Figure 5.3A). Additionally, an increase in Neurogenin expression in the regions of primary 
neurogenesis (Figure 5.3C), in neuroblasts as indicated by Runx1 staining (Figure 5.3E), and in the 
number of differentiated neurons as indicated by NST (Figure 5.3D) and HNK1 (Figure 5.4B) 
staining was observed. The increase in neuron numbers was quantified through Islet1 antibody 
staining and the number of primary neurons in morphants embryos was found to be increased by 
20% compared to control embryos (Figure 5.5C).  
 
The increase in primary neurogenesis in embryos lacking H2A.Z2 was proposed to occur through a 
loss of Notch expression in the undifferentiated cells of the neural plate, since Notch expression 
was decreased in the neural plate and neural crest of morphant embryos (Figure 5.9).  
 
Previous studies in human embryonic carcinoma cells (Shahhoseini et al., 2010) and mouse 
embryonic stem cells (Amat and Gudas, 2011) have shown that H2A.Z disappears from the RAREs 
of several important genes after retinoic acid-induced neural differentiation. Therefore, it could 
be possible that the loss of H2A.Z2 from X. laevis embryos causes a decrease in neural progenitor 
numbers but differentiation in a higher proportion of these neural precursors. This hypothesis 
would also correlate with the expression of H2A.Z2, which is expressed at the onset of 
neurulation in the neural plate and crest, and is located in anterior and neural tissues throughout 
later development. To determine the effects of the loss of H2A.Z2 on the individual populations of 
neurons, further WISH experiments could be performed. 
 
Although Sox2 expression was decreased in embryos lacking the H2A.Z2 protein, the size and 
shape of the neural crest were found to be unchanged. Furthermore, the migration of neural crest 
cells was unaffected in morphant embryos as indicated by Slug staining (Figure 5.3B). Therefore, 
markers of other regions of the neural plate could be investigated; to test whether other effects 
of H2A.Z2 knock down on neural development occur. 
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Figure 5.13 – mRNA expression level of H2A.Z2.  
RT-PCR was performed from RNA purified from ten stages over the course of early development 
from a single X. laevis female’s embryos. Primers were used to amplify a portion of the H2A.Z2 
mRNA (black arrow in A.) and the ODC mRNA (red arrow in A.) as a loading control. The 
expression level of H2A.Z2 is given by its ratio to the ODC level, the expression of ODC assumed to 
be constant. The expression of H2A.Z2 mRNA was detectable around the start of neurulation 
(stage 11/14) and was seen to increase over time. Yanai and colleagues (2011) quantified the 
mRNA levels of H2A.Z2 by spiking RNA extracted from X. laevis and X. tropicalis with heterologous 
RNA at known concentrations, and then hybridising these samples to microarrays (B.). Their 
expression data is given in log10 units of relative mRNA expression. Both data sets indicate a 
steady increase in the levels of H2A.Z2 mRNA over the course of early development.  
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Muscle (Figure 5.6B), liver (Figure 5.7B), heart (Figure 5.7D) and blood (Figure 5.7F) development 
were all shown to be unaffected in embryos injected with the H2A.Z2 MO, supporting the 
significance of the effects observed on primary neurogenesis. To ensure greater confidence in the 
cell types affected by the loss of H2A.Z2, further WISH experiments on other tissues could be 
performed. 
 
Previous inhibition of H2A.Z expression in a mouse cell line resulted in genome instability and 
chromosome segregation defects (Rangasamy et al., 2004). This inhibition was accomplished 
using RNA interference, which would have most likely have knocked down the expression of 
H2A.Z1 and H2A.Z2 due to the high nucleotide sequence identity between the two isoforms. Since 
the results generated here only affected primary neuron development, it is unlikely that the 
genome would have been affected so severely in these embryos because this would be expected 
to generate very severe phenotypes. Although this may be reflected in the death of embryos 
injected with 80ng of H2A.Z2 MO. 
 
5.5.3 Rescue Experiments 
When using morpholino oligonucleotides in loss of function experiments, misleading results can 
be gathered due to off target effects of the injected MO. Although it was shown that the H2A.Z2 
MO was able to inhibit the expression of exogenous mRNA encoding FLAG-tagged H2A.Z2 protein, 
it was not possible to confirm the effect on endogenous expression. As an additional control to 
test whether the effects of the H2A.Z2 MO were specific, an mRNA lacking the MO binding site, 
encoding H2A.Z2 was co-injected with the MO. This type of experiment is considered the most 
reliable control for loss of function experiments, since the protein of interest is reintroduced into 
the embryo in an attempt to rescue the normal phenotype (Eisen and Smith, 2008). 
 
Since the H2A.Z2 MO was targeted against the 5’UTRs of both the H2A.Z2-1 and H2A.Z2-2 mRNAs, 
a construct was cloned that removed this region of the mRNAs. The ORF from the H2A.Z2-1 mRNA 
was used, since both ORFs encode identical proteins, and mRNA was successfully transcribed from 
this construct (Figure 5.10A). A Western blot using a sheep α-H2A.Z antibody showed the H2A.Z2 
mRNA was translated when the mRNA was injected into embryos (Figure 5.10B). 
 
Co-injection of the H2A.Z2 mRNA with the H2A.Z2 MO resulted in the majority of embryos 
regaining normal morphology when compared to embryos injected with H2A.Z2 MO alone (Figure 
5.11). Since only ten embryos were co-injected with H2A.Z2 MO and mRNA however, it would be 
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necessary to repeat the rescue experiment with a larger sample population to further confirm the 
specificity of the MO. Furthermore, as 40% of the injected embryos died, the amount of H2A.Z2 
mRNA could be causing problems within the cells. The ectopic over-expression of H2A.Z1 has 
previously been shown to reduce the amount of H2A.Z2 present in chromatin (Matsuda et al., 
2010). Consequently it would be necessary in future work to determine the amount of H2A.Z2 
mRNA required to recover the normal phenotype in embryos without causing increased mortality 
rates. 
 
Since the normal morphology of morphant embryos was recovered in the preliminary rescue 
experiment, the expression of Notch was investigated. Quantitative RT-PCR was performed from 
RNA purified from control, morphant and rescue embryos using amplicons for ODC, Notch and 
Gata2 (Figure 5.12). The ODC expression data was used to normalise the levels of Notch and 
Gata2, and the fold expression changes were calculated by comparing the morphant and rescue 
data to that of the controls. Gata2 was used as a gene that would not have been affected by the 
loss of H2A.Z2, which was shown by the unaffected expression levels in the morphants. The 
expression of Gata2 was much more variable in the rescue embryos, which was likely caused by 
the ectopic expression of H2A.Z2 being deposited in chromatin at random locations. Conversely, 
Notch expression was decreased in embryos lacking H2A.Z2, as expected. Though, with the 
reintroduction of H2A.Z2 protein into these embryos, the expression of Notch was rescued above 
normal levels. This indicates that the knock down of H2A.Z2 specifically causes a decrease in 
Notch expression. Notch is then unable to inhibit the expression of Neurogenin in undifferentiated 
cells (Coffman et al., 1993, Chitnis et al., 1995). The increase in Neurogenin then causes these cells 
to form primary neurons, which activates the expression of the neural differentiation marker, NST 
(Lee et al., 1995). 
 
These rescue experiments confirm the specificity of the H2A.Z2 morpholino oligonucleotide and 
indicate that the loss of H2A.Z2 expression increases the number of primary neurons through a 
down-regulation of Notch. To test whether H2A.Z2 directly regulates the Notch gene at the 
epigenetic level however, chromatin immunoprecipitation (ChIP) experiments would need to be 
performed. Furthermore, to determine the direct effects of the rescue on primary neuron 
development, the neuronal nuclei counting assay (Sharpe and Goldstone, 2000) could be 
performed in lineage traced embryos co-injected in one half with H2A.Z2 MO and mRNA, and 
injected in the other half with MO alone. To further ensure MO specificity, additional controls 
could be used; including a second non-overlapping MO or a five base pair mismatched MO (Eisen 
and Smith, 2008). 
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The results presented here indicate an important role for the histone variant, H2A.Z2, in primary 
neuron development in X. laevis, through the down-regulation of Notch. Although this histone 
variant has not been directly linked to Notch regulation at the chromatin level, this work will help 
characterise the functional properties of H2A.Z2 and distinguish this H2A.Z isoform from H2A.Z1.  
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6. H2A.Z1 Loss of Function Analysis 
 
6.1 Introduction 
 
Both H2A.Z1 and H2A.Z2 are highly conserved throughout evolution, more so than the canonical 
H2A, suggesting important roles for both of these proteins within chromatin (Thatcher and 
Gorovsky, 1994, Eirin-Lopez et al., 2009). Prior to the discovery of these separate isoforms 
however, H2A.Z was classed as one protein, which has been the subject of many investigations. 
Although H2A.Z1 and H2A.Z2 only differ by three amino acids in most vertebrates, it is likely that 
this isoform was under investigation in the majority of these previous studies since H2A.Z1 was 
considered to be the only H2A.Z protein in the majority of vertebrates (Eirin-Lopez et al., 2009), 
though the function of this histone variant still remains controversial. 
 
At the functional level, H2A.Z has been observed to be involved in gene activation (Bruce et al., 
2005), inactivation (Guillemette et al., 2005) or both of these functions (Raisner et al., 2005). 
Evidence supporting an active role in transcription was shown in studies using a H2A.Z knock out 
strain of yeast, which caused defects in the activation of a number of inducible genes (Guillemette 
and Gaudreau, 2006). Whereas support for H2A.Z in a silencing role came from the finding that 
H2A.Z is associated with the heterochromatin binding protein, HP1α (Fan et al., 2004). H2A.Z is 
also involved in many other biological processes, including chromosome segregation (Rangasamy 
et al., 2004), heterochromatin silencing (Rangasamy et al., 2003, Swaminathan et al., 2005), and 
progression through the cell cycle (Dhillon et al., 2006). The role of H2A.Z in these diverse 
processes is also likely to be linked with its suggested role in oncogenesis, since a significant over-
expression of H2A.Z has been observed in a number of different types of tumour (Rhodes et al., 
2004). 
 
The structural characterisation and localisation of H2A.Z within the nucleosome and chromatin 
has also resulted in contradictory results. When the structure of a H2A.Z containing nucleosome 
core particle (NCP) was first solved, it was suggested that the presence of H2A.Z induced a subtle 
destabilisation of the nucleosome (Suto et al., 2000). Further work from the same group however, 
also suggested that H2A.Z stabilises the NCP (Park et al., 2004). In chromatin, H2A.Z has been 
observed at the promoters of a number of genes, as well as at enhancers and insulators 
(Guillemette and Gaudreau, 2006, Marques et al., 2010). H2A.Z at gene promoters was originally 
thought to occupy nucleosomes either side of a nucleosome free region (NFR) (Guillemette et al., 
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2005). Recent work in mammalian cells however, has revealed that H2A.Z co-localises with the 
histone H3 variant, H3.3, into nucleosomes at these regions (Jin et al., 2009). The H2A.Z/H3.3 
nucleosomes were discovered to be more easily displaced than those containing canonical 
histones and were suggested to play a role in transcriptional activation (Jin et al., 2009). 
 
Although the structural and functional characterisation of H2A.Z remains controversial, it is 
certain that this histone variant plays a major role in the cell, since H2A.Z has been demonstrated 
to be essential for the normal development of many organisms, such as Tetrahymena thermophila 
(Liu et al., 1996), Drosophila melanogaster (van Daal and Elgin, 1992), Xenopus laevis (Ridgway et 
al., 2004) and mice (Faast et al., 2001). The complete loss of H2A.Z in T. thermophila (Liu et al., 
1996) and D. melanogaster (van Daal and Elgin, 1992) was lethal in these organisms. Furthermore, 
homozygous H2A.Z knock out mouse embryos died early in development, during the stage of 
rapid proliferation and differentiation (Faast et al., 2001). In X. laevis only a third of embryos 
displayed gastrulation defects when H2A.Z was knocked down, although this could have been due 
to the use of RNAi, which resulted in a 20-30% reduction of H2A.Z mRNA (Ridgway et al., 2004). 
Although only one form of H2A.Z exists in T. thermophilia and D. melanogaster, both isoforms are 
present in mice and X. laevis. In these vertebrate studies only the H2A.Z1 isoform was lost, 
therefore, it would appear that these two isoforms have distinct functions since H2A.Z2 is unable 
to compensate completely for the loss of H2A.Z1. 
 
To investigate the role that H2A.Z1 plays in X. laevis development in greater detail, a loss of 
function study was performed. The expression of H2A.Z1 was knocked down using morpholino 
oligonucleotides and the ability of the MOs to bind to their targets was confirmed. A comparison 
between the phenotypes observed in embryos injected with standard control (SC) MO and those 
injected with the H2A.Z1 MOs was performed using wholemount in situ hybridisation (WISH). 
Using dissected embryos and Western blots, the processes that were affected by the loss of the 
H2A.Z1 protein were investigated in greater detail. To determine whether H2A.Z1 directly 
regulated these candidate genes at the epigenetic level, chromatin immunoprecipitation (ChIP) 
was performed to test whether this histone variant was present at the promoters. Rescue 
experiments, whereby the MO was co-injected with a synthetic mRNA encoding H2A.Z1, were 
performed to ensure that any defects observed were specific to the knock down of H2A.Z1, and 
were not due to off target action of the MO.  
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6.2 Morpholino Oligonucleotide Knockdown of H2A.Z1 
 
6.2.1 Loss of H2A.Z1 Leads to Severe Morphogenic Defects 
A loss of function study was performed to investigate the requirement of the histone variant, 
H2A.Z1, during early X. laevis development. Since the coding regions of H2A.Z1 and H2A.Z2 are 
nearly identical, the 5’UTRs of both H2A.Z1 mRNAs were the intended target sequences. Since 
these sequences are different, two MOs were designed; one to target the H2A.Z1-1 mRNA (Figure 
6.1A) and one to target the H2A.Z1-2 mRNA (Figure 6.1B). As with the other MOs used in this 
study, a BLAST search, restricted to Xenopus nucleotides, was performed on the XenBase website 
to ensure both H2A.Z1 MOs were specific for their intended target sequences and would not bind 
to any other nucleic acids. This search revealed no other target sequences in X. laevis, indicating 
these MOs should bind specifically to the H2A.Z1-1 and H2A.Z1-2 mRNAs. 
 
Since both the H2A.Z1-1 MO and the H2A.Z1-2 MO would be required for the inhibition of both 
H2A.Z1 mRNAs, both MOs were titrated into X. laevis embryos together to determine the 
amounts required to induce an effect. Both MOs were diluted to 2mM, 1mM and 0.5mM so when 
they were combined, stock solutions of both MOs together contained 1mM, 0.5mM and 0.25mM, 
respectively, of H2A.Z1-1 MO and H2A.Z1-2 MO. These were co-injected in embryos of a single 
female frog to give 10ng, 20ng and 40ng of each MO per embryo (Figure 6.1C). The SC MO was 
injected at 20ng, 40ng and 80ng, corresponding to the total amounts of H2A.Z1 MOs, into the 
same batch of embryos to determine any off target effects of the morpholine backbone (Figure 
6.2). All of the embryos were monitored throughout development and were allowed to develop 
to the early tadpole stage before being photographed. 
 
The majority of embryos injected with 20ng and 40ng of SC MO developed to the swimming 
tadpole stage with normal morphology, with only 5% and 10% of embryos dying, respectively. 
Although the mortality rate increased to around 25% in embryos injected with 80ng of SC MO, the 
rest of the embryos still developed normally (Figure 6.2B). Conversely, all concentrations of the 
H2A.Z1 MOs had an impact on normal development, most noticeably in the severe developmental 
retardation of the morphant embryos (Figure 6.1D, E and F). Around 60% of the embryos injected 
with 10ng each of H2A.Z1-1 and H2A.Z1-2 MOs had problems moving and responding to stimuli, 
or were completely paralysed (Figure 6.1D). The mortality rate was above average at around 15% 
in these embryos, yet the remaining 25% of embryos developed normally.  
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Figure 6.1 – Microinjection of H2A.Z1 morpholino oligonucleotides into X. laevis embryos. 
X. laevis embryos from a single female were injected with the H2A.Z1-1 MO, which targeted the 
5’UTR and translational start site of the H2A.Z1-1 mRNA (A.), and the H2A.Z1-2 MO, which 
targeted the 5’UTR and translational start site of the H2A.Z1-2 mRNA (B.). Embryos were co-
injected with increasing amounts of both MOs. These embryos were allowed to develop to the 
early tadpole stage (stage 34) and were then monitored throughout. Movement and death were 
scored and plotted as percentages (C.). Embryos co-injected with 10ng (D.), 20ng (E.) and 40ng (F.) 
each of H2A.Z1-1 and H2A.Z1-2 MOs were photographed at stage 29/30 to show the increased 
severity of the morphologies observed. 
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Figure 6.2 – Microinjection of SC MO into X. laevis embryos.  
Sibling embryos to those injected with the H2A.Z1 MOs were injected with the SC MO (A.) using 
increasing amounts. Injected embryos were monitored throughout development, and the 
numbers of normal and dead embryos were recorded and plotted as percentages (B.). An embryo 
injected with 40ng of SC MO was photographed at stage 35/36 to show the normal morphology of 
a swimming tadpole stage embryo (C.).  
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Embryos injected with 20ng each of the H2A.Z1 MOs had a further increased mortality rate, with 
around 20% of embryos dying. Although the embryos injected with these amounts of MO 
developed normally until the early tailbud stage, all but one of the remaining embryos were 
completely paralysed, and exhibited kinked A-P axes and head defects (Figure 6.1E). Three-
quarters of the embryos injected with 40ng each of the H2A.Z1-1 and H2A.Z1-2 MOs died early 
during development, mainly around gastrulation and neurulation. Only 25% of these embryos 
survived to the late tailbud stage but those that did were severely affected, displaying shortened, 
deformed bodies and large oedema (Figure 6.1F). 
 
Since around 30% of embryos injected with 10ng each of H2A.Z1-1 MO and H2A.Z1-2 MO retained 
normal morphology, and around 75% of embryos injected with 40ng each of the H2A.Z1 MOs 
died. It was concluded that 20ng each of the H2A.Z1-1 and H2A.Z1-2 MOs would be used (which 
will be further referred to as 40ng H2A.Z1 MOs), since nearly all of these embryos exhibited 
defects and the mortality rate did not increase dramatically. Given that these MOs result in severe 
morphology defects, Western blotting was performed to test whether the MO was able to inhibit 
H2A.Z1 protein synthesis. 
 
6.2.2 Recombinant H2A.Z1 Protein Expression Is Inhibited by the H2A.Z1 MOs 
To test whether the H2A.Z1 MOs were able to bind to the target sequences and, therefore, inhibit 
H2A.Z1 protein synthesis, Western blotting was performed. As stated before, commercial 
antibodies raised against H2A.Z are unable to distinguish between H2A.Z1 and H2A.Z2 (Matsuda 
et al., 2010), so a FLAG-tagged H2A.Z1 protein was used to determine the effectiveness of the 
H2A.Z1 MOs (Figure 6.3). 
 
In order to express FLAG-tagged H2A.Z1, first it was necessary to sub-clone two constructs 
containing the FLAG-tag DNA sequence in frame with the H2A.Z1 ORF, preceded by the 5’UTR 
from either H2A.Z1-1 or H2A.Z1-2 since these sequences contained the MO binding sites (Figure 
6.3A). Therefore, primers were designed to separately amplify the 5’UTR from H2A.Z1-1 and the 
FLAG-tag sequence, the 5’UTR from H2A.Z1-2 and the FLAG-tag sequence and the ORF from 
H2A.Z1-1. It was not possible to amplify the H2A.Z1-1 5’UTR however, so only the H2A.Z1-2 
sequence was used for the cloning. The 5’UTR-FLAG sequence and the ORF were ligated together 
and cloned into pCS2+ (see 9.2.3). After the correct sequence was confirmed by DNA sequencing, 
the plasmid was linearised and transcribed to synthesise the FLAG-H2A.Z1 mRNA. Increasing 
amounts of this mRNA were injected into fertilised eggs from a single frog.  
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Figure 6.3 – Western blot analysis of FLAG-tagged H2A.Z1 mRNA expression and the efficacy of 
the H2A.Z1 MOs. 
Primers (grey half arrows in A.) were designed to amplify two constructs. One containing the 
H2A.Z1-2 5’UTR (blue) next to FLAG-tag encoding DNA (yellow) and flanked by recognition sites 
for Xho1 (purple) at the 5’ end and BamH1 (red) at the 3’ end. The other consisting of the H2A.Z1-
2 ORF (green) flanked by a BamH1 site (red) at the 5’ end and an Xba1 site (orange) at the 3’ end. 
The DNA from both PCR reactions were digested with BamH1 and gel purified. These two 
sequences were then ligated together and the resulting construct was further amplified using the 
5’UTR forward primer and the ORF reverse primer. This DNA was digested with Xho1 and Xba1, 
gel purified and ligated in an Xho1/Xba1 cut pCS2+ vector. This plasmid was then sequenced and, 
after confirmation, mRNA was synthesised from the construct using in vitro transcription (A.). 
Embryos from a single X. laevis female were injected with increasing amounts of FLAG-H2A.Z1 
mRNA. Half of these embryos were also injected with 40ng of H2A.Z1 MOs. All embryos were 
allowed to develop to stage 13/14 and total protein was purified from 20 embryos for each 
condition. One embryo equivalent of protein from each sample was separated on a 15% SDS-
PAGE gel and transferred to nitrocellulose. The membrane was probed with a mouse α-FLAG-HRP 
antibody (B.). The FLAG-H2A.Z1 protein (black arrow in B.) was detectable with injections of 
100pg FLAG-H2A.Z1 mRNA or more. Co-injection of the H2A.Z1 MOs completely inhibited the 
production of protein from, 100pg and 200pg mRNA injections, and almost completely inhibited 
the amount produced from 500pg and 1ng of mRNA. A non-specific band acted as a loading 
control (red arrow in B.). 
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 Half of these embryos were further injected with 40ng of the H2A.Z1 MOs and the other half 
were left without MO to check that the H2A.Z1 mRNA had been translated. The embryos were 
collected for protein purification at late gastrulation. The proteins purified from each set of 
embryos were separated on an SDS-PAGE gel, transferred to nitrocellulose membrane and 
immunoblotted with an α-FLAG-HRP antibody (Figure 6.3B). The FLAG-H2A.Z1 protein was 
detected in embryos injected with 100pg of mRNA and the amount of protein was observed to 
increase with increasing amounts of FLAG-H2A.Z1 mRNA, showing this mRNA was successfully 
translated. When embryos were co-injected with the H2A.Z1 MOs, the FLAG-H2A.Z1 protein was 
absent at 100pg and 200pg mRNA injections, and was almost completely inhibited at 500pg and 
1ng injections. These results showed the H2A.Z1 MOs were capable of binding to the 5’UTR of the 
H2A.Z1 mRNA in vivo and were able to inhibit the synthesis of an exogenous mRNA. 
 
Since the abnormal morphologies observed in the morphant embryos might be caused by a 
specific inhibition of H2A.Z1 protein synthesis, the phenotypes were investigated in greater detail 
using tissue-specific markers in WISH experiments.  
 
6.3 Phenotypic Analysis of the H2A.Z1 Morphant Embryos 
 
6.3.1 Inhibition of H2A.Z1 Expression Affects Multiple Tissues 
The inhibition of H2A.Z1 expression in embryos injected with 40ng of the H2A.Z1 MOs exhibited 
morphological defects and paralysis. Since these morphologies were also observed for both of the 
hnRNP (see Chapter 4) and the H2A.Z2 (see Chapter 5) knock downs, which ultimately had defects 
in neural development, WISH was used to determine the expression of neural markers in H2A.Z1 
MO injected embryos at neurulation (Figure 6.4). 
 
In control embryos, Sox2 expression was detected in the neural plate and the neural crest. 
Although the expression level of Sox2 in embryos lacking H2A.Z1 was similar to that observed in 
the controls, the pattern of expression was always more diffuse and occurred in a larger area of 
the neural plate (Figure 6.4A). This suggested that there was an increase in undifferentiated 
neural progenitor cells (Graham et al., 2003). In addition, the expression of Slug was consistently 
decreased in embryos injected with the H2A.Z1 MOs, yet the patterns of expression were the 
same in both control and morphants embryos (Figure 6.4B), indicating a decrease in the pre-
migratory neural crest cells (Carl et al., 1999). 
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Figure 6.4 – Wholemount in situ hybridisation analysis of Sox2, Slug, NST and Runx1 expression 
in SC and H2A.Z1 MO-injected embryos.  
Embryos from a single female X. laevis were injected with either the SC MO or the H2A.Z1 MOs. 
The embryos were allowed to develop to various stages during neurulation and were then fixed. 
WISH was performed on these embryos using Sox2 (A.), Slug (B.), NST (C.) and Runx1 (D. and E.) 
probes. The expression of Sox2 was seen at similar levels in both the control and morphant 
embryos at stage 15, however, the neural plate was diffuse and larger (A.). At stage 17, Slug 
expression was seen in similar patterns in both SC and H2A.Z1 injected embryos (B.), though the 
expression was decreased in the morphants. NST expression (C.), and both the dorsal (E.) and 
ventral (F.) expression of Runx1 (highlighted in the hashed lines) at stage 17 were all observed to 
decrease in embryos injected with the H2A.Z1 MOs compared to the controls. The numbers in A, 
B, C, and D and E indicate how many embryos looked like those in the pictures. 
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Furthermore, the expression of NST in the differentiated neurons (Figure 6.4C) and Runx1 in the 
neuroblasts (Figure 6.4D) of embryos with knocked down H2A.Z1 expression were always 
decreased compared to the control embryos. The regions of expression of both of these markers 
were conserved in the morphant embryos. The ventral staining of Runx1 in the VBI of H2A.Z1 
injected embryos was also seen in the same region as that in the embryos injected with SC MO, 
however, the expression level was severely decreased in the majority of morphants (Figure 6.4E). 
 
Since neural development was severely affected in embryos where H2A.Z1 was inhibited, further 
analysis was performed on the somite marker gja3 at the late tailbud stage (Figure 6.5). Before 
the stained embryos were cleared, it was obvious that the expression of gja3 in the majority of 
the morphant embryos was greatly reduced, especially in the posterior region (Figure 6.5B). After 
these embryos were cleared, the structures of the somites in the control embryos were observed 
to occur in discrete chevron-shaped patterns (Figure 6.5C). The loss of H2A.Z1 consistently 
resulted in the complete disorganisation of this patterning however (Figure 6.5D), suggesting a 
loss of somite differentiation. 
 
In order to determine the effects of the loss of H2A.Z1 on blood and vasculature development, 
WISH was performed with probes for LMO2 and Erg1, repectively (Figure 6.6). In embryos injected 
with SC MO at the early tailbud stage, the expression of LMO2 was detected in the VBI, DLP and 
the extending tailbud region (Figure 6.6A). Knock down of H2A.Z1 expression consistently resulted 
in an almost complete loss of LMO2 expression in the VBI and DLP, and also caused a decrease in 
expression in the tailbud region (Figure 6.6B). The expression of Erg1 was observed in the 
vasculature throughout the SC MO injected embryos, most prominently in the posterior cardinal 
vein (PCV) and in the blood vessels of the developing plexus on the sides of the embryos (Figure 
6.6C). In the majority of embryos lacking H2A.Z1, Erg1 expression was still detected in these 
regions; however, an overall decrease in the number of blood vessels was observed (Figure 6.6D). 
 
Since the loss of the histone variant, H2A.Z1, was seen to affect neural, muscle and blood 
development, further investigation into the effects of this knock down were performed using 
markers of other tissues in WISH experiments (Figure 6.7). Xlim1 is involved in the growth and 
differentiation of the pronephric tubules of the kidney (Chan et al., 2000), and was detected in 
this region in late tailbud stage control embryos (Figure 6.7A).  
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Figure 6.5 – Wholemount in situ hybridisation analysis of gja3 expression in SC and H2A.Z1 MO-
injected embryos. 
Embryos from a single female X. laevis were injected with either the SC MO (A. and C.) or the 
H2A.Z1 MOs (B. and D.). The embryos were allowed to develop to the late tailbud stage and were 
then fixed. WISH was performed on these embryos using a gja3 probe. In stage 29/30 control 
embryos, gja3 expression was seen in the somites in the distinct chevron patterning (A.), 
however, there was a dramatic decrease in staining in morphant embryos at the same stage (B.). 
These embryos were cleared to better visualise the structure of the somites (C. and D.). 
Compared to the controls (C.), the structure of the somites in H2A.Z1 MO injected embryos was 
seen to be severely affected (D.). The numbers in A and B indicate how many embryos looked like 
those in the pictures. 
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Figure 6.6 – Wholemount in situ hybridisation analysis of LMO2 and Erg1 expression in SC and 
H2A.Z1 MO-injected embryos. 
Embryos from a single female X. laevis were injected with either SC MO (A. and C.) or H2A.Z1 MOs 
(B. and D.). The embryos were allowed to develop to the desired stage and were then fixed. WISH 
was performed on these embryos using LMO2 (A. and B.) and Erg1 (C. and D.) probes. The 
expression of LMO2 in stage 23 control embryos was seen in the VBI, DLP and the extending 
tailbud (tb) region (A.). In H2A.Z1 injected embryos at the same stage (B.), almost all of the VBI 
and DLP expression was absent and the expression in the tailbud region was decreased (compare 
arrowed structures in A. and B.). In stage 31 control embryos (C.), Erg1 expression was observed 
in the posterior cardinal vein (pcv) and in the blood vessels of the plexus (pl). In same stage 
morphant embryos (D.), the expression of Erg1 in these two regions was decreased (compare 
arrows in C. and D.). The numbers in A, B, C and D indicate how many embryos looked like those 
in the pictures. 
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Figure 6.7 – Wholemount in situ hybridisation analysis of Xlim1, Tbx20 and Hex expression in SC 
and H2A.Z1 MO-injected embryos.  
Embryos from a single female X. laevis were injected with either the SC MO (A., C. and E.) or the 
H2A.Z1 MOs (B., D. and F.). The embryos were allowed to develop to the late tailbud stage and 
were then fixed. WISH was performed on these embryos using Xlim1 (A. and B.), Tbx20 (C. and D.) 
and Hex (E. and F.) probes. The expression of Xlim1 in stage 29/30 control (A.) and morphant (B.) 
embryos was observed in the pronephric kidneys; however, the expression was lower in embryos 
injected with the H2A.Z1 MOs. At stage 29/30, Tbx20 expression was seen in the heart (h) and 
cement gland (cg) of SC MO injected embryos (C.). Tbx20 expression was observed in the same 
regions of embryos injected with the H2A.Z1 MOs but at a much lower level (D.). Hex expression 
in stage 31 embryos injected with SC MO was detected in the liver (l), VBI and DLB (E.). In 
morphant embryos at the same stage (F.), expression in the VBI and DLP were decreased 
(compare black arrows in E. and F.). Hex expression in the liver was seen to be relatively normal 
(compare red arrows in E. and F.). The numbers in A, B, C, D, E and F indicate how many embryos 
looked like those in the pictures. 
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Xlim1 expression however, was seen to decrease due to the loss of H2A.Z1 in the majority of the 
morphant embryos. There also appeared to be a consistent loss of pronephric tubules in these 
embryos (Figure 6.7B), which would correlate with this loss of expression. To determine the 
effects of the loss of H2A.Z1 on heart development, a Tbx20 probe was used. Normal expression 
of Tbx20 was observed in the SC MO injected embryos; in the heart and also in the cement gland 
(Figure 6.7C). Tbx20 expression was also seen in these regions in embryos injected with the 
H2A.Z1 MOs. This expression was always reduced in these morphant embryos however, which 
resulted in a significantly smaller heart (Figure 6.7D). In control embryos at the late tailbud stage, 
Hex expression was seen in the VBI, DLP and liver (Figure 6.7E). Although a decrease in the 
expression of Hex in the VBI and DLP of embryos lacking H2A.Z1 was observed, Hex expression in 
the liver remained normal in the majority of the morphant embryos (Figure 6.7F). 
 
The results gathered here suggest that the loss of H2A.Z1 has significant effects on the 
development of a number of tissues. This widespread effect suggests there may be a defect 
occurring in the specification of these tissues earlier in development. To investigate this 
hypothesis, WISH was performed using markers of the three germ layers. 
 
6.3.2 Loss of H2A.Z1 Affects Germ Layer Specification 
The MO-mediated knock down of H2A.Z1 expression resulted in the down-regulation of genes 
involved in neural, muscle, blood, heart, and kidney development. It was therefore hypothesised 
that a decreased expression of H2A.Z1 protein could be affecting the specification of the germ 
layer these tissues are derived from at the gastrula stage.  
 
The tissues and organs that make up any higher animal all originate from three germ layers; the 
ectoderm, mesoderm and endoderm (Figure 6.8). The specification of these germ layers in X. 
laevis embryos occurs shortly before gastrulation. During the gastrula stage, the ectoderm 
migrates around the outside of the embryo and eventually gives rise to the epidermis and the 
central nervous system, including all nerves, sensory organs and the brain. The mesoderm 
migrates between the ectoderm and endoderm, and these cells ultimately form the muscle, bone, 
blood, heart and kidneys. The migration of the ectoderm and mesoderm envelops the endoderm, 
which forms the lungs and the digestive system, including the stomach, intestines, liver and 
pancreas (Gilbert, 2006). 
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Figure 6.8 – Cell types derived from the ectoderm and mesoderm are affected by the loss of 
H2A.Z1. 
All tissues in the embryo are derived from three germ layers; the ectoderm, mesoderm and 
endoderm. The ectoderm gives rise to the skin and central nervous system, the mesoderm to 
muscle, blood and the kidneys, and the endoderm to the digestive system and lungs. From the 
phenotypic analysis, the loss of H2A.Z1 appears mostly to affect tissues derived from the 
mesoderm, some of those from the ectoderm but none from the endoderm (Gilbert, 2006).  
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Since the loss of H2A.Z1 appeared to only affect tissues derived from the ectoderm (neural) and 
mesoderm (muscle, blood, heart and kidney), and not the expression of Hex in the liver, which 
originates from the endoderm (Figure 6.8). It was hypothesised that this histone variant was 
involved in the specification of these two germs layers but not the endoderm. Therefore, WISH 
was performed on gastrula stage embryos using markers of each germ layer (Figure 6.9). 
 
The expression of FoxC1 in SC MO injected embryos was seen throughout the ectoderm and also 
in the mesoderm (Figure 6.9A). In the majority of embryos with decreased H2A.Z1 expression, the 
staining of FoxC1 was slightly decreased throughout the ectoderm and was completely absent 
from the mesoderm (compare black arrow to red arrow in Figure 6.9A). At the gastrula stage, 
Xbra is expressed in the invaginating mesoderm, as detected in the control embryos. In embryos 
injected with the H2A.Z1 MOs at the same stage however, the expression of Xbra was always 
severely reduced (Figure 6.9B). Conversely, Sox17β expression was consistently detected in the 
yolky endoderm cells of blastopore in control and morphant embryos at a similar level (Figure 
6.9C). 
 
These results support with the hypothesis that a loss of H2A.Z1 only affects ectodermal and 
mesodermal tissues, and not the endoderm. Since only a small reduction in the ectodermal 
expression of FoxC1 was observed, yet a complete inhibition of mesodermal FoxC1 expression and 
a significant reduction in Xbra expression was seen, the role of H2A.Z1 in mesoderm induction 
was investigated. 
 
6.4 The Role of H2A.Z1 in Mesoderm Induction 
 
6.4.1 Mesoderm Induction 
Given that a decrease in H2A.Z1 expression affected mesoderm-derived tissues and also resulted 
in a down-regulation of the important mesodermal gene, Xbra, the function of H2A.Z1 in 
mesoderm induction was investigated. It was first necessary however, to understand the signals 
and pathways that lead to the induction of mesodermal tissue in X. laevis embryos (Figure 6.10). 
 
In amphibian embryos, the mesoderm originates in the equatorial tissue of the late blastula. It is 
well known that the mesoderm is formed through an inductive interaction in response to a signal 
derived from the cells of the vegetal hemisphere (Smith, 2009).  
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Figure 6.9 – Wholemount in situ hybridisation analysis of FoxC1, Xbra and Sox17β expression in 
SC and H2A.Z1 MO-injected embryos.  
Embryos from a single female X. laevis were injected with either SC MO or H2A.Z1 MOs. These 
embryos were allowed to develop to mid-gastrulation (stage 10.5/11) and were then fixed. WISH 
was performed on embryos using FoxC1 (A.), Xbra (B.) and Sox17β (C.) probes. The expression of 
FoxC1 was detected in the ectoderm of both control and morphant embryos (A.), however, there 
was a slight decrease in this expression in the morphants. There was also a complete loss of 
mesodermal expression of FoxC1 in H2A.Z1 MO injected embryos (compare black and red arrows 
in A.). In both control and morphant embryos, the expression of Xbra were seen in the mesoderm, 
however, the expression in embryos injected with H2A.Z1 MO was dramatically decreased (B.). 
Sox17β expression was observed at the same levels in SC MO and H2A.Z1 MO injected embryos in 
the endoderm (C.). The numbers in A, B and C indicate how many embryos looked like those in 
the pictures. 
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Figure 6.10 – A simplified schematic of mesoderm induction. 
In normal development, the mesoderm is specified in the marginal zone of the embryo through 
signalling from the vegetal pole. The maternal protein, VegT, is located in the vegetal pole of the 
embryo, which then activates mesoderm inducing factors, such as the Xnrs (Xenopus nodal-
related proteins). These signalling molecules then activate the TGFβ and FGF signalling cascades 
that lead to the induction of mesodermal tissue.  
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Since almost all zygotic transcription in Xenopus embryos does not occur until the mid-blastula 
transition (MBT), maternal stores are required for embryonic patterning (Heasman, 2006), one of 
which is the transcriptional activator protein, VegT (Zhang et al., 1998). VegT is only found in the 
vegetal hemisphere at the blastula stage, and is involved in the formation of endoderm and 
mesoderm (Zhang et al., 1998). After the MBT, VegT activates the expression of mesoderm-
inducing factors, such as the Xenopus nodal-related (Xnr) proteins (Heasman, 2006). The Xnr 
proteins are members of the transforming growth factor type β (TGFβ) family, and play a crucial 
role in mesoderm formation downstream of VegT (Agius et al., 2000). These mesoderm-inducing 
factors activate the transcription of other TGFβ family members, such as activin, and several 
members of the fibroblast growth factor family (FGF) (Heasman, 2006, Smith, 2009). These, in 
turn, activate intra-cellular signalling cascades; Smad2 signalling in response to TGFβs and MAP 
kinase signalling in response to FGFs. These signalling events eventually lead to the expression of 
a number of zygotic genes, including Xbra in the equatorial cells (Heasman, 2006).  
 
To determine where in the mesoderm induction pathway the loss of H2A.Z1 was affecting, the 
extra- and intra-cellular signalling pathways were analysed through embryo dissections and 
Western blotting, respectively. 
 
6.4.2 Mesoderm-Inducing Factors are Present in H2A.Z1 Morphant Embryos but the Response 
to Them Is Reduced 
Since the mesoderm in X. laevis is induced through signalling molecules originating from the 
vegetal hemisphere, the ability of these signals to induce mesodermal tissue in H2A.Z1 deficient 
cells was investigated to determine where in the mesoderm induction pathway H2A.Z1 acts. 
 
To investigate whether the TGFβ family of proteins were able to activate mesoderm formation in 
embryos lacking the H2A.Z1 protein, a mesoderm induction assay was performed on animal caps 
taken from control and morphant embryos (Figure 6.11). The animal cap forms the roof of the 
blastocoel and explants of this region form balls of undifferentiated ectodermal tissue when 
cultured. Mesoderm can be induced in this tissue however, by adding the TGFβ signalling 
molecule, activin A, to the media and the caps will undergo elongation during the neurula stage 
(Figure 6.11A). Embryos from a single female frog were injected with the SC MO or H2A.Z1 MOs 
and were allowed to develop to the MBT. Animal caps were dissected from both sets of embryos 
and were cultured with two different concentrations of activin A until the late neurula stage 
(Figure 6.11B). Animal caps from control and morphant embryos were also cultured without 
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activin A as controls for ectoderm formation. Both sets of these untreated animal caps always 
rounded into balls and did not elongate, indicating there was no endogenous mesoderm-inducing 
signals present in these explants (Figure 6.11B i. and ii.). The animal caps dissected from embryos 
injected with the SC MO consistently underwent elongation when treated with both 
concentrations of activin A; however, the explants treated with a higher dose of activin A were 
always slightly shorter (Figure 6.11B iii. and v.). This showed that the control tissue was able to 
respond to mesoderm-inducing factors, as expected. Conversely, all of the animal caps dissected 
from H2A.Z1 MO injected embryos only underwent slight elongation but more so in the explants 
treated with the lower concentration of activin A (Figure 6.11B iv. and vi.). These results 
suggested that the H2A.Z1 deficient explants were able to respond to activin A but the level of 
mesoderm induction was diminished. These results correlated with the reduced, but not 
completely absent, expression of Xbra in whole embryos (Figure 6.9B). Although this showed that 
the animal caps lacking H2A.Z1 had a slight induction of mesodermal tissue in response to 
exogenous signalling, it did not show whether the endogenous signals were present at normal 
levels in the morphant embryos. 
 
In order to determine whether the loss of H2A.Z1 had an effect on the endogenous signalling 
from the vegetal hemisphere in morphant embryos, Nieuwkoop conjugates were formed from 
control and morphant embryos (Figure 6.12). Nieuwkoop conjugates are formed from the animal 
cap and vegetal signalling region of an embryo (Figure 6.12A), and were originally used to identify 
the mesoderm inducing potential of the vegetal hemisphere (Smith, 2009). Animal caps and 
vegetal poles were dissected from blastula stage embryos that had been injected with either SC 
MO or the H2A.Z1 MOs. Four different combinations of Nieuwkoop conjugates were formed and 
these were cultured until mid-gastrulation. Since these conjugates do not elongate, it was 
necessary to perform WISH using an Xbra probe to determine the levels of mesoderm induction in 
these explants (Figure 6.12B). As expected, conjugates formed from animal caps and vegetal poles 
from control embryos always expressed a high level of Xbra (Figure 6.12B i.), and those formed 
from morphant explants alone always had low levels of expression (Figure 6.12B iv.). When the 
animal caps from control embryos were combined with the vegetal poles from the morphants, 
the resulting conjugates consistently expressed Xbra at a level similar to the control conjugates 
(Figure 6.12 iii.). Conversely, when animal caps from the morphant embryos were combined with 
the vegetal poles from the controls, all of the resulting conjugates expressed only a low level of 
Xbra, similar to that of the morphant conjugates (Figure 6.12B ii.). These results indicated that the 
vegetally-derived mesoderm-inducing factors were unaffected by the loss of H2A.Z1 in morphant 
embryos and were able to induce mesoderm formation in cells with normal H2A.Z1 levels.  
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Figure 6.11 – Analysis of mesoderm induction in animal cap explants from SC and H2A.Z1 MO 
injected embryos. 
Animal caps dissected from normal blastula stage embryos will form a ball of undifferentiated 
ectoderm if left untreated. If activin A is added to the media, the animal caps will form 
mesodermal tissue and undergo elongation (A.). Animal caps were dissected from embryos 
injected with either SC MO or H2A.Z1 MOs from a single female X. laevis. These were treated with 
either 20ng/ml or 50ng/ml of activin A, or were left untreated as controls (B.). The animal caps 
were incubated alongside undissected embryos, which were allowed to develop until late 
neurulation (stage 18). The caps were then fixed and photographed. Both the untreated control 
(i.) and morphant (ii.) animal caps rounded into balls of ectoderm. Animal caps dissected from SC 
MO injected embryos treated with 20ng/ml (iii.) and 50ng/ml (v.) activin A both formed 
mesoderm and elongated. Whereas, only a small amount of elongation, if any, was observed in 
animal caps from embryos injected with the H2A.Z1 MOs that were treated with 20ng/ml (iv.) or 
50ng/ml (vi.) activin A. The mean lengths of both sets of explants treated with 20ng/ml are shown 
with the standard deviations. 
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Figure 6.12 – Endogenous signalling analysis of SC and H2A.Z1 MO injected embryos using 
Nieuwkoop conjugates. 
A Nieuwkoop conjugate were formed by combining an animal cap of an embryo with the vegetal 
signalling region (A.). In normal embryos, the vegetal pole will then induce mesoderm formation 
in the animal cap. Nieuwkoop conjugates were formed from four different combinations of 
animal caps and vegetal poles dissected from embryos injected with either the SC MO or the 
H2A.Z1 MOs from a single female X. laevis. The conjugates were incubated alongside undissected 
embryos, which were allowed to develop to mid-gastrulation (stage 10.5/11). The conjugates 
were then fixed and WISH was performed using an Xbra probe (B.). Nieuwkoop conjugates 
formed from animal caps and vegetal poles from embryos injected with SC MO, expressed Xbra 
(i.), as did conjugates formed from control animal caps and morphant vegetal poles (iii.). 
However, conjugates formed from either morphant animal caps and control vegetal poles (ii.) or 
both animal caps and vegetal poles from morphant embryos (iv.) had dramatically reduced 
expression of Xbra in the animal caps.  
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They also suggested that the loss of H2A.Z1 resulted in a severely diminished response to 
mesoderm induction, as observed with the animal cap assay. Since it was shown that the VegT-
activated mesoderm-inducing factors were present in H2A.Z1 knock down embryos but the 
response to these factors was significantly affected, the intra-cellular signalling cascades activated 
by these proteins were investigated. 
 
6.4.3 Intra-cellular Signalling Occurs Normally in H2A.Z1 Morphant Embryos 
Given that normal vegetal signalling was observed in H2A.Z1 deficient embryos, yet the ability of 
these embryos to respond to this signalling was affected, the signalling cascades that relay these 
extra-cellular signals to the nucleus were investigated. TGFβ and FGF proteins activate two 
separate intra-cellular signalling proteins, Smad2 and MAP kinase, respectively. The activation of 
which results in the phosphorylation of Smad2 and MAPK that can be detected using Western 
blots. Antibodies raised against both the unmodified and phosphorylated forms of these proteins 
have previously been used to successfully detect mesoderm induction in X. laevis (Morris et al., 
2007, Luxardi et al., 2010). 
 
The TGFβ signalling pathway is activated when a member of the TGFβ family, in this case activin 
or the Xnrs, binds to a TGFβ type II receptor (TGFβRII) dimer (Figure 6.13A). TGFβRII is a 
serine/threonine receptor kinase that recruits and phosphorylates a TGFβ type I receptor (TGFβRI) 
dimer after the ligand is bound (Wrana et al., 1992). This activates the TGFβRI dimer, which in 
turn phosphorylates the receptor regulated Smad proteins (Souchelnytskyi et al., 2001). Smad2 
and Smad3 are the transcription factors phosphorylated in response to activin and Xnr signalling 
(Wharton and Derynck, 2009). The phosphorylation of Smad2/3 enables the recruitment of 
Smad4, and this complex is then translocated into the nucleus where it binds to cofactors and 
activates the expression of mesodermal genes (Smith et al., 1991). 
 
To determine the effect of the loss of H2A.Z1 on the TGFβ signalling pathway, Western blotting 
was performed to detect the levels of Smad2/3 and phospho-Smad2 in control and morphant 
embryos (Figure 6.13B). The SC MO or the H2A.Z1 MOs were injected into embryos from a single 
female frog and were allowed to develop to stage 9 and stage 10. Protein was purified from 20 
embryos from both stages of control and morphant embryos. Protein equivalent to one embryo 
from each sample was separated on a 10% SDS-PAGE, in duplicate. The proteins were transferred 
to a nitrocellulose membrane, one half of which was probed with a rabbit α-Smad2/3 antibody 
and the other half with a rabbit α-phospho-Smad2 (Ser465/467) antibody. The Smad2/3 proteins 
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were detected at the same levels in both control and morphant embryos at stage 9 and stage 10. 
However, phospho-Smad2 was only detected in stage 10 embryos but the level of 
phosphorylation was equivalent in both control SC MO and morphant H2A.Z1 MO injected 
embryos. These results indicated that loss of H2A.Z1 had no effect on the transduction of the 
TGFβ signal. FGF signalling was therefore investigated. 
 
The FGF signalling pathway is activated when a signalling molecule of the FGF family, in this case 
FGF2 or FGF4 (Smith, 2009), binds to the FGF receptor (FGFr), which belongs to a subfamily of 
receptor tyrosine kinases (Bottcher and Niehrs, 2005). The binding of the ligand results in 
receptor dimerisation and activates the tyrosine kinase domains, which trans-phosphorylate the 
intra-cellular domains of both FGFrs (McKeehan et al., 1998). There are several pathways of FGF 
signal transduction; the one that is essential for mesoderm induction is the MAPK pathway (Smith 
et al., 1991). The activation of the FGFr dimer results in the phosphorylation and activation of the 
MAPK kinase kinase (MAPKKK), Raf, which in turn phosphorylates and activates the MAPK kinase 
(MAPKK), MEK. Finally, MEK phosphorylates the MAP kinase (MAPK) proteins, Erk1 and Erk2, 
which are then translocated to the nucleus. Once in the nucleus, phospho-Erk1/2 phosphorylates 
target transcription factors that activate the transcription of mesodermal genes (Kimelman, 
2006).  
 
To test whether the FGF signalling pathway was working in H2A.Z1 deficient embryos, Western 
blotting was performed to detect the levels of Erk1/2 and phospho-Erk1/2 in control and 
morphant embryos (Figure 6.14B). Protein was purified from 20 embryos at stage 8, stage 9 and 
stage 10 that had been injected with either SC MO or the H2A.Z1 MOs. An equivalent of one 
embryo’s protein from each sample was separated on a 10% SDS-PAGE in duplicate and 
transferred to a nitrocellulose membrane. Half of the membrane was probed with a rabbit α-
Erk1/2 (MAPK) antibody, the other with a rabbit α-phospho-Erk1/2 (Thr202/Tyr204) antibody. The 
Erk1/2 proteins were detected at the same levels in control and morphant embryos at each of the 
stages assayed. Whereas, the phospho-Erk1/2 proteins were detected at the same levels in both 
sets of embryos at all 3 stages, the overall level of Erk1/2 phosphorylation increased steadily from 
stage 8 to stage 10.  
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Figure 6.13 – Analysis of TGFβ signalling in SC MO and H2A.Z1 MO injected embryos. 
The TGFβ signalling pathway is activated when a TGFβ family protein docks with the TGFβRII 
receptor. The TGFβRI receptor is recruited and phosphorylated by TGFβRII. The phosphorylated 
receptor complex, in turn, phosphorylates the Smad2/Smad3 proteins, which then recruit Smad4. 
This Smad complex is translocated to the nucleus where it activates transcription of genes 
involved in mesoderm formation (A.). Embryos from a single female X. laevis were injected with 
either the SC MO or the H2A.Z1 MOs. Total protein was purified from 20 control and morphant 
embryos at stage 9 and stage 10. One embryo equivalent of protein from each sample was 
separated in duplicate on a 10% SDS-PAGE gel and transferred to nitrocellulose. The membrane 
was cut in half, and one side was probed with a rabbit α-Smad2/3 antibody, the other with a 
rabbit α-phospho-Smad2 (Ser465/467) antibody (B.). The Smad2/3 proteins (indicated by the 
black arrow) were detected at the same levels in control and morphant embryos at stage 9 and 
stage 10. The phosphorylated Smad2 protein (indicated by the black arrow) was only detected in 
stage 10 embryos, but at the same level in SC MO and H2A.Z1 MO injected embryos.  
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Figure 6.14 – Analysis of FGF signalling in SC MO and H2A.Z1 MO injected embryos. 
The FGF signalling pathway is activated when an FGF family protein docks with the FGFr receptor 
(A.). This causes a trans-phosphorylation of an FGFr dimer, which then initiates a MAP kinase 
phosphorylation cascade. Raf is phosphorylated by the receptor complex, which in turn 
phosphorylates MEK that phosphorylates the Erk1/2 proteins. The phospho-Erk1/2 proteins are 
translocated to the nucleus where they act as a co-activator of transcription factors involved in 
mesodermal gene expression. Embryos from a single female X. laevis were injected with either 
the SC MO or the H2A.Z1 MOs. Total protein was purified from 20 control and morphant embryos 
at stages 8, 9 and 10. One embryo equivalent of protein from each sample was separated in 
duplicate on a 10% SDS-PAGE gel and transferred to nitrocellulose. The membrane was cut in half, 
and one side was probed with a rabbit α-Erk1/2 (MAPK) antibody, the other with a rabbit α-
phospho-Erk1/2 (Thr202/Tyr204) antibody (B.). The Erk1/2 proteins were detected at the same 
level in control and morphant embryos in all stages tested. The phosphorylated Erk1/2 proteins 
were also at the same levels in SC MO and H2A.Z1 MO injected embryos and increased over the 3 
stages studied. 
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Together, these results show that the knock down of H2A.Z1 affects neither the TGFβ nor the FGF 
intra-cellular signalling cascades. Therefore, the factors that are responsible for the activation of 
Xbra transcription should be present and active in the nuclei of cells lacking H2A.Z1. As a result of 
this, it was likely that H2A.Z1 regulates Xbra expression directly at the gene. To test this 
hypothesis ChIP experiments were performed. 
 
6.4.4 H2A.Z1 is Located at the Xbra Promoter 
Since both the extra- and intra-cellular signalling pathways that induce mesoderm formation were 
shown to be normal in embryos with decreased H2A.Z1 expression, it was hypothesised that 
H2A.Z1 was regulating Xbra expression directly at the gene. Chromatin immunoprecipitation 
(ChIP) was performed on control and morphant embryos, followed by quantitative PCR (qPCR) to 
determine if H2A.Z1 was located at the Xbra promoter (Figure 6.15). 
 
The SC MO and the H2AZ.Z1 MOs were injected into embryos from a single female frog and were 
allowed to develop to mid-gastrulation. The chromatin from both sets of whole embryos was then 
crosslinked and sonicated until the average size of the fragments was 0.5kb. Since it was 
necessary to detect the endogenous H2A.Z1 protein, ChIP was performed with a sheep α-acetyl-
H2A.Z (AcH2A.Z) antibody. Since this antibody would also recognise the AcH2A.Z2 isoform as well 
as AcH2A.Z1, H2A.Z1 was specifically inhibited in the morphant embryos. Pre-immune IgGs were 
used as a negative control and a sheep α-H3-lysine 4-dimethyl (H3K4me2) antibody was used as a 
positive control since this histone modification is located at the 5’ region of active genes (Barski et 
al., 2007). After the ChIP experiments, qPCR was performed on the input and bound samples 
using the promoter regions of Xbra, Gata2, globin and Sox17β as targets. Gata2 was included as a 
positive control for gene expression and globin as a negative control. Sox17β represents an 
additional control since the expression of this gene was unaffected by the loss of H2A.Z1. 
 
The results of the ChIP-qPCR experiments were plotted as fold enrichments when the bound 
signal was higher than that of the input, and fold depletions when the reverse occurred. As 
expected, the pre-immune IgGs showed depletions at each promoter region in both control and 
morphant embryos (Figure 6.15A), suggesting no non-specific selection by these antibodies. In 
embryos injected with the SC MO, AcH2A.Z was enriched at the promoters of Xbra, Gata2 and 
globin, and depleted at the Sox17β promoter. In the H2A.Z1 MO injected embryos however, a 
depletion of AcH2A.Z was detected at the promoters of Xbra, Gata2 and globin.  
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Figure 6.15 – Occupancy of AcH2A.Z and H3K4me2 at the promoters of Xbra, Gata2, globin and 
Sox17β in SC MO and H2A.Z1 MO injected embryos. 
Embryos from a single female X. laevis were injected with either SC MO or the H2A.Z1 MOs. These 
embryos were allowed to develop to mid-gastrulation (stage 10.5/11) and the embryonic 
chromatin was then crosslinked. The chromatin from both sets of embryos was sonicated, and 
chromatin immunoprecipitation was performed using pre-immune IgG antibodies (A.), an α-
acetyl-H2A.Z antibody (B.) and an α-H3-lysine 4-dimethyl antibody (C.). Quantitative PCR was 
performed on the input and bound samples from each ChIP assay using the promoter regions of 
Xbra, Gata2, globin, and Sox17β as amplicons. Fold enrichments were plotted as the ratio of 
bound to input signal (B/I) above the unity lines, and fold depletions were plotted when the 
bound signal was less than the input signal (I/B) below the unity lines. Error bars are standard 
deviations from triplicate amplifications. The IgG control showed depletions across each promoter 
region, in both control and morphant embryos (A.). In SC MO injected embryos, AcH2A.Z was 
enriched at the promoters of Xbra, Gata2 and globin, but depleted at the Sox17β promoter. In 
embryos injected with the H2A.Z1 MOs, AcH2A.Z was depleted at the promoters of Xbra, Gata2 
and globin promoters and remained depleted at the Sox17β promoter (B.). In control embryos, 
H3K4me2 was somewhat enriched at each promoter assayed but in morphant embryos the 
amount of H3K4me2 was further enriched (C.).  
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AcH2A.Z was also observed to remain depleted at the Sox17β promoter (Figure 6.15B). The post-
translational modification of histone H3K4me2 was found to be enriched at each promoter in 
both control and morphant embryos. In H2A.Z1 morphant embryos however, the amount of 
H3K4me2 at these promoter regions was further enriched by around 2.5 fold (Figure 6.15C). 
These results indicated that H2A.Z1 was located at the promoter of genes affected by the loss of 
its expression in that Xbra was down-regulated and Sox17β was unaffected in morphant embryos. 
 
Given that the mesoderm-inducing signals were shown to be functioning normally in embryos 
when H2A.Z1 was inhibited, and H2A.Z1 was shown to be located at the Xbra promoter, it was 
highly likely that this histone variant was directly regulating Xbra expression at the chromatin 
level. Before these results could be considered as strong evidence however, the specificity of the 
H2A.Z1 knock down needed to be confirmed. 
 
6.5 H2A.Z1 MO Specificity Controls 
 
6.5.1 Co-injection of H2A.Z1 mRNA Rescues Normal Development in H2A.Z1 Morphant Embryos 
To test whether the results generated in the H2A.Z1 MO injected embryos could be considered to 
be the result of a specific loss of the H2A.Z1 histone variant, rescue experiments were performed 
whereby a synthetic mRNA encoding H2A.Z1 was co-injected into embryos alongside the H2A.Z1 
MOs in an attempt to recover normal development. 
 
In order to perform these rescue experiments, the ORF of H2A.Z1-2 was cloned into the pβUT2-
Sfi1 vector (see 9.2.2). Since this plasmid contains the X. laevis β-globin UTRs, the H2A.Z1 MOs 
would not bind to the mRNA transcribed from this construct, thereby reintroducing the H2A.Z1 
protein back into the morphant embryos. After the correct DNA sequence was confirmed by 
sequencing, the construct was linearised using Sfi1 and an in vitro transcription reaction, 
containing T3 RNA polymerase, was performed (Figure 6.16A). Since the H2A.Z1 mRNA was 
successfully transcribed, it was necessary to check if the mRNA could be translated in vivo. 
 
To determine if the synthetic H2A.Z1 mRNA could be translated, protein was purified from 
embryos injected with 2ng of the H2A.Z1 mRNA, 1ng H2A.Z2 mRNA and 40ng of a H2A.Z1/Z2 MO, 
as well as uninjected embryos. These protein samples were separated on a 15% SDS-PAGE, 
transferred to nitrocellulose membrane and probed with an α-H2A.Z antibody (Figure 6.16B).  
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Figure 6.16 – In vitro transcription and in vivo translation of H2A.Z1 ORF mRNA. 
(A.) The ORF of H2A.Z1-2 was cloned into pβUT2-Sfi1 and the resulting plasmid linearised using 
Sfi1. An in vitro transcription reaction was performed using this template DNA to synthesise 
H2A.Z1 mRNA. DNaseI was added to the reaction to remove the DNA template and leave only the 
mRNA transcript. Aliquots of the reaction before and after incubation with DNaseI were run on a 
1% agarose gel. The template DNA was only observed in the sample before DNaseI treatment (red 
arrow), whereas the H2A.Z1 mRNA was seen in two bands before and after incubation (black 
arrows). (B.) Embryos from a single female X. laevis were injected with 1ng H2A.Z2 mRNA, 2ng of 
the H2A.Z1 mRNA or 40ng of a H2A.Z1/Z2 MO (double knockout). Half of the embryos were left 
uninjected as controls of endogenous protein expression. The embryos were allowed to develop 
to stage 13/14 and total protein purified from 50 embryos for all conditions. Six embryos 
equivalent of protein from uninjected and injected embryos was separated on a 15% SDS-PAGE 
gel and transferred to a nitrocellulose membrane, then probed with a sheep α-H2A.Z antibody 
(B.). The endogenous H2A.Z protein was detected as a very faint band (see black arrow in 
Uninjected). More intense bands were detected from embryos injected with H2A.Z2 mRNA and 
H2A.Z1 mRNA, whereas no H2A.Z protein was detected in the double knockdown. A non-specific 
band (red arrow) acted as a loading control. 
 185 
 
The bands detected from embryos injected with the H2A.Z mRNAs were much more intense than 
the band detected for the endogenous protein. Furthermore, no H2A.Z protein was detected from 
the double knockdown embryos. Therefore, it was clear that the H2A.Z1 mRNA was successfully 
translated in X. laevis embryos.  
 
To test whether the reintroduction of the H2A.Z1 protein was able to recover normal 
development, a morphological rescue experiment was performed (Figure 6.17). Fertilised eggs 
from a single female frog were injected with 40ng of the H2A.Z1 MOs and were allowed to 
develop to the two-cell stage. Half of these embryos were then injected with 1ng of H2A.Z1 mRNA 
into each cell of the two-cell stage embryos, giving a total of 2ng mRNA per embryo (Figure 
6.17A). The other half of the embryos were left without mRNA to provide a comparison between 
the morphant and rescue embryos. All of the embryos were monitored throughout development 
and were allowed to reach the swimming tadpole stage. As expected, all of the H2A.Z1 MO 
injected embryos were paralysed and showed retarded development (Figure 6.17B). Although 
two of the embryos co-injected with the H2A.Z1 MOs and mRNA died, the remaining three 
displayed normal developmental morphology and timing, and were also able to swim (Figure 
6.17C). 
 
These results showed that, although at low numbers, the co-injection of the H2A.Z1 mRNA with 
the MOs rescued normal morphology and therefore suggested that the morphological defects 
observed in the morphant embryos were the result of a specific loss of the H2A.Z1 protein. To test 
whether Xbra expression was recovered by the reintroduction of H2A.Z1 protein expression, a 
further rescue experiment was performed. 
 
6.5.2 Co-injection of H2A.Z1 mRNA Rescues Xbra Expression in H2A.Z1 Morphant Embryos 
The MO mediated knock down of H2A.Z1 resulted in a reduced Xbra expression, which caused 
defects in a number of tissues derived from the mesoderm. It was also shown that H2A.Z1 was 
located at the promoter of this gene and therefore potentially regulates the expression of Xbra 
directly. Since normal morphology was rescued by the co-injection of H2A.Z1 mRNA into 
morphant embryos, a further rescue experiment was performed to determine if the expression of 
Xbra was returned to normal levels through the reintroduction of the H2A.Z1 protein (Figure 
6.18). 
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Figure 6.17 – Morphological rescue of H2A.Z1 MO-mediated knock down using H2A.Z1 mRNA. 
Fertilised eggs from a single female were injected with 40ng of the H2A.Z1 MOs and incubated at 
18oC for 2 hours. Half of these embryos were injected with 1ng of H2A.Z1 mRNA into each cell of 
the two-cell stage embryos (A.). The embryos were monitored throughout development and 
allowed to reach the swimming tadpole stage. All of the embryos injected with the H2A.Z1 MOs 
alone were paralysed, had retarded development and morphological defects (B.). The surviving 
embryos co-injected with the H2A.Z1 MOs and H2A.Z1 mRNA were able to swim and displayed 
normal development and morphologies (C.). The numbers in B and C indicate how many embryos 
looked like those in the pictures. 
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Figure 6.18 – Wholemount in situ hybridisation analysis of Xbra expression in control, morphant 
and rescue embryos. 
Fertilised eggs from a single female were injected with 40ng of either SC MO or the H2A.Z1 MOs, 
and incubated at 18oC for 3 hours. Half of the embryos injected with the H2A.Z1 MOs were also 
injected with 1ng of H2A.Z1 mRNA into two cells of the four-cell stage embryos. All of the 
embryos were allowed to develop to mid-gastrulation (stage 10.5/11) and were then fixed. WISH 
was performed using an Xbra probe (A.). The expression of Xbra in morphant embryos was 
decreased compared to the controls. This decrease in expression was also seen in the side of the 
rescue embryos with only H2A.Z1 MOs (red arrow in A.), whereas the side also injected with 
mRNA had Xbra expression levels similar to those of the control embryos (black arrow in A.). The 
experiment was repeated with 250pg of β-Gal mRNA co-injected with the H2A.Z1 mRNA, and β-
Gal staining was performed on all of the embryos (B.). Again, an increase in Xbra expression was 
observed in the region with β-Gal expression (black arrow in B.), compared to the decreased 
expression in the morphant half (red arrow in B.). The numbers in A and B indicate how many 
embryos looked like those in the pictures. 
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Fertilised eggs from a single female X. laevis were injected with 40ng of SC MO or the H2A.Z1 MOs 
and were allowed to develop to the four-cell stage. Half of the embryos injected with the H2A.Z1 
MOs were then also injected with 1ng of H2A.Z1 mRNA into two blastomeres of the four-cell 
stage embryos, giving a total of 2ng mRNA per embryos. All of the embryos were allowed to 
develop to mid-gastrulation and WISH was performed with an Xbra probe (Figure 6.18A).  
 
As expected, Xbra expression in the majority of the embryos lacking H2A.Z1 was decreased 
compared to the expression seen in the controls. In the rescue embryos, one half of the embryos 
always showed a decrease in Xbra expression similar to that of the morphants (red arrow in 
Figure 6.18A) and the other halves always showed expression similar to the controls (black arrow 
in Figure 6.18A). This suggested the H2A.Z1 protein was able to rescue the expression of Xbra, 
however, since it could not be determined which side the mRNA was injected into the rescue 
embryos, the experiment was repeated with a lineage tracer.  
 
The rescue experiment was repeated as before, however, 250pg of β-Gal mRNA was also injected 
with the H2A.Z1 mRNA into two blastomeres of four-cell stage embryos. The embryos were 
incubated in β-Gal Staining Buffer with X-Gal to determine the localisation of the injected mRNAs. 
All of the embryos were treated in the same manner to prevent any differences in the in situ 
hybridisation staining. After the β-Gal staining, WISH was performed using an Xbra probe (Figure 
6.18B). Again, the same Xbra expression levels were consistently observed in the control and 
morphant embryos. It could clearly be seen however, that the decrease in Xbra expression in the 
rescue embryos was in the side injected with the H2A.Z1 MOs alone (red arrow in Figure 6.18B), 
whereas the increase in expression occurred in the side co-injected with H2A.Z1 mRNA as 
indicated by the light blue β-Gal staining (Figure 6.18B). Although these results indicated that the 
H2A.Z1 protein was sufficient to rescue normal Xbra expression, the specificity of the H2A.Z1 MOs 
needed to be further confirmed. 
 
6.5.3 Second H2A.Z1 MOs Phenocopy the Down-Regulation of Xbra 
Since it had been shown that the SC MO had no effects on development, that the H2A.Z1 MOs 
were able to bind to their targets and that the reintroduction of H2A.Z1 protein into morphants 
was able to rescue normal phenotypes, there was strong evidence for the specificity of the 
H2A.Z1 knock down. To be certain that no off-target phenotypes were being caused by the 
H2A.Z1 MOs, a second set of non-overlapping morpholino oligonucleotides were designed and 
used to determine the effect on Xbra expression (Figure 6.19). 
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Figure 6.19 – Second H2A.Z MO design and wholemount in situ hybridisation analysis of Xbra 
expression in SC MO and H2A.Z1 MO2 injected embryos. 
Second morpholino oligonucleotides were designed to bind non-overlapping regions of the 
5’UTRs of H2A.Z1-1 (A.) and H2A.Z1-2 (B.). Embryos from a single female X. laevis were injected 
with either 40ng SC MO or 20ng H2A.Z1-1 MO2 and 20ng H2A.Z1-2 MO2. These embryos were 
allowed to develop to mid-gastrulation (stage 10.5/11) and were then fixed. WISH was performed 
on the embryos using an Xbra probe (C.). The expression of Xbra in control embryos was seen in 
the mesoderm at normal levels. In H2A.Z1 MO2 injected embryos, there was a significant 
decrease in Xbra expression. The numbers in C indicate how many embryos looked like those in 
the picture. 
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Given that the 5’UTRs of both H2A.Z1 mRNAs are different and the ORFs are nearly identical to 
H2A.Z2, it was necessary to design two additional MOs further into the 5’UTRs for H2A.Z1-1 
(Figure 6.19A) and H2A.Z1-2 (Figure 6.19B).  
 
To determine if the secondary MOs (MO2) had the same effect on Xbra expression as the original 
H2A.Z1 MOs, 20ng of H2A.Z1-1 MO2 and 20ng of H2A.Z1-2 MO2 were co-injected into embryos, 
alongside embryos from the same frog injected with 40ng SC MO. These embryos were allowed to 
develop to mid-gastrulation and WISH was then performed using an Xbra probe (Figure 6.19C). 
The expression of Xbra in both sets of embryos was seen in the involuting mesoderm surrounding 
the blastopore. The expression in the majority of the H2A.Z1 MO2 injected embryos however was 
decreased to a similar level seen with the original knock down. 
 
Together, these results confirm the specificity of the H2A.Z1 MOs and strongly suggest that the 
observed phenotypes are due to the loss of the histone variant H2A.Z1. To understand the role of 
H2A.Z1 within each germ layer in further detail, quantitative analysis was performed. 
 
6.6 H2A.Z1 Acts on Specific Genes, Not Germ Layers 
 
6.6.1 Quantitative Data Reveal that the Loss of H2A.Z1 Affects Specific Genes Not Germ Layers 
Since the loss of H2A.Z1 from X. laevis embryos appeared to affect only tissues derived from the 
ectoderm and mesoderm, but not those from the endoderm, quantitative PCR to determine 
mRNA levels was performed on two genes from each germ layer and two genes that are 
expressed in more than one germ layer (Figure 6.20). 
 
The SC MO and H2A.Z1 MOs were injected into fertilised eggs from a single female X. laevis and 
were allowed to develop to the two-cell stage. Half of the embryos injected with the H2A.Z1 MOs 
were also injected with 1ng of the H2A.Z1 mRNA into both cells of the two-cell embryos. When 
the embryos had reached mid-gastrulation, 10 embryos from each set of injections were collected 
and total RNA was purified for qRT-PCR. mRNAs involved in the early specification of the 
ectoderm (Figure 6.20A), mesoderm (Figure 6.20B) and endoderm (Figure 6.20C) were amplified, 
as well as genes that are expressed in multiple germ layers (Figure 6.20D) and ODC as a reference 
gene. The threshold cycle (Ct) values for each PCR were normalised to the reference expression of 
ODC.  
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Figure 6.20 – Quantitative RT-PCR analysis of germ layer-specific and multiple germ layer 
markers in morphant and rescue embryos. 
Fertilised eggs from a single female were injected with SC MO or H2A.Z1 MOs, and incubated at 
18oC for 2 hours. Half of the embryos injected with the H2A.Z1 MOs were also injected with 1ng 
of H2A.Z1 mRNA into each cell of the two-cell stage embryos. All of the embryos were allowed to 
develop to stage 10.5/11 and total RNA was purified from 10 embryos for all conditions. 
Quantitative RT-PCR was performed on specific markers of the ectoderm (A.), mesoderm (B.) and 
endoderm (C.), and also markers that are expressed in more than one germ layer (D.). The 
threshold cycle (Ct) value for each PCR was normalised to ODC expression. The ΔΔCt method was 
used to calculate the fold changes in expression in morphant and rescue embryos in relation to 
the control expression levels (1.0 = control expression level). The fold changes from at least three 
biological replicates were averaged and plotted with the standard deviations indicated by the 
error bars. In morphant embryos, there was a decrease in the amount of FoxI1 expression, which 
greatly increased with the co-injection of H2A.Z1 mRNA. The expression of Ectodermin was 
increased only very slightly in both morphant and rescue embryos (A.). The expression of Xbra in 
H2A.Z1 MO injected embryos was decreased but was observed to increase in rescue embryos. 
Eomesodermin expression was seen to increase slightly in both morphant and rescue embryos 
(B.). The expression of Sox17β was unaffected in embryos injected with the H2A.Z1 MOs but the 
co-injection of H2A.Z1 mRNA resulted in a large increase in expression (C.). In both morphant and 
rescue embryos, decreases in the expression of Gata2 and FoxC1 were detected, although there 
was an increased expression in the rescue embryos compared to the morphants (D.).  
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The fold changes in expression in morphant and rescue embryos were calculated with respect to 
the expression levels determined in the control embryos using the ΔΔCt method. The effects of 
the loss and reintroduction of H2A.Z1 were not consistent over each separate germ layer. The 
expression of FoxI1 in the ectoderm was decreased in morphant embryos and increased in the 
rescues. The expression of another ectodermal marker, Ectodermin, was however slightly 
increased in both morphant and control embryos. As previously shown by WISH, the loss of 
H2A.Z1 resulted in a decrease in Xbra expression, whereas the co-injection of H2A.Z1 mRNA 
increased this expression. Nevertheless, the expression of Eomesodermin was seen to slightly 
increase in both morphant and rescue embryos. Again, as previously shown by WISH, Sox17β 
expression was unaffected by the loss of H2A.Z1, although a large increase in expression was 
observed when the H2A.Z1 protein was reintroduced. The expression of Endodermin, on the other 
hand, was seen to decrease in morphant embryos but an increase in expression was still observed 
in the rescue embryos. The expressions of Gata2 and FoxC1 were both decreased in morphant 
and rescue embryos, though the expression of these two genes were closer to normal levels after 
the co-injection of H2A.Z1 mRNA. The up-regulation in expression observed for some of the genes 
assayed in the rescue embryos could, however, be due to an over-expression of H2A.Z1 above 
normal levels. 
 
These data indicate that at this stage of development, the loss of H2A.Z1 affects specific genes, 
independent of the germ layer they are expressed in. To further test this, WISH was performed at 
the late tailbud stage using markers of endodermally derived tissues. 
 
6.6.2 Endoderm Markers are Down-Regulated in H2A.Z1 Morphant Embryos 
Since it appeared that specific genes, and not germ layers, were affected by the H2A.Z1 knock 
down, further WISH analysis was performed using two markers of the liver to test whether the 
loss of H2A.Z1 also down-regulated genes expressed in endodermally derived tissue at a later 
stage of development (Figure 6.21), which had not been observed for Hex (Figure 6.7F) 
 
Embryos from a single female frog were injected with either the SC MO or the H2A.Z1 MOs, and 
were allowed to develop to the late tailbud stage. WISH was performed on these embryos using 
markers of Gata4 and XEH1 expression. The expression of Gata4 in the SC MO injected embryos 
was seen in the liver primordium (red arrow in Figure 6.21A) and also in the myocardium (black 
arrow in Figure 6.21A).  
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Figure 6.21 – Wholemount in situ hybridisation analysis of Gata4 and XEH1 expression in SC and 
H2A.Z1 MO-injected embryos.  
Embryos from a single female X. laevis were injected with either the SC MO (A. and C.) or the 
H2A.Z1 MOs (B. and D.). The embryos were allowed to develop to the late tailbud stage and were 
then fixed. WISH was performed on these embryos using Gata4 (A. and B.) and XEH1 (C. and D.) 
probes. In stage 31 control embryos (A.), Gata4 expression was observed in the myocardium (mc) 
and liver primordium (lp). The expression of Gata4 was also seen in the myocardium of morphant 
embryos at stage 29/30 (B.), at a similar level to the controls (compare black arrows in A. and B.). 
Gata4 expression in the liver primordium of H2A.Z1 MO injected embryos was slightly decreased 
(compare red arrows in A. and B.). XEH1 expression was detected in the liver diverticulum of 
embryos injected with SC MO (C.) and H2A.Z1 MOs (D.) at stage 28 and stage 29/30, respectively. 
The expression of XEH1 was severely reduced in the morphant embryos. The numbers in A, B, C 
and indicate how many embryos looked like those in the pictures. 
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In the embryos lacking H2A.Z1, Gata4 was consistently expressed in the myocardium at a similar 
level to the controls, however, the expression in the liver primordium was decreased (Figure 
6.21B). In control embryos, XEH1 expression was always observed in the liver diverticulum (Figure 
6.21C). Although the expression of XEH1 was detected in the same region in the morphant 
embryos, the expression level was severely reduced in the majority of these embryos (Figure 
6.21D). These results further suggested a role of the histone variant, H2A.Z1, in the regulation of 
specific genes rather than having activity in specific germ layers.  
 
6.7 Discussion 
 
6.7.1 Loss of Function 
In a previous study in X. laevis, the decreased expression of H2A.Z1 caused defects during 
gastrulation, resulting in embryos with shortened trunks and a failure of the blastopore to close 
(Ridgway et al., 2004). Although H2A.Z1 was specifically targeted in this study, using RNAi only 
resulted in a 20-30% reduction of H2A.Z1 mRNA. Furthermore, the use of antisense RNA has been 
shown to cause widespread effects that are sequence independent in both Xenopus (Heasman, 
2002) and zebrafish (Oates et al., 2000). Therefore, the aim of the work presented here was to 
further investigate the role of H2A.Z1 during early X. laevis development, through a loss of 
function study making use of the less toxic morpholino oligonucleotides (Eisen and Smith, 2008) in 
order to gain a better understanding of the functions of this histone variant. To accomplish this 
aim, two morpholino oligonucleotides were designed to target the 5’UTRs of both the H2A.Z1-1 
and H2A.Z1-2 alloalleles, since the ORFs of H2A.Z1 and H2A.Z2 share very high sequence identity. 
 
The MO-mediated knock down of H2A.Z1 resulted in morphologies similar to but less severe than 
previous observations in X. laevis (Ridgway et al., 2004). Embryos injected with the H2A.Z1 
morpholino oligonucleotides all displayed delayed development and a loss of movement. 
Increasing concentrations of H2A.Z1 MOs led to more severe affects on development. Over half of 
the embryos injected with 10ng each of H2A.Z1-1 MO and H2A.Z1-2 MO exhibited movement 
defects. Whereas, injections of 20ng of each H2A.Z1 MO caused complete paralysis in around 75% 
of the morphant embryos, which also displayed A-P axis and anterior defects. Only 25% of the 
embryos injected with 40ng each of the H2A.Z1 MOs survived and those that did showed severe 
morphological defects. It has previously been shown in X. laevis that 40ng injections of a GFP MO 
resulted in 45% of embryos displaying developmental abnormalities, suggesting that at this 
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concentration the MO has off-target effects (Nutt et al., 2001). Normal development was 
observed in all of the surviving embryos injected with equivalent amounts of the standard control 
MO however, indicating that the morphological defects seen in the morphant embryos were due 
to a loss of H2A.Z1. 
 
As well as an increase in the severity of the morphologies observed in embryos injected with the 
H2A.Z1 MOs, the mortality rates for these embryos also rose; from 15% with 10ng of each MO, to 
25% with 20ng each, and 75% with 40ng of each MO. In the control embryos however, the 
mortality rate only reached around 25% with injections of 80ng of SC MO. Together these results 
suggested that H2A.Z1 plays an important role in X. laevis development, and at least a low level of 
H2A.Z1 expression is required for the survival of these embryos. 
 
Since MOs do not degrade the mRNA they are targeted to, the ability of the MO to bind to the 
target mRNA needs to be confirmed through protein analysis. As discovered in a previous study, 
commercial H2A.Z antibodies are unable to distinguish between the two H2A.Z isoforms (Matsuda 
et al., 2010). Therefore, immunoblotting of a FLAG-tagged version of the H2A.Z1 protein was used 
to assess the ability of the MOs to bind to their target sequences. Since the two H2A.Z1 MOs were 
designed to target the 5’UTRs of both H2A.Z1 alloalleles, primers were designed to amplify these 
regions from H2A.Z1-1 and H2A.Z1-2, each followed by the FLAG-tag DNA sequence, however, it 
was not possible to amplify the H2A.Z1-1 5’UTR. One suggestion for this could be that H2A.Z1-1 is 
expressed at a much lower level than H2A.Z1-2 during early X. laevis development. In support of 
this theory, the primers designed to amplify the ORF of H2A.Z1-1 were found to amplify the ORF 
of H2A.Z1-2 after the DNA was sequenced. This could also be due to the near identical ORF 
sequences however, since both mRNAs encode exactly the same protein. 
 
After the construct containing the H2A.Z1-2 5’UTR followed by the FLAG-tag sequence and 
H2A.Z1-2 ORF was cloned and successfully transcribed. It was shown that the FLAG-H2A.Z1 mRNA 
was translated within X. laevis embryos, in a dose-dependent manner. Although only the H2A.Z1-
2 MO target was present, the co-injection of 40ng of the H2A.Z1 MOs caused a significant 
decrease in the expression of the FLAG-H2A.Z1 protein. These results indicated that at least one 
of the H2A.Z1 MOs was able to bind to and inhibit the translation of protein from an exogenous 
mRNA. One limitation of this approach however, is that it does not guarantee that the MO will 
effectively inhibit the expression of the endogenous mRNA (Eisen and Smith, 2008). 
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To date, it has been shown that H2A.Z is one of the few histone variants required for survival (van 
Daal and Elgin, 1992, Liu et al., 1996, Faast et al., 2001). Although there is only one H2A.Z protein 
in protozoans and fruit flies, this histone variant is essential for the survival of both of these 
organisms (van Daal and Elgin, 1992). H2A.Z has also shown to be crucial for early mouse 
development (Faast et al., 2001), however, in this study only H2A.Z1 was knocked out. This 
suggests that H2A.Z2 is unable to compensate for the loss of H2A.Z1. Since both H2A.Z1 and 
H2A.Z2 (see Chapter 5) were seen to be essential for normal X. laevis development but not lethal, 
a MO targeted against the first 25 bases of all four of the H2A.Z ORFs in X. laevis was injected into 
embryos (not shown). As expected, embryos lacking both isoforms of H2A.Z died. This did not 
occur until the end of neurulation however, suggesting the maternal proteins of either or both 
isoforms persist until this stage of development. Together the results in this study indicate that in 
X. laevis, both H2A.Z isoforms are essential for embryonic survival. Furthermore, in agreement 
with previous work in mammalian development (Faast et al., 2001), it would appear that the 
neither H2A.Z1 nor H2A.Z2 is able to compensate for the loss of the other isoform, suggesting 
separate, essential roles for both of these histone variants. 
 
6.7.2 Phenotypic Analysis 
The loss of H2A.Z1 resulted in the abnormal development of several tissues. These appeared to be 
caused by a defect in ectoderm and mesoderm specification but not endoderm specification 
during gastrulation. Consistent with these observations, although expressed throughout 
development, a peak in H2A.Z1 expression was observed around the gastrula and early neurula 
stages (Figure 6.22), and its expression was observed in the ectodermal and mesodermal regions 
at gastrulation (Figure 3.9D). 
 
The loss of H2A.Z1 resulted in a decrease in Slug, NST and Runx1 expression, indicating a 
reduction of premigratory neural crest cells (Carl et al., 1999), primary neurons (Oschwald et al., 
1991) and neuroblasts (Tracey et al., 1998), respectively. Sox2 expression however, was observed 
at a similar level to that seen in the control embryos but over a larger area of the neural plate. 
These results indicated that although neural progenitor cells (Graham et al., 2003) were present in 
the morphant embryos, further differentiation of the neural tissues was not occurring normally. In 
agreement with a role of H2A.Z1 in neural development, this histone variant was previously 
identified in an expression cloning screen in X. laevis, which was seen to cause neural 
mispatterning when over-expressed (Dichmann et al., 2008); however, no further characterisation 
of this phenotype was performed. 
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Figure 6.22 – mRNA expression level of H2A.Z1.  
RT-PCR was performed from RNA purified from embryos at ten different stages over the course of 
early development from a single X. laevis female. RT-PCR was used to amplify the 5’UTR of H2A.Z1 
mRNA (black arrow in A.) and the ODC mRNA (red arrow in A.), which was used as a loading 
control. The expression level of H2A.Z1 is given by its ratio to the ODC level, the expression of 
ODC assumed to be constant. The expression of H2A.Z1 mRNA was detectable throughout 
development, with an increase around gastrulation and neurulation (stage 11-22). Yanai and 
colleagues (2011) quantified the mRNA levels of H2A.Z1 by spiking RNA extracted from X. laevis 
and X. tropicalis with heterologous RNA at known concentrations, and then hybridising these 
samples to microarrays (B.). Their expression data is given in log10 units of relative mRNA 
expression. Both data sets indicate an increase in H2A.Z1 mRNA during gastrulation and 
neurulation. 
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A decrease in the expression of genes in a number of other tissues was also observed in embryos 
lacking the H2A.Z1 histone variant. The patterning of the somites in the anterior halves of the 
morphant embryos were disordered, as shown by the mRNA expression of the somite-specific gap 
junction protein, gja3 (De Boer et al., 2005). Furthermore, the expression of this gene was almost 
completely abolished in the posterior regions of these embryos, suggesting a loss of muscle 
differentiation and tissue is caused by the H2A.Z1 knock down.  
 
A loss of H2A.Z1 also appeared to cause a severe defect in embryonic blood formation, as 
indicated by the decrease in LMO2 expression (Mead et al., 2001). It is likely that this was caused 
by an almost complete loss of haemangioblasts earlier in development (Tracey et al., 1998), as 
indicated by the loss of Runx1 expression. This decrease in haemangioblasts was also likely to 
have caused the decrease in the vasculature marker, Erg1, since the angioblasts, the vasculature 
precursor cells, originate from the haemangioblasts (Soufi and Jayaraman, 2008). 
 
As well as defects in neural, muscle and blood development, the loss of H2A.Z1 also resulted in a 
loss of kidney and heart tissue. Analysis of Hex expression however, indicated that the 
development of the liver was normal in morphant embryos. Since the liver originates from the 
endoderm, unlike the other affected tissues, which are derived from the ectoderm and mesoderm 
(Gilbert, 2006), these results suggested that defects in the specification of the germ layers may be 
occurring when H2A.Z1 was lost. Results supporting this hypothesis were generated when 
analysing the expression of gene markers for each germ layer.  
 
In X. laevis, induction and patterning of the three germ layers occurs at gastrulation. FoxC1 is 
normally expressed in ectodermal and mesodermal cells at the gastrula stage (Cha et al., 2007). 
When H2A.Z1 was depleted however, a slight reduction of FoxC1 expression in the ectoderm was 
observed but expression in the mesoderm was completely lost. In addition, the loss of H2A.Z1 also 
results in a significant decrease in the expression of Xbra, a gene essential for the development of 
mesoderm (Smith et al., 1991). Conversely, one of the first genes expressed in the endoderm after 
the MBT, Sox17β (Howard et al., 2007), remained unaffected in the morphant embryos. Although 
it initially appeared that only the ectoderm and mesoderm specification was abnormal in embryos 
lacking H2A.Z1 and the specification of the endoderm was normal, it was later discovered that 
H2A.Z1 appears to affect individual genes rather than specific germ layers. The genes affected at 
this early stage of development however, would have considerable downstream affects on the 
growth of these embryos. 
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6.7.3 Mesoderm Induction Analysis 
The Xenopus homologue of the Brachyury gene, Xbra, plays a crucial role in the normal formation 
of the mesoderm (Smith et al., 1991). Losses of neural tube differentiation and mesoderm 
posterior to somite 7 are characteristic phenotypes of a Brachyury mutation (Smith, 2001). To a 
lesser degree, these phenotypes were observed after H2A.Z1 was inhibited in X. laevis embryos, 
which was likely due to a decrease in Xbra expression. Since FoxC1, which is required for 
mesoderm maintenance (Cha et al., 2007), was also down-regulated in these morphant embryos, 
it was hypothesised that the process of mesoderm induction was defective when H2A.Z1 was 
knocked down. Although no expression analysis was performed, H2A.Z has previously been linked 
to mesoderm formation in X. laevis (Ridgway et al., 2004). The data presented here show a direct 
link of this histone variant with mesoderm induction. 
 
The instigator of mesoderm induction is the maternal, vegetally located transcription factor, VegT 
(Zhang et al., 1998). At the MBT, VegT directly activates the expression of signalling molecules, 
which, in turn, activate the TGFβ and FGF signalling pathways that are essential for the 
specification of mesodermal tissue (Heasman, 2006). It has previously been shown that exposing 
the explanted prospective ectoderm tissue of the animal cap to a member of the TGFβ family, 
activin, results in the expression of Xbra and an elongation of the tissue (Smith et al., 1991). In 
animal caps dissected from embryos where the expression of H2A.Z1 had been inhibited, the 
exposure to activin A only led to a slight extension of this tissue. It is interesting to note that an 
increased concentration of activin A resulted in less elongation in both the control and H2A.Z1-
deficient caps, since the response of Xbra to activin is strictly concentration dependent (Green et 
al., 1992). Furthermore, through the use of Nieuwkoop conjugates (Smith, 2009), the endogenous 
signalling capability of the morphant vegetal hemispheres were shown to induce a high level of 
Xbra expression in control animal caps, yet only a small amount of expression in animal caps with 
decreased H2A.Z1 levels. Therefore, the functions of these signalling molecules were shown to be 
unaffected in embryos with decreased H2A.Z1 expression, suggesting that the defect in 
mesoderm induction lay further downstream. 
 
The expression of the TGFβ and FGF families of mesoderm inducing factors at the late blastula 
stages activate intra-cellular signal transduction pathways that lead to the transcriptional 
activation of many genes, including Xbra (Heasman, 2006). The TGFβ and FGF pathways result in 
the phosphorylation of Smad2 and MAP kinase, respectively, which are then translocated into the 
nucleus where they activate their target transcription factors. The phosphorylation of both of 
these proteins was shown to occur in control and morphant embryos at indistinguishable levels. 
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These phosphorylation events were not observed until the start of gastrulation since these 
proteins are inactive up until the MBT (Heasman, 2006). Since both the extra- and intra-cellular 
mesoderm induction signals were unaffected by the loss of H2A.Z1, it was hypothesised that this 
histone variant was directly regulating the expression of Xbra at the epigenetic level.  
 
Chromatin immunoprecipitation (ChIP) was performed using antibodies against acetylated H2A.Z 
and dimethylated lysine 4 of histone H3, since these modifications are known to occur at the 
transcriptional start sites of genes (Bruce et al., 2005, Barski et al., 2007). Since the α-AcH2A.Z 
antibody was unable to differentiate between the two H2A.Z isoforms, cross-linked chromatin 
from control and morphant embryos was used in these experiments.  Therefore, if the amount of 
AcH2A.Z was decreased at a specific promoter in the morphant embryos compared to the same 
loci in the controls, this would indicate that the acetylated form of H2A.Z1 was located at this 
particular region. Following quantitative analysis of the ChIP samples, it was shown that 
acetylated H2A.Z1 was located at the promoters of Xbra, Gata2 and globin, but depleted at the 
Sox17β promoter. The location of H2A.Z1 at the Xbra promoter and its absence from the Sox17β 
promoter correlated with the previous results obtained, since the expression of Xbra was down-
regulated when H2A.Z1 was lost but Sox17β was unaffected. Together with what is already known 
about the involvement of AcH2A.Z in transcriptional regulation (Bruce et al., 2005, Barski et al., 
2007); these results indicate that H2A.Z1 in its acetylated form is able, in part, to directly regulate 
the expression of certain genes. In addition, the expression of Gata2 was later shown to be 
affected by the loss of H2A.Z1 (see 6.6.1). Since AcH2A.Z1 was located at the promoter of this 
gene, this result further suggests an involvement of H2A.Z1 in gene activation. Although these 
experiments only involved the analysis of four different loci, it would be possible to perform a 
genome wide investigation of the occupancy of AcH2A.Z1 by using ChIP combined with 
microarray analysis or high-throughput sequencing to gain a better understanding of the role this 
histone variant plays at promoters. 
 
The post-translational modification of histone H3, H3K4me2, was detected at the promoters of 
each gene amplified. The location of H3K4me2 at the promoters of Xbra, Gata2 and Sox17β was 
expected since these genes were active at the stage of development assayed. Enrichment of both 
H3K4me2 and AcH2A.Z at the globin promoter however, was unexpected since the globin gene 
would not have been active at this stage of development (Walmsley et al., 1994), suggesting that 
this gene was poised for activation (Guillemette and Gaudreau, 2006). Interestingly, when the 
expression of H2A.Z1 was decreased, the presence of H3K4me2 was further enriched at each of 
the promoter regions investigated. This finding indicates that the deposition of this post-
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translational modification is increased potentially to compensate for the loss of H2A.Z1. Since the 
inhibition of H2A.Z1 causes an increase in H3K4me2, it would be interesting to investigate the 
occupancy of other histone PTMs at these promoters to determine the effects that a loss of 
H2A.Z1 has on the chromatin landscape at these regions. Furthermore, it would also be of interest 
to determine the localisation of H3.3 before and after H2A.Z1 knock down, since both of these 
histone variants have recently been implicated in gene activation, and both H2A.Z1 and H3.3 co-
localise at the transcriptional start sites of genes (Jin et al., 2009). 
 
6.7.4 MO Specificity Controls 
As stated earlier, Eisen and Smith published a set of controls to ensure the specificity of 
morpholino-mediated knock down experiments (Eisen and Smith, 2008). Though the H2A.Z1 MOs 
were shown to be able to bind to and inhibit exogenous mRNA, the specificity of these 
morpholino oligonucleotides were confirmed by performing rescue experiments and using second 
non-overlapping MOs.  
 
A rescue construct was cloned containing the H2A.Z1-2 ORF flanked by the 5’ and 3’ UTRs from X. 
laevis β-globin mRNA and was shown to be successfully translated in embryos. Since the majority 
of both H2A.Z1 MOs were targeted against the 5’UTRs of H2A.Z1-1 and H2A.Z1-2, the MOs would 
not bind to this mRNA and therefore, the H2A.Z1 protein would be reintroduced back into the 
morphant embryos. A previous study discovered that the morphology caused by the inhibition of 
H2A.Z1 expression using RNAi was partially rescued by injecting 1ng of mouse H2A.Z1 mRNA 
(Ridgway et al., 2004). Therefore, both cells of two-cell stage morphant embryos were injected 
with 1ng of H2A.Z1 mRNA to ensure complete recovery. This resulted in the majority of embryos 
having normal morphology, developmental timing and the ability to move compared to the 
morphant embryos that all had morphological defects, and were developmentally retarded and 
paralysed. Since only five embryos were co-injected with the H2A.Z1 MOs and mRNA, it would be 
necessary to repeat this rescue experiment with a larger sample population to confirm the 
specificity of the MO further. 
 
Since the loss of H2A.Z1 down-regulated Xbra expression and acetylated H2A.Z was present at the 
Xbra promoter, the effect of reintroducing the H2A.Z1 protein into morphant embryos on Xbra 
expression was investigated. Co-injection of H2A.Z1 mRNA into two cells of four-cell stage 
morphant embryos, along with a lineage tracer was performed. The expression of Xbra returned 
to normal where the mRNA had been injected, whereas a decrease in expression was seen in the 
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halves lacking H2A.Z1. Although the reintroduction of H2A.Z1 rescued normal Xbra expression, 
since the acetylated form of H2A.Z1 was detected at the Xbra promoter, it is not known whether 
this modification is required for gene activation in X. laevis, as has previous been found in chicken 
(Bruce et al., 2005). Therefore, to determine if this PTM is important, it would be possible to 
perform rescue experiments with mutated forms of the H2A.Z1 mRNA; one where the N-terminal 
lysines are mutated to glutamines to mimic acetylation (Wang and Hayes, 2008), and another 
where the lysines are mutated to arginines, an amino acid similar to lysine that is not acetylated. 
 
To test the specificity of the H2A.Z1 knock down, an additional set of morpholino oligonucleotides 
were designed to target non-overlapping regions of the H2A.Z1-1 and H2A.Z1-2 5’UTRs. WISH was 
used to determine the effect of these secondary H2A.Z1 MOs on Xbra expression, since there was 
substantial evidence for a role of H2A.Z1 in the regulation of this gene. The decreased expression 
of Xbra seen with the first set of H2A.Z1 MOs was also observed when using the second set of 
MOs, therefore, confirming the ability of the morpholino oligonucleotides to specifically inhibit 
H2A.Z1. These results, together with the previous observations made in this study, provide strong 
evidence to state confidently that H2A.Z1 is involved in the regulation of Xbra expression, through 
its occupancy at the Xbra promoter. 
 
6.7.5 Quantitative Results 
The inhibition of H2A.Z1 in X. laevis embryos caused a loss of Xbra expression that led to a defect 
in mesoderm induction. Restoring the levels of H2A.Z1 protein rescued the expression of Xbra, 
resulting in the normal development of these embryos. Therefore, the effects of the loss and the 
reintroduction of H2A.Z1 on other important genes involved in germ layer specification were 
analysed. 
 
FoxI1 and Ectodermin are expressed specifically in the ectoderm of X. laevis embryos at the 
gastrula stage and are essential for the specification of ectodermal tissue (Dupont et al., 2005, 
Suri et al., 2005). When H2A.Z1 was knocked down, the expression of FoxI1 was decreased but 
Ectodermin was slightly increased. Co-injection of H2A.Z1 mRNA rescued the expression of FoxI1 
but caused a further increase in Ectodermin expression. Although these ectodermal genes are 
differentially affected by H2A.Z1, these results correlated with the morphant phenotypes. FoxI1 
activates ectodermal specification (Mir et al., 2007), whereas Ectodermin inhibits mesoderm 
induction (Dupont et al., 2005). Therefore, a decrease in FoxI1 expression would cause a 
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reduction in ectodermal tissue and an increase in Ectodermin would cause a loss of mesodermal 
tissue. 
 
The expression of Xbra and Eomesodermin occur in the mesoderm and both are required for 
mesodermal specification (Smith et al., 1991, Ryan et al., 1996). As expected, the expression of 
Xbra was down-regulated when H2A.Z1 was inhibited and increased on the reintroduction of 
H2A.Z1. Eomesodermin expression however, increased slightly in morphant embryos and a further 
increase was observed after co-injection of the H2A.Z1 mRNA. Eomesodermin is expressed earlier 
than Xbra and is thought to be involved in activating Xbra expression (Ryan et al., 1996). 
Therefore, the increase in Eomesodermin expression could potentially cause an increase in 
mesoderm induction. Since H2A.Z1 is directly involved in the regulation of Xbra however, the 
decrease in Xbra expression resulted in a loss of mesodermal tissue. 
 
Both Sox17β and Endodermin are expressed in the endoderm of gastrula stage embryos and are 
required for the specification of endodermal tissues (Sasai et al., 1996, Hudson et al., 1997). The 
expression of Sox17β was unaffected by the loss of H2A.Z1 but its expression was increased when 
H2A.Z1 was reintroduced. Endodermin expression however, was decreased when H2A.Z1 was 
knocked down and its expression was restored in rescue embryos. Although Sox17β expression 
was unaffected by the loss of H2A.Z1, as also seen with WISH, this transcription factor activates 
Endodermin (Hudson et al., 1997). Therefore, these results indicate that the H2A.Z1 knock down 
affects endodermal tissue but downstream of Sox17β. The finding that H2A.Z1 affects endoderm 
specification at the gastrula stage was further confirmed by the loss of Gata4 and XEH1 in the liver 
primordium and diverticulum, respectively, in morphant embryos at the late tadpole stage. 
 
At gastrulation, Gata2 is expressed in the ectoderm and at a lower level in the mesoderm 
(Walmsley et al., 1994) and is required for haematopoiesis (Dalgin et al., 2007). When H2A.Z1 was 
knocked down, the expression of Gata2 decreased. Although this expression was not completely 
rescued by co-injecting H2A.Z1 mRNA into these embryos, the expression level was closer to 
normal than in the morphant embryos. The finding that Gata2 was reduced in the morphants is 
consistent with the defect in blood development observed in these embryos, since the loss of 
Gata2 has previously been shown to severely reduce LMO2 expression (Kroll and Amaya, 1996). 
Given that the level of Gata2 expression remained low in rescue embryos, it would be interesting 
to determine if blood development was returned to normal in these embryos. Furthermore, to 
determine when blood development is affected by the loss of H2A.Z1, the expression of Fli1 could 
be analysed since Gata2 is activated by Fli1 (Kroll and Amaya, 1996). 
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FoxC1 expression is located in the mesoderm and at a lower level in the ectoderm and is required 
for the maintenance of adhesion in mesodermal tissue (Cha et al., 2007). In both morphant and 
rescue embryos, the expression of FoxC1 was decreased compared to control embryo expression 
levels. Reintroducing H2A.Z1 back into morphant embryos however, caused a slight recovery of 
expression. Although a loss of FoxC1 has been shown to increase apoptosis in the mesoderm (Cha 
et al., 2007), rescue embryos have normal morphology suggesting no abnormalities in 
mesodermal tissue. It is interesting to note that FoxC1 expression is activated by VegT-induced 
TGFβ signalling (Cha et al., 2007), which was shown to be normal in embryos lacking H2A.Z1. 
Therefore, it could be possible that other factors are involved in the activation and/or 
maintenance of the FoxC1 expression. 
 
It is likely that the injection of the H2A.Z1 mRNA into the morphant embryos caused an increase 
in H2A.Z1 protein above normal levels. This excess of H2A.Z1 could integrate into chromatin at 
random sites, which could account for the increased expression above normal levels of some of 
the genes tested here. It would therefore be possible to perform gain of function analysis, 
whereby the H2A.Z1 mRNA could be injected into embryos to determine if the over-expression of 
H2A.Z1 causes further increases in these genes and to investigate the effects on early X. laevis 
development. 
 
In yeast, H2A.Z has been found at 63% of promoters (Guillemette and Gaudreau, 2006), it would 
therefore appear that not all genes are regulated by H2A.Z1. Since only a small subset of genes 
have been analysed here, it would be possible to dissect blastula stage control and morphant 
embryos into animal cap, marginal zone and vegetal pole regions, and perform transcriptome 
analysis to gain a more in-depth understanding of the roles H2A.Z1 plays within each germ layer. 
 
During early X. laevis development, it has been shown that the H2A.Z isoform, H2A.Z1, is required 
for the correct expression of a number of genes, and it has been shown to regulate the expression 
of Xbra at the epigenetic level specifically. These results together with the observations made in 
the previous chapter, indicate that both H2A.Z1 and H2A.Z2 have distinct roles in X. laevis and 
both are necessary for normal development, which has previously been unreported. It is 
therefore likely that these two H2A.Z isoforms have acquired separate functions throughout the 
course of vertebrate evolution, which could contribute to the literature describing the diverse 
roles of H2A.Z in higher organisms. 
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7. Final Discussion and Future Work 
 
The principal aim of this study was to investigate the functions of the histone variant H2A.Z and 
two potential histone modifying proteins, hnRNP AB and hnRNP D, during the early development 
of X. laevis. More specifically, the aim was to identify genes that are regulated by these chromatin 
components in order to further understanding of gene regulation at the epigenetic level during 
vertebrate embryogenesis. 
 
In order to achieve these aims, mRNA expression analysis was performed for several histone 
variants in X. laevis, and for hnRNP AB and hnRNP D to determine the spatial and temporal 
expression of each transcript throughout early development. The expression of two isoforms of 
the histone variant, H2A.Z, and the two hnRNP proteins were inhibited to investigate how the loss 
of each of these proteins affected the developing embryos. The main results from these 
experiments are summarised below. 
 
The localisation of 14 histone variant mRNA transcripts has been characterised throughout early 
development: the majority of these were predominantly expressed in anterior and neural tissues. 
These expression patterns correlate with the expression of several cyclins and cdks (Vernon and 
Philpott, 2003) that are required for cell cycle progression, and the phosphorylation of histone H3, 
which marks mitotic cells (Saka and Smith, 2001). Therefore, the expression of these histone 
variants appears to occur mainly in actively proliferating cells.  
 
The hnRNP AB and hnRNP D transcripts were also expressed in anterior and neural tissues regions 
throughout early development, and a knockdown in the expression of either protein resulted in 
defects in neural development. The loss of hnRNP AB caused an increase in Sox2 expression, an 
over-expression of which has previously been shown to reduce neural differentiation (Archer et 
al., 2011). Conversely, a knockdown of hnRNP D caused a decrease in Sox2 expression, which 
would have resulted in a loss of neural progenitors (Graham et al., 2003). Furthermore, muscle 
development appeared to be affected by both knockdowns and blood differentiation was 
inhibited by the loss of hnRNP D.  
 
Knockdown of H2A.Z2 resulted in a significant increase in the number of primary neurons without 
affecting the development of other tissues, and this increase appeared to be caused by a down-
regulation of Notch expression, which returned to normal levels when a rescue was performed. 
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The loss of H2A.Z1 however, caused more global problems. H2A.Z1 morphants had defects in a 
number of tissues, which appeared to be caused by a mis-expression of a number of genes. 
Furthermore, Xbra expression was down-regulated by the loss of H2A.Z1, which resulted in an 
inhibition of mesoderm induction. The specificity of these findings was confirmed for both 
isoforms through rescue experiments. However, only the phenotype of the H2A.Z1 morphants 
was copied using a second morpholino. 
 
7.1 Future Work 
 
Since the expression analysis performed in this thesis started at the MBT, the point at which the 
zygotic genome is activated (Newport and Kirschner, 1982), to determine if any of the histone 
variants are expressed maternally, RNA analysis could be performed in younger embryos and 
oocytes using either WISH or RT-PCR. Furthermore, qRT-PCR could be used to quantify the 
amounts of each transcript throughout early development. Also, since the expression patterns of 
the histone variants and hnRNPs appeared similar, the stained embryos could be sectioned to test 
whether there are any internal differences in the expression of these transcripts.  
 
Although determining these expression patterns can give clues about the tissues in which these 
proteins function, it is important to note that the mRNA expression patterns and the protein 
localisation do not always correlate, since there are many mechanisms of translational control in 
Xenopus. Therefore, it would be useful to generate antibodies towards the histone variants and 
both hnRNP AB and hnRNP D, which could be used to determine the localisation of each protein 
throughout early development to see if this correlated with the mRNA expression, and also for 
further analytical techniques, such as Western blotting. 
 
These antibodies could also be used to detect protein levels in morphant embryos to confirm the 
specificity of the MOs. In the case of histone variants indistinguishable by immunoblotting, such 
as H2A.Z1 and H2A.Z2, a splice blocking MO could be used, the effect of which is easily detectable 
by RT-PCR. Further controls are needed to confirm the specificity of the hnRNP knockdowns, e.g. 
rescue experiments. Also, a second MO against H2A.Z2 would also need to be used to further 
ensure the specificity of these results. 
 
Since only a relatively small amount of genes have been analysed by WISH in this study, to 
determine the effects of these knockdowns on gene regulation on a global scale, transcriptome 
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analysis by RNA-Seq could be performed to gain a better understanding of the roles of these 
proteins during development.  Further experiments could also be performed to investigate the 
gene regulatory functions of H2A.Z1 and H2A.Z2 in greater detail. Using ChIP in conjunction with 
genomic sequencing would allow the genomic locations of these H2A.Z isoforms throughout the 
X.laevis genome to be determined. Additional ChIP experiments could also be used to determine 
which post-translational modifications of H2A.Z1 and H2A.Z2, and of other histones within close 
proximity, are present during the transcription of the affected genes since the post-translational 
modifications of histone variants are important for their function (Ausio, 2006). Furthermore, 
mutant rescue constructs could be used to knock out the modified residues in the N-terminal tails 
of these H2A.Z isoforms to further dissect the importance of these PTMs. 
 
In addition to investigating the functions of individual histone variants, it would also be useful to 
study the roles of combinations of modifications on histone variants, since H2A.Z and H3.3 were 
recently shown to co-localise in nucleosomes at active promoters, a situation suggested to 
facilitate nucleosome loss and transcriptional activation (Jin et al., 2009).  
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9. Appendices 
 
9.1 RT-PCR Primers 
 
9.1.1 RNA Probes 
Name Forward Primer Reverse Primer 
B4 ATG GCT CCT AAG AAG GCG G 
GTT TCT TTG CCG GAG CCT 
TG 
H1A 
ATG GCT GAA GCC GCC GAA TCC 
G 
GGC AGC AAC TTT GGG CTT G 
H1B 
ATG ACA GCT ACA ACT GAA ACC 
G 
CTT TGG GTT TGG CGA CTT 
TG 
H1C 
ATG GCT GAA ACT GCC TCA ACT 
G 
TTG GCT TTG GCT ATT TTG 
GG 
H1o-1 GAG CGA TAG CTC CAC AAA GC 
CAA GAT GCA AAG AGG CTG 
GT 
H1o-2 CAC AAA CAA ACA TTG CGC TC 
TTT CGG TGA AGC AAG AGG 
TT 
H1X ATG GCT CTA GAG CTG GAA GAG 
CGC TTT CTT GGA TTT AGG 
CG 
   
H2A.1 TGC AGT ATG TCA GGC AGA GG 
TCA TCG GAA CAT GAA CAG 
GA 
H2A.2 ACG GTG TAA AAT CGC CTT TG 
GGA TCC TAG AAG TCT CCG 
CC 
H2A.X ATG TCG GGC AGA GGA AAA G 
GTA TTC TTG CGA TTG CTG 
GG 
H2A.Z1 CTC TAT CAC CCG ATC CTC CA 
TGA CTC CAC CAC CAG CAA 
TA 
H2A.Z2 ATG GCT GGT GGA AAG GCT GG CCC TTC TTT CCA ATC AGA G 
mH2A1 GAC AAC AAA GAC CAC ACG G GAG TTC AGA GTT TGT CGG G 
mH2A2 AAG TGG CAT CCA GTT CAA CC 
AAG AGC TGG AAG CTG CAA 
AG 
   
H3.3 ATG AGC TGC CCA ATC ACC T 
TTG TGA GCT GTA GCT GCC 
TG 
CENPA CCA CTC CTC CAT CCC GCA GG CCC CAC GTA TCC GTC TGG 
   
H4 ATG TCT GGA CGC GGC AAA GG 
CTC CGA AGC CGT AGA GAG 
TG 
   
hnRNP AB ATG TCC GAC ACC GAG CAG CAG 
ACC ACC TCT GCC GCC ATA 
CTG 
hnRNP D GAT TTC TGA AGA CGA CGA AG 
TAT ATC CCT GGC TCC AGC 
TCT G 
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9.1.2 FLAG-Tag Constructs 
Name Forward Primer Reverse Primer 
H2A.Z1 5’UTR 
CTC GAG AGC TTG TGT TCG 
GGT 
GGA TCC AGC CGA CTT GTC 
ATC GTC ATC CTT GTA ATC 
CAT AGC CAT TTG TCT CAA 
H2A.Z1 ORF 
GGA TCC ATG GCT GGA GGC 
AAG GCT 
TCT AGA CTA GAC TGT TTT 
CTG CTG 
   
H2A.Z2 5’UTR 
CTC GAG AAA GCT AGG AGT 
GCG 
GGA TCC AGC CGA CTT GTC 
ATC GTC ATC CTT GTA ATC 
CAT GTT CCG GAG GTC CGC 
H2A.Z2 ORF 
GGA TCC ATG GCT GGT GGA 
AAG 
TCT AGA TTA TGC GGT TTT 
CTG 
 
 
9.2 Plasmid Maps 
 
9.2.1 pGEM-T Easy 
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9.2.2 pβUT2-Sfi1 
 
 
 
9.2.3 pCS2+ 
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9.3 Quantitative PCR Primers and Probes 
 
9.3.1 qRT-PCR 
Name Forward Primer Reverse Primer Probe 
ODC 
AAA AAG CAT GTG 
CGT TGG TTT 
TCG TTG CAT TTT 
ACG GCA TAA A 
AAG CGC TCC CCC 
GTG TCA CTC C 
Notch 
TGC AGG AAA ATG 
GAT CGG ATA 
CCC ACC GTT CAG 
GCA CAT 
CAC ACA AGG TCT 
TCG ATG CAC TCA 
GAC TG 
Gata2 
CAT TCA GGG CAC 
ATC TTG CA 
TTT ATC CCA TAG 
CCG TCA CCA T 
ACC CCG ACT CCC 
ATC CAC CCT TC 
FoxI1 
TTC AAT TCG ACA 
CAA CCT GTC TCT 
GCC CTT GCC TGG 
ATC ATC T 
AAT GAT TGC TTC 
AAG AAA GTA CCA 
AGA GAT 
Ectodermin 
GTG TCC CTG GTG 
GAA CTA ATG G 
TCA ATC TGC CTG 
CAT TCT TGT C 
TCC AGC AAG TTG 
GTG TAA TAA GGT 
GCC TAG TG 
Xbra 
GAC CTG TGG ACG 
AGG TTC AAG 
CGA CAT GCT CAC 
CTT CAG AAC T 
AGA TGA TCG TCA 
CCA AGA ATG GAA 
GAC GA 
Eomesodermin 
TTC CAC CGG CAC 
CAG ACT 
CCA GTG ATG TTG 
AAA CTG AGG AAA 
ACC AAG CAG GGC 
AGG AGG ATG TT 
Sox17β 
GAA CCC CGA CCT 
GCA CAA 
GGG CGT TTA GTT 
GCC AGA GTA A 
CAG CAA GAT GCT 
TGG TAA ATC ATG 
GAA ATC C 
Endodermin 
AGG TCA CGG ATA 
AAG AAG ATG ATA 
GC 
AGC GTG AGA TAG 
CCC ACC TCT A 
TGT CCC CTT CCA 
GAC TCC CAA GTT 
AGA CAA T 
FoxC1 
TGG CTG CCC CCA 
TGA G 
ATG GTG ATG AGA 
GCG ATG TAG CT 
AGC CTA TGG GCC 
CTA CAC CCC CCC 
 
9.3.2 ChIP-qPCR 
Name Forward Primer Reverse Primer Probe 
Xbra 
GGG TTT CTG TGC 
TCC AAT CAG 
GGT GCC AGG CAG 
CTC ATT 
TTG CCT CAC CAA 
CAT CAA AGA GAA 
AAC TGA C 
Gata2 
TCC CCC CCC TGC 
AAT C 
CTA ATT CAC TCC 
AAA CAG CAA AGA GT 
CAC CCA TAG TAA 
TAA GCC CCC TCC 
CTT CA 
Globin 
GAT GGA TGG AGA 
ATT AGA GCA CTT G 
GAC GAT CAT GTG 
CTG TCA AAC C 
TTT TTG CAG AAG 
CTC AGA ATA AAC 
GCT CAA CTT T 
Sox17β 
TTC CAT TAG GCC 
AGA CTT TAA CCT 
ATA ACT ACT GCC 
CCA GCC AAT C 
CCC GCT TAA TCT 
CTC CCA GTC CCA AC 
 
